data_2mm3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mm3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.29 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.57 117.846 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 1.08 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 1.37 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.65 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 1.05 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.72 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.92 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 2.4 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.24 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 3.18 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.67 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.479 ' CD ' ' HZ1' ' A' ' 19' ' ' LYS . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.26 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.11 114.504 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 2.33 112.294 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 1.12 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.8 112.448 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.4 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 1.1 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 1.09 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.6 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 1.27 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 1.08 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.79 109.192 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 1.17 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.87 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.09 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 3.69 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.98 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 1.17 117.559 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 1.49 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 1.09 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.41 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 1.05 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.74 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.16 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.68 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.45 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.85 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 1.13 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.36 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.65 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.74 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 1.31 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 . . . . . 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67 111.973 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 1.31 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.615 -0.513 . . . . 1.17 109.615 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 1.23 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.22 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 1.18 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.84 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 1.46 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.791 ' CE1' ' CD2' ' A' ' 47' ' ' PHE . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.33 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 1.05 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 1.57 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 2.03 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.89 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 1.22 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 1.06 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 2.56 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 1.14 116.688 -162.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.33 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.73 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 2.4 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 1.18 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.35 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 2.52 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 1.01 109.063 154.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 1.01 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 1.05 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.8 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 1.04 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.68 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 3.2 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 1.1 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 1.11 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 1.34 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.89 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26 105.199 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.65 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.89 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.89 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.42 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 1.04 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.28 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.67 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 1.09 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 1.28 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.71 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.3 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.73 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 1.29 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 1.53 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.07 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 1.06 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 1.04 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 1.01 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 1.1 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.29 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.22 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 1.04 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 1.05 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.29 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.98 108.462 -166.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 1.57 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.72 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 2.2 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.61 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 1.08 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.602 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.29 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.57 113.581 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 1.08 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 1.37 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.65 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' C ' ' HG ' ' A' ' 123' ' ' SER . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 1.05 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.72 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.92 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 2.4 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.24 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 3.18 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.67 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.26 110.228 -166.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.11 114.202 -176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 2.33 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 1.12 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.8 111.386 164.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.4 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 1.1 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 1.09 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.6 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 1.27 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 1.08 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.79 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 1.17 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.87 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.09 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 3.69 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.98 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 1.17 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 1.49 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 1.09 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.41 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.74 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.602 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.16 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.68 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.45 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.85 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 4.94 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 1.13 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.36 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.65 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.74 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . 0.406 7.4 p90 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.91 113.742 159.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 113.829 1.048 . . . . 1.17 113.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 1.23 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.22 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 1.18 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.84 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 1.46 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.8 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 1.05 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 1.57 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 2.03 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.89 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 1.22 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 1.06 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 2.56 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 1.14 115.396 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.33 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.73 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 2.4 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 1.18 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.35 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 2.52 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 1.01 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 1.01 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 1.05 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.8 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 1.04 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.68 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 3.2 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 1.1 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 1.11 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 1.34 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.89 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.65 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.89 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.573 ' CD1' HG12 ' A' ' 114' ' ' ILE . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.41 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.42 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 1.04 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.28 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.67 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 1.09 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 1.28 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.71 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.3 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.73 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 1.29 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 1.53 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.07 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 1.06 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 1.04 109.265 -150.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 1.01 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.573 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 1.1 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.29 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.22 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 1.04 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 1.05 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 1.11 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.98 113.047 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 1.57 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.426 ' HG ' ' C ' ' A' ' 7' ' ' GLU . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.72 115.03 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 2.2 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.61 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 1.08 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.29 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.57 110.282 -161.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 1.08 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HE3' ' OE2' ' A' ' 7' ' ' GLU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 1.37 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.65 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' C ' ' HG ' ' A' ' 123' ' ' SER . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 1.05 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.527 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.72 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.92 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 2.4 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.24 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 3.18 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.67 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.26 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.11 114.06 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 2.33 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 1.12 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.8 112.074 167.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.4 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 1.1 107.699 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 1.09 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.6 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 1.27 112.052 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 1.08 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.79 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 1.17 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.87 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.09 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 3.69 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HZ1' ' CD ' ' A' ' 11' ' ' GLU . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.98 108.521 166.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 1.17 119.555 166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 1.49 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 1.09 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.41 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 1.05 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.74 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.16 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.68 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.45 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.85 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 4.94 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 1.13 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.36 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.65 109.909 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' THR . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.74 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 . . . . . 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.91 115.783 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.17 105.687 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 1.23 110.327 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.22 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 1.18 105.797 -162.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.84 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 1.46 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.8 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 1.05 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 1.57 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 2.03 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.89 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 1.22 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 1.06 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 2.56 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 1.14 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.33 112.616 164.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.73 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 2.4 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 1.18 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.35 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 2.52 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 1.01 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 1.01 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 1.05 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.8 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 1.04 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.68 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 3.2 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 1.1 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 1.11 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 1.34 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.89 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.65 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.89 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.41 115.981 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.42 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 1.04 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.28 112.653 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.67 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 1.09 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 1.28 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.71 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.3 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.73 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 1.29 108.488 -161.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 1.53 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.07 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 1.06 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 1.04 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 1.01 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 1.1 107.475 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.29 119.952 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.22 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 1.04 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 1.05 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 1.11 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.51 ' HE ' ' C ' ' A' ' 10' ' ' SER . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.98 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.527 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 1.57 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.51 ' HG ' ' C ' ' A' ' 7' ' ' GLU . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.72 110.728 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 2.2 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.61 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 1.08 113.964 168.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.29 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.57 114.347 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 1.08 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 1.37 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.65 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 1.05 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.72 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.92 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 2.4 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.24 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 3.18 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.67 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 27' ' ' VAL . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.11 117.088 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 2.33 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 1.12 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD23 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.8 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.4 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 1.1 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 1.09 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.6 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' SD ' ' A' ' 18' ' ' MET . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 1.27 114.03 169.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 1.08 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.79 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 1.17 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.87 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.09 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78 117.961 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.98 116.794 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 1.17 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 1.49 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 1.09 114.76 -166.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.41 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 1.05 107.211 -168.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.74 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.16 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.68 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.45 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.85 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 4.94 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 1.13 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.481 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.36 106.727 167.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.65 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.481 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.74 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.91 116.399 174.124 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--O 1.266 1.954 0 N-CA-C 106.117 -1.808 . . . . 1.17 106.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 1.23 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.22 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 1.18 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.84 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 1.46 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' CE1' ' CB ' ' A' ' 47' ' ' PHE . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.8 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 1.05 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 1.57 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 2.03 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.89 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 1.22 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 1.06 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 2.56 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 1.14 114.518 -163.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.33 115.047 162.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.73 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 2.4 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 1.18 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.35 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 2.52 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 1.01 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 1.01 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 1.05 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.8 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 1.04 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.68 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 3.2 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 1.1 112.423 -167.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 1.11 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 1.34 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.89 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.65 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.89 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.837 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.41 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.42 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.458 HE22 ' CD ' ' A' ' 110' ' ' GLU . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 1.04 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.28 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.67 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 1.09 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 1.28 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.71 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.3 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.73 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 1.29 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 1.53 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.458 ' CD ' HE22 ' A' ' 99' ' ' GLN . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.07 110.978 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 1.06 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.57 ' OG ' ' OH ' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 1.04 108.113 -161.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 1.01 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.837 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 1.1 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.29 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.22 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 1.04 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 1.05 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 1.11 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.98 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 1.57 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.72 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 2.2 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.61 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 1.08 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.29 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.57 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 1.08 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 1.37 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.65 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 1.05 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.72 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.92 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 2.4 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.24 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 3.18 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.67 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.26 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.11 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 2.33 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 1.12 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.8 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.4 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 1.1 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 1.09 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.6 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 1.27 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 1.08 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.79 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 1.17 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.87 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.09 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 3.69 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.98 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 1.17 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 1.49 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 1.09 114.542 -172.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.41 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 1.05 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.74 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.16 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.68 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.45 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.85 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 4.94 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 1.13 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.41 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.36 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.65 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.41 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.74 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.91 106.238 161.212 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 CA--C 1.504 -0.82 0 CA-C-O 120.703 0.287 . . . . 1.17 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 1.23 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.22 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 1.18 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.84 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 1.46 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.8 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 1.05 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 1.57 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 2.03 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.89 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 1.22 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 1.06 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 2.56 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 1.14 115.002 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.33 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.73 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 2.4 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 1.18 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.35 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 2.52 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 1.01 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 1.01 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 1.05 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.8 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 1.04 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.68 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 3.2 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 1.1 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 1.11 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 1.34 107.41 160.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.89 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.65 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.89 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.89 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.42 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 1.04 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.28 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.67 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 1.09 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 1.28 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.71 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.3 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.73 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 1.29 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 1.53 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.07 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 1.06 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 1.04 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 1.01 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 1.1 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.29 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.22 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 1.04 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 1.05 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 1.11 111.166 164.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.98 111.986 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 1.57 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.72 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 2.2 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.61 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 1.08 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.29 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.57 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 1.08 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 1.37 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.65 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 1.05 112.882 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.596 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.72 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.92 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 2.4 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.24 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.25 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.67 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.26 113.661 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.11 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 2.33 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 1.12 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.8 111.735 165.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.4 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 1.1 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 1.09 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.6 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 1.27 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 1.08 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.79 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 1.17 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.87 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.09 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 3.69 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.98 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 1.17 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 1.49 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 1.09 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.41 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 1.05 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.74 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.16 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.68 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.45 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.85 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 4.94 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 1.13 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.36 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.65 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.74 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 p90 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67 113.09 -178.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 122.936 1.351 . . . . 0.94 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 1.23 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.22 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 1.18 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.84 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 1.46 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.8 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 1.05 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 1.57 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 2.03 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.89 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 1.22 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 1.06 109.318 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 2.56 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 1.14 118.818 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.33 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.73 113.81 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 2.4 109.919 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 1.18 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.35 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 2.52 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 1.01 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 1.01 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 1.05 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.8 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 1.04 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.68 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 3.2 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 1.1 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 1.11 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 1.34 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.89 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.65 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' GLY . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.89 112.621 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.41 113.687 -170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.42 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 1.04 117.955 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.28 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.67 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 1.09 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 1.28 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.71 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.3 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.73 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 1.29 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 1.53 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.07 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 1.06 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 1.04 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 1.01 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 1.1 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 96' ' ' ASN . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.29 110.355 165.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.22 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 1.04 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 1.05 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 1.11 113.044 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.98 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 1.57 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.72 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 2.2 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.61 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 1.08 108.486 153.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.29 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.57 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 1.08 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.563 ' H ' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 1.37 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.65 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 1.05 115.894 165.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.72 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.619 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.92 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 2.4 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.24 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.25 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.67 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 19' ' ' LYS . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.26 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.11 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 16' ' ' GLU . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 2.33 109.859 165.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 1.12 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.8 114.769 -166.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.4 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 1.1 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 1.09 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.6 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 1.27 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 1.08 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.79 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 1.17 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.87 112.108 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.09 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 3.69 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.98 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 1.17 109.938 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 1.49 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 1.09 116.653 -169.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.41 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 1.05 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.74 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.16 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.68 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.45 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.85 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 4.94 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 1.13 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.36 105.9 171.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.65 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.405 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 7.3 mp0 -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.74 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67 106.709 173.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 108.734 -0.839 . . . . 1.17 108.734 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 1.23 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.22 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 1.18 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.84 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 1.46 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.8 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 1.05 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 1.57 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 2.03 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.89 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 1.22 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 1.06 107.531 -165.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 2.56 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 1.14 113.833 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.33 114.507 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.73 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 2.4 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 1.18 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.35 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 2.52 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 1.01 108.613 167.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 1.01 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 1.05 110.184 168.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.8 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 1.04 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.68 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.471 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 3.2 106.999 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 1.1 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 1.11 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 1.34 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.89 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26 109.368 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.65 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.89 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.89 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.42 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 1.04 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.28 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' CD ' ' HZ1' ' A' ' 89' ' ' LYS . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.67 116.755 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 1.09 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 1.28 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.71 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.3 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.73 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 1.29 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 1.53 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.07 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 1.06 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 1.04 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 1.01 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 1.1 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.29 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.22 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 1.04 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 1.05 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 1.11 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.98 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 1.57 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.72 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 2.2 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.61 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 1.08 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.563 ' HB1' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.29 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.57 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 1.08 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 1.37 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.65 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 1.05 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.72 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.92 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 2.4 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.24 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 3.18 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.67 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.26 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.11 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 2.33 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 1.12 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.8 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.4 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 1.1 108.537 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 1.09 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.6 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 1.27 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 1.08 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.79 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 1.17 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.87 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.09 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 3.69 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.98 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 1.17 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 1.49 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 1.09 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.41 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 1.05 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.74 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.16 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.68 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.45 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.85 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 4.94 108.816 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 1.13 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.36 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.65 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.74 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.91 106.918 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.347 -0.612 . . . . 1.17 109.347 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 1.23 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.22 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 1.18 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.84 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 1.46 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.8 107.879 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 1.05 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 1.57 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 2.03 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.89 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 1.22 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 1.06 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 2.56 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.475 HG23 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 1.14 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.33 109.449 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.73 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 2.4 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 1.18 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.35 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 2.52 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 1.01 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 1.01 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 1.05 111.344 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.8 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 1.04 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.68 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 3.2 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 1.1 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 1.11 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 1.34 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.89 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.65 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.89 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.89 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.42 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 1.04 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.28 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.67 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 1.09 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 1.28 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.71 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.3 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.73 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 1.29 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 1.53 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.07 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 1.06 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.491 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 1.04 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 1.01 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 1.1 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.29 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.22 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 1.04 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 1.05 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.449 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 1.11 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.449 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.98 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 1.57 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.72 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 2.2 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.61 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 1.08 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.29 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.57 117.196 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 1.08 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 1.37 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.65 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.522 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 1.05 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.522 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.72 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.92 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 2.4 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 t30 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.24 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 3.18 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.67 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.26 108.96 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.11 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 2.33 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 1.12 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.8 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.4 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 1.1 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 1.09 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.6 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 1.27 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 1.08 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.65 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.79 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 1.17 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.87 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.09 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 3.69 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.98 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 1.17 112.917 -166.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 1.49 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 1.09 110.338 -161.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.41 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 1.05 111.654 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.74 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.16 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.68 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.45 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.85 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 4.94 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 1.13 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.535 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.36 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.65 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.535 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.74 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.91 105.55 154.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.431 -0.581 . . . . 1.17 109.431 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 1.23 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.22 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 1.18 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.84 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 1.46 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.8 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 1.05 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 1.57 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 2.03 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.89 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 1.22 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 1.06 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 2.56 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 1.14 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.33 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.73 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 2.4 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 1.18 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.35 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 2.52 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 1.01 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 1.01 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 1.05 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.8 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 1.04 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.68 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 3.2 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 1.1 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 1.11 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 1.34 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.89 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.65 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.89 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.566 ' CE1' HD21 ' A' ' 21' ' ' LEU . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.41 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.42 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 1.04 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.28 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.67 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 1.09 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 1.28 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.71 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.3 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.73 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 1.29 108.678 -154.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 1.53 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.07 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 1.06 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 1.04 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 1.01 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 1.1 107.636 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.29 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.22 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 1.04 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 1.05 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 1.11 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.98 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 1.57 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.72 110.012 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 2.2 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.61 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 1.08 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.505 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.29 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.57 117.047 -160.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 1.08 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 1.37 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.65 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 1.05 113.946 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.72 113.985 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.92 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 2.4 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.24 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 3.18 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.67 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.26 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.11 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 2.33 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 1.12 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.8 114.005 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.4 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 1.1 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 1.09 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.6 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 1.27 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 1.08 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.79 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 1.17 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.87 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.09 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 3.69 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.98 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 1.17 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 1.49 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 1.09 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.41 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 1.05 113.132 -163.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.74 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.16 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.68 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.45 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.85 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 4.94 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 1.13 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.36 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.65 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.74 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.91 105.038 173.726 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.686 -0.197 . . . . 1.17 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 1.23 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.22 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 1.18 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.84 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 1.46 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.8 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 1.05 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 1.57 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 2.03 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.89 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 1.22 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 1.06 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 2.56 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 1.14 111.925 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.33 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.73 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 2.4 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 1.18 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.35 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 2.52 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 1.01 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 1.01 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 1.05 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.8 109.992 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 1.04 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.68 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 102' ' ' GLU . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 3.2 108.171 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 1.1 109.61 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 1.11 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 1.34 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.89 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.65 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.89 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.89 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.42 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.464 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.4 ' HG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 1.04 108.163 161.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.28 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 89' ' ' LYS . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.67 117.566 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 1.09 107.622 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 1.28 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.71 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.3 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.73 109.411 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 1.29 105.104 -169.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 1.53 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.07 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.4 HG13 ' HG1' ' A' ' 100' ' ' THR . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 1.06 109.037 -169.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.464 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 1.04 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 1.01 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 1.1 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.29 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.22 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 1.04 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 1.05 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 1.11 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.98 107.111 164.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 1.57 111.019 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.72 112.498 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 2.2 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.61 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 1.08 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.29 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.57 117.846 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 1.08 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 1.37 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.65 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 1.05 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.72 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.92 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 2.4 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.24 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 3.18 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.67 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.479 ' CD ' ' HZ1' ' A' ' 19' ' ' LYS . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.26 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.533 ' HE1' ' C24' ' A' ' 201' ' ' GCH . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.11 114.504 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 2.33 112.294 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 1.12 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.8 112.448 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.4 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 1.1 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 1.09 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.6 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 1.27 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 1.08 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.79 109.192 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 1.17 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.87 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.09 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 3.69 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.98 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 1.17 117.559 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 1.49 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 1.09 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.41 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 1.05 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.74 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.16 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.68 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.45 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.85 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 1.13 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.36 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.65 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.74 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 1.31 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 -130.59 159.09 38.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67 111.973 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m -23.72 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 120.797 3.628 . . . . 2.91 120.797 -159.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.82 -2.32 84.36 Favored Glycine 0 CA--C 1.478 -2.242 0 CA-C-N 122.227 2.285 . . . . 3.07 111.043 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.25 33.19 7.8 Favored Glycine 0 CA--C 1.476 -2.346 0 O-C-N 118.09 -3.006 . . . . 2.01 106.153 164.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 1.31 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 -71.99 138.17 47.79 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 119.834 -1.98 . . . . 1.17 109.615 160.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 1.23 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.22 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 1.18 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.84 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 1.46 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.896 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.33 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 1.05 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 1.57 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 2.03 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.89 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 1.22 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 1.06 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 2.56 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' H162 ' A' ' 202' ' ' CHO . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 1.14 116.688 -162.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.33 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.73 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 2.4 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 1.18 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.35 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 2.52 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 1.01 109.063 154.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 1.01 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 1.05 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.8 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 1.04 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.68 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 3.2 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 1.1 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 1.11 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 1.34 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.89 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26 105.199 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.65 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.89 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.89 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.42 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 1.04 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.28 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.67 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 1.09 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 1.28 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.71 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.3 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.73 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 1.29 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 1.53 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.07 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 1.06 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 1.04 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 1.01 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 1.1 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.29 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.22 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 1.04 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 1.05 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.29 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.403 ' HD3' ' H31' ' A' ' 201' ' ' GCH . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.98 108.462 -166.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 1.57 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.72 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 2.2 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.61 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 1.08 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.572 ' H12' ' CG ' ' A' ' 2' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.896 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.602 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.29 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.57 113.581 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 1.08 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 1.37 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.65 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' C ' ' HG ' ' A' ' 123' ' ' SER . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 1.05 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.72 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.92 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 2.4 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.24 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 3.18 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.67 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.26 110.228 -166.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.11 114.202 -176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 2.33 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 1.12 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.8 111.386 164.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.4 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 1.1 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 1.09 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.6 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 1.27 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 1.08 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.79 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 1.17 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.87 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.09 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 3.69 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.98 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 1.17 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 1.49 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 1.09 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.41 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.74 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.602 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.16 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.68 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.45 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.85 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 4.94 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 1.13 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.36 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.65 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.74 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . 0.406 7.4 p90 -70.19 103.11 2.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.91 113.742 159.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.7 p 37.58 -123.75 0.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.759 2.503 . . . . 2.91 117.759 -154.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.91 3.32 67.25 Favored Glycine 0 N--CA 1.481 1.64 0 O-C-N 119.397 -2.064 . . . . 3.07 113.156 159.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.92 -52.23 52.32 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 128.43 2.919 . . . . 2.01 115.806 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -159.45 146.26 16.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 119.258 -2.319 . . . . 1.17 113.829 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 1.23 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.22 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 1.18 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.84 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 1.46 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.8 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 1.05 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 1.57 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 2.03 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.89 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 1.22 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 1.06 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 2.56 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.66 ' HG1' ' C27' ' A' ' 202' ' ' CHO . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 1.14 115.396 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.33 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.73 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 2.4 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 1.18 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.35 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 2.52 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 1.01 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 1.01 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 1.05 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.8 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 1.04 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.68 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 3.2 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 1.1 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 1.11 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 1.34 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.89 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.65 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.89 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.858 ' OH ' ' C21' ' A' ' 202' ' ' CHO . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.41 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.42 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 1.04 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.28 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.67 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 1.09 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 1.28 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.71 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.3 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.73 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 1.29 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 1.53 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.07 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 1.06 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 1.04 109.265 -150.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 1.01 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.573 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 1.1 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.29 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.22 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 1.04 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 1.05 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 1.11 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.501 ' HE ' ' H30' ' A' ' 201' ' ' GCH . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.98 113.047 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 1.57 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.426 ' HG ' ' C ' ' A' ' 7' ' ' GLU . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.72 115.03 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 2.2 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.61 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 1.08 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.501 ' H30' ' HE ' ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.858 ' C21' ' OH ' ' A' ' 97' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.29 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.411 ' HB3' ' H2 ' ' A' ' 201' ' ' GCH . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.57 110.282 -161.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 1.08 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HE3' ' OE2' ' A' ' 7' ' ' GLU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 1.37 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.65 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' C ' ' HG ' ' A' ' 123' ' ' SER . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 1.05 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.527 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.72 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.92 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 2.4 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.24 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 3.18 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.67 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.26 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.11 114.06 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 2.33 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 1.12 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.8 112.074 167.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.4 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 1.1 107.699 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 1.09 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.6 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 1.27 112.052 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 1.08 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.79 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 1.17 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.87 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.09 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 3.69 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HZ1' ' CD ' ' A' ' 11' ' ' GLU . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.98 108.521 166.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 1.17 119.555 166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 1.49 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 1.09 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.41 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 1.05 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.74 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.16 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.68 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.45 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.85 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 4.94 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 1.13 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.36 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.65 109.909 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' THR . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.74 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 -65.61 103.54 0.88 Allowed 'General case' 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.91 115.783 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.0 p 49.61 28.15 2.45 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 129.008 2.923 . . . . 2.91 114.586 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.79 -3.98 47.22 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 121.357 3.303 . . . . 3.07 121.357 -165.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.42 -25.23 48.21 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.021 -1.87 . . . . 2.01 115.347 -170.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 -162.81 167.42 22.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.17 105.687 172.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 1.23 110.327 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.22 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 1.18 105.797 -162.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.84 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 1.46 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.8 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 1.05 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 1.57 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 2.03 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.89 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 1.22 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 1.06 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 2.56 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 1.14 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.455 ' H ' H161 ' A' ' 202' ' ' CHO . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.33 112.616 164.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.73 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 2.4 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 1.18 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.35 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 2.52 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 1.01 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 1.01 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 1.05 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.8 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 1.04 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.68 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 3.2 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 1.1 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 1.11 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 1.34 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.89 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.65 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.89 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.41 115.981 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.42 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' OE1' ' C12' ' A' ' 202' ' ' CHO . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 1.04 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.28 112.653 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.67 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 1.09 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 1.28 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.71 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.3 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.73 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 1.29 108.488 -161.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 1.53 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.07 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 1.06 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 1.04 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 1.01 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 1.1 107.475 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.29 119.952 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.22 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 1.04 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 1.05 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 1.11 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.51 ' HE ' ' C ' ' A' ' 10' ' ' SER . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.98 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.527 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 1.57 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.517 ' CB ' ' H38' ' A' ' 201' ' ' GCH . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.72 110.728 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 2.2 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.61 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 1.08 113.964 168.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.517 ' H38' ' CB ' ' A' ' 123' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.455 H161 ' H ' ' A' ' 74' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.29 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.472 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.57 114.347 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 1.08 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 1.37 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.65 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 1.05 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.72 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.92 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 2.4 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.24 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 3.18 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.67 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 27' ' ' VAL . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.11 117.088 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 2.33 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 1.12 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD23 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.8 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.4 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 1.1 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 1.09 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.6 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' SD ' ' A' ' 18' ' ' MET . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 1.27 114.03 169.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 1.08 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.79 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 1.17 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.87 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.09 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 54' ' ' SER . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78 117.961 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HA ' ' O5 ' ' A' ' 201' ' ' GCH 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.98 116.794 -175.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 1.17 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 1.49 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 1.09 114.76 -166.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.41 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG2' ' H4 ' ' A' ' 201' ' ' GCH . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 1.05 107.211 -168.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.74 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.16 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.68 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.45 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.85 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 4.94 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 1.13 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.481 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.36 106.727 167.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.65 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.481 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.74 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -63.88 65.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.91 116.399 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.474 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . 82.7 p 59.22 8.33 1.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.223 2.209 . . . . 2.91 115.018 -158.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.94 55.86 Favored Glycine 0 C--O 1.258 1.654 0 O-C-N 121.943 -0.473 . . . . 3.07 114.071 -165.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.78 -16.12 68.79 Favored Glycine 0 C--N 1.364 2.121 0 O-C-N 117.942 -3.093 . . . . 2.01 111.793 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -170.35 123.0 0.67 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-N 123.65 3.725 . . . . 1.17 106.117 -167.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 1.23 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.22 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 1.18 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.84 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 1.46 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.718 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.8 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 1.05 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 1.57 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 2.03 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.89 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 1.22 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 1.06 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 2.56 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.498 ' HG1' ' C27' ' A' ' 202' ' ' CHO . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 1.14 114.518 -163.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.505 ' SD ' H211 ' A' ' 202' ' ' CHO . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.33 115.047 162.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.73 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 2.4 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 1.18 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.35 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 2.52 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 1.01 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 1.01 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 1.05 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.8 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 1.04 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.68 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 3.2 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 ' HB2' ' H21' ' A' ' 202' ' ' CHO . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 1.1 112.423 -167.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 1.11 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 1.34 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.89 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.65 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.89 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.837 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.41 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.42 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.466 ' HG2' ' C12' ' A' ' 202' ' ' CHO . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 1.04 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.28 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.67 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 1.09 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 1.28 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.71 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.3 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.73 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 1.29 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 1.53 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.458 ' CD ' HE22 ' A' ' 99' ' ' GLN . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.07 110.978 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 1.06 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.57 ' OG ' ' OH ' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 1.04 108.113 -161.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 1.01 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.837 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 1.1 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.29 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.22 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 1.04 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 1.05 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 1.11 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.98 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 1.57 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.72 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 2.2 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.61 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 1.08 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.517 ' H4 ' ' CG2' ' A' ' 40' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.718 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.29 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.57 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 1.08 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 1.37 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.65 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 1.05 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.72 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.92 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 2.4 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.24 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 3.18 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.67 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.26 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.11 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 2.33 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 1.12 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.8 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.4 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 1.1 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 1.09 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.6 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 1.27 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 1.08 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.79 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 1.17 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.87 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.09 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 3.69 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.98 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 1.17 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 1.49 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 1.09 114.542 -172.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.41 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 1.05 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.74 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.16 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.68 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.45 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.85 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 4.94 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 1.13 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.41 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.36 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.65 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.41 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.74 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -70.37 133.54 47.01 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.91 106.238 161.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 m -67.1 100.27 0.75 Allowed 'General case' 0 C--O 1.253 1.276 0 CA-C-O 123.504 1.621 . . . . 2.91 114.898 164.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.02 -8.02 4.79 Favored Glycine 0 CA--C 1.451 -3.925 0 N-CA-C 121.083 3.193 . . . . 3.07 121.083 -162.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 91.15 2.14 Favored Glycine 0 N--CA 1.473 1.165 0 O-C-N 120.381 -1.658 . . . . 2.01 114.171 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 171.54 143.59 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 129.214 3.006 . . . . 1.17 110.732 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 1.23 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.22 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 1.18 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.84 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 1.46 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.8 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 1.05 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 1.57 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 2.03 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.89 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 1.22 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 1.06 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 2.56 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 1.14 115.002 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.33 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.73 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 2.4 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 1.18 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.35 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 2.52 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 1.01 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 1.01 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 1.05 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.8 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 1.04 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.68 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 3.2 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 1.1 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 1.11 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 1.34 107.41 160.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.89 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.65 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.89 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.89 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.42 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 1.04 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.28 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.67 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 1.09 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 1.28 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.71 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.3 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.73 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 1.29 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 1.53 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.07 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 1.06 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 1.04 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 1.01 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 1.1 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.29 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.22 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 1.04 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 1.05 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.517 ' HH ' ' C24' ' A' ' 201' ' ' GCH . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 1.11 111.166 164.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.98 111.986 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 1.57 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.72 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 2.2 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.61 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 1.08 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.517 ' C24' ' HH ' ' A' ' 119' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.42 H183 ' H8 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.29 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.57 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 1.08 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 1.37 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.65 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.401 ' SD ' ' H20' ' A' ' 201' ' ' GCH . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 1.05 112.882 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.596 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.72 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.92 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 2.4 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.24 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.25 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.67 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.26 113.661 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.11 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 2.33 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 1.12 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.8 111.735 165.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.4 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 1.1 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 1.09 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.6 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 1.27 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 1.08 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.79 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 1.17 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.87 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.09 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 3.69 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.98 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 1.17 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 1.49 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 1.09 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.41 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 1.05 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.74 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.16 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.68 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.45 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.85 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 4.94 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 1.13 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.36 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.65 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.475 ' HG2' ' H26' ' A' ' 201' ' ' GCH . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.74 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -102.48 159.72 15.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67 113.09 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -17.93 40.44 Favored 'General case' 0 N--CA 1.483 1.183 1 N-CA-C 122.061 4.097 . . . . 2.91 122.061 -162.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.9 2.87 31.14 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 119.909 2.723 . . . . 3.07 119.909 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.31 24.71 42.57 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 115.523 -2.821 . . . . 2.01 112.939 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -102.74 129.83 49.5 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.094 1.947 . . . . 0.94 111.158 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 1.23 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.22 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 1.18 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.84 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 1.46 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.8 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 1.05 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 1.57 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 2.03 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.89 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 1.22 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 1.06 109.318 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 2.56 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.641 ' HG1' ' C27' ' A' ' 202' ' ' CHO . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 1.14 118.818 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.33 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' N ' ' OT1' ' A' ' 202' ' ' CHO . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.73 113.81 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 2.4 109.919 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 1.18 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.35 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 2.52 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 1.01 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 1.01 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 1.05 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.8 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 1.04 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.68 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 3.2 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 1.1 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 1.11 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 1.34 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.89 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.65 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' GLY . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.89 112.621 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.41 113.687 -170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.42 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 1.04 117.955 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.28 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.67 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 1.09 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 1.28 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.71 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.3 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.73 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 1.29 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 1.53 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.07 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 1.06 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 1.04 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 1.01 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 1.1 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 96' ' ' ASN . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.29 110.355 165.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.22 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 1.04 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 1.05 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 1.11 113.044 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.98 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 1.57 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.72 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 2.2 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.61 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 1.08 108.486 153.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.475 ' H26' ' HG2' ' A' ' 51' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.641 ' C27' ' HG1' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.29 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.57 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 1.08 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.563 ' H ' ' HB1' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 1.37 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.65 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.545 ' HE2' ' C24' ' A' ' 201' ' ' GCH . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 1.05 115.894 165.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.72 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.619 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.92 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 2.4 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.24 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.25 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.67 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 19' ' ' LYS . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.26 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.11 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 16' ' ' GLU . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 2.33 109.859 165.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 1.12 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.8 114.769 -166.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.4 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 1.1 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 1.09 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.6 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 1.27 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 1.08 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.79 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 1.17 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.87 112.108 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.09 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 3.69 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.98 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 1.17 109.938 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 1.49 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 1.09 116.653 -169.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.41 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 1.05 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.74 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.16 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.68 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.45 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.85 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 4.94 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 1.13 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.419 ' CE3' ' H2 ' ' A' ' 201' ' ' GCH . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.36 105.9 171.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.65 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.405 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 7.3 mp0 -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.74 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -65.05 133.11 50.94 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67 106.709 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -68.17 -26.06 65.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.548 0.739 . . . . 2.91 112.848 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.78 -0.66 27.06 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.654 1.597 . . . . 3.07 115.695 163.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.68 54.84 1.11 Allowed Glycine 0 CA--C 1.473 -2.569 0 N-CA-C 118.175 2.03 . . . . 2.01 118.175 155.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -145.25 141.41 28.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.781 -1.423 . . . . 1.17 108.734 162.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 1.23 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.22 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 1.18 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.84 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 1.46 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.8 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 1.05 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 1.57 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 2.03 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.89 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 1.22 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 1.06 107.531 -165.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 2.56 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.67 ' HG1' ' C27' ' A' ' 202' ' ' CHO . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 1.14 113.833 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.33 114.507 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.73 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 2.4 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 1.18 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.35 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 2.52 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 1.01 108.613 167.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 1.01 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 1.05 110.184 168.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.8 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 1.04 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.68 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.471 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 3.2 106.999 -175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 1.1 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 1.11 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 1.34 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.89 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26 109.368 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.65 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.89 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.89 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.42 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 1.04 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.28 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' CD ' ' HZ1' ' A' ' 89' ' ' LYS . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.67 116.755 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 1.09 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 1.28 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.71 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.3 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.73 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 1.29 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 1.53 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.07 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 1.06 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 1.04 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 1.01 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 1.1 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.29 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.22 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 1.04 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 1.05 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 1.11 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.98 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 1.57 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.72 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 2.2 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.61 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 1.08 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.563 ' HB1' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.545 ' C24' ' HE2' ' A' ' 8' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.67 ' C27' ' HG1' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.29 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.57 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 1.08 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 1.37 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.65 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 1.05 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.72 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.92 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 2.4 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.24 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 3.18 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.67 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.26 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.11 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 2.33 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 1.12 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.8 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.4 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.485 HD11 ' HN ' ' A' ' 202' ' ' CHO . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 1.1 108.537 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 1.09 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.6 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 1.27 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 1.08 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.79 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 1.17 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.87 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.09 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 3.69 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.98 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 1.17 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 1.49 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 1.09 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.41 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 1.05 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.74 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.16 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.68 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.45 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.85 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 4.94 108.816 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 1.13 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.36 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.65 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.74 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 -59.24 132.56 54.37 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.91 106.918 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -75.58 6.99 4.07 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 126.46 3.028 . . . . 2.91 115.445 164.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.18 -7.54 88.33 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 119.021 -2.3 . . . . 3.07 115.665 159.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.56 47.83 2.27 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 121.161 2.48 . . . . 2.01 116.39 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 -154.06 162.9 40.87 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.755 1.277 . . . . 1.17 109.347 170.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 1.23 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.22 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 1.18 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.84 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 1.46 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.8 107.879 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 1.05 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 1.57 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 2.03 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.89 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 1.22 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 1.06 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 2.56 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.475 HG23 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 1.14 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.465 ' H ' H162 ' A' ' 202' ' ' CHO . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.33 109.449 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.73 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 2.4 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 1.18 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.35 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 2.52 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 1.01 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 1.01 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 1.05 111.344 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.8 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 1.04 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.68 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 3.2 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 1.1 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 1.11 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 1.34 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.89 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.65 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.89 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.89 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.42 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 1.04 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.28 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.67 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 1.09 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 1.28 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.71 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.3 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.73 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 1.29 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 1.53 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.07 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 1.06 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.491 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 1.04 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 1.01 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 1.1 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.29 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.22 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 1.04 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 1.05 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.563 ' HH ' ' C24' ' A' ' 201' ' ' GCH . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 1.11 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.449 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.98 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 1.57 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.72 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 2.2 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.61 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 1.08 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.563 ' C24' ' HH ' ' A' ' 119' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.485 ' HN ' HD11 ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.29 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.582 ' CD2' ' H9 ' ' A' ' 201' ' ' GCH . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.57 117.196 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 1.08 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 1.37 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.65 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.522 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 1.05 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.522 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.72 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.92 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 2.4 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 t30 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.24 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 3.18 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.67 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.26 108.96 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.11 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 2.33 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 1.12 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.8 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.4 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 1.1 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 1.09 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.6 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 1.27 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 1.08 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.65 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.79 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 1.17 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.87 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.09 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 3.69 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.98 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.409 HG12 ' C24' ' A' ' 201' ' ' GCH . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 1.17 112.917 -166.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 1.49 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.689 ' CG2' ' H42' ' A' ' 201' ' ' GCH 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 1.09 110.338 -161.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.41 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 1.05 111.654 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.74 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.16 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.68 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.45 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.85 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 4.94 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 1.13 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.802 ' CH2' ' H14' ' A' ' 202' ' ' CHO . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.36 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.65 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.535 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.74 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 -58.07 121.38 10.49 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.91 105.55 154.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -58.26 124.34 19.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.856 -0.794 . . . . 2.91 108.856 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.6 -5.68 54.64 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.022 -1.432 . . . . 3.07 116.225 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.21 69.32 0.63 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 119.95 1.875 . . . . 2.01 116.314 158.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.66 155.17 40.69 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.599 -1.53 . . . . 1.17 109.431 158.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 1.23 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.22 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 1.18 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.84 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 1.46 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.8 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 1.05 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 1.57 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 2.03 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.89 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 1.22 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 1.06 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 2.56 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 1.14 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.33 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.73 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 2.4 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 1.18 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.35 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 2.52 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 1.01 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 1.01 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 1.05 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.8 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 1.04 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.68 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 3.2 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 1.1 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 1.11 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 1.34 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.89 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.65 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.89 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.615 ' OH ' H121 ' A' ' 202' ' ' CHO . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.41 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.42 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.448 ' CD ' H111 ' A' ' 202' ' ' CHO . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 1.04 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.28 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.67 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 1.09 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 1.28 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.71 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.3 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.73 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD11 ' H17' ' A' ' 201' ' ' GCH . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 1.29 108.678 -154.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 1.53 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.07 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 1.06 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 1.04 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 1.01 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 1.1 107.636 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.29 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.22 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 1.04 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 1.05 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 1.11 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.98 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 1.57 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.488 ' HG ' ' H37' ' A' ' 201' ' ' GCH . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.72 110.012 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 2.2 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.61 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 1.08 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.689 ' H42' ' CG2' ' A' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.802 ' H14' ' CH2' ' A' ' 49' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.29 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.491 ' CB ' ' H12' ' A' ' 201' ' ' GCH . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.57 117.047 -160.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 1.08 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 1.37 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.65 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.664 ' HB2' ' H28' ' A' ' 201' ' ' GCH 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 1.05 113.946 176.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.72 113.985 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.92 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 2.4 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.24 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 3.18 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.67 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.26 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.11 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 2.33 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 1.12 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.8 114.005 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.4 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 1.1 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 1.09 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.6 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 1.27 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 1.08 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.79 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 1.17 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.87 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.09 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 3.69 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.98 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 1.17 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 1.49 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 1.09 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.41 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 1.05 113.132 -163.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.74 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.16 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.68 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.45 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.85 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 4.94 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 1.13 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.36 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.65 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.74 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -62.35 151.97 35.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.91 105.038 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -63.88 -18.93 64.68 Favored 'General case' 0 N--CA 1.518 2.928 0 O-C-N 121.788 -0.57 . . . . 2.91 110.066 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.71 3.48 63.96 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 117.639 1.816 . . . . 3.07 117.639 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.16 33.81 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.628 -2.101 . . . . 2.01 116.329 167.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -114.33 145.45 41.78 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.952 1.376 . . . . 1.17 111.183 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 1.23 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.22 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 1.18 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.84 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 1.46 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.8 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 1.05 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 1.57 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 2.03 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.89 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 1.22 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 1.06 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 2.56 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.992 ' HB ' ' C27' ' A' ' 202' ' ' CHO . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 1.14 111.925 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.33 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.73 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 2.4 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 1.18 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.35 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 2.52 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 1.01 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 1.01 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 1.05 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.8 109.992 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 1.04 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.68 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 102' ' ' GLU . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 3.2 108.171 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' CB ' ' H3 ' ' A' ' 202' ' ' CHO . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 1.1 109.61 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 1.11 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 1.34 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.89 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.65 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.89 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.89 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.42 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.464 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.4 ' HG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 1.04 108.163 161.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.28 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 89' ' ' LYS . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.67 117.566 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 1.09 107.622 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 1.28 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.71 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.3 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.73 109.411 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HB3' ' H15' ' A' ' 201' ' ' GCH 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 1.29 105.104 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 1.53 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.07 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG13 ' HG1' ' A' ' 100' ' ' THR . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 1.06 109.037 -169.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.464 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 1.04 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 1.01 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 1.1 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.29 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.22 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 1.04 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 1.05 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 1.11 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.543 ' HD3' ' H25' ' A' ' 201' ' ' GCH . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.98 107.111 164.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 1.57 111.019 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 1.119 ' CB ' ' H32' ' A' ' 201' ' ' GCH . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.72 112.498 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 2.2 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.61 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 1.08 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 1.119 ' H32' ' CB ' ' A' ' 123' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.992 ' C27' ' HB ' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.01 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.35999999999999999 117.846 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 0.27000000000000002 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46000000000000002 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 0.72999999999999998 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.42999999999999999 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 0.96999999999999997 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.52 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.9199999999999999 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 1.8999999999999999 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.23999999999999999 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 2.54 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.6699999999999999 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.22 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.0600000000000001 114.504 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 1.8200000000000001 112.294 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 0.27000000000000002 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 21' ' ' LEU . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.2 112.448 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.40000000000000002 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 0.38 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 0.70999999999999996 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.04 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 0.57999999999999996 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 0.28000000000000003 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.1899999999999999 109.192 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 0.40000000000000002 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.3999999999999999 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.0900000000000001 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 2.8399999999999999 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.5600000000000001 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 36' ' ' ILE . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 0.44 117.559 -174.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 0.84999999999999998 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 0.39000000000000001 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.4099999999999999 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 0.20000000000000001 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.1499999999999999 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.1599999999999999 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.6799999999999999 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.3700000000000001 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.8500000000000001 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26000000000000001 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 0.28999999999999998 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.28999999999999998 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.22 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.21 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 1.308 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 . . . . . 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67000000000000004 111.973 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 1.308 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.615 -0.513 . . . . 1.1699999999999999 109.615 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 0.72999999999999998 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.1299999999999999 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 0.68000000000000005 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.83999999999999997 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 0.82999999999999996 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.791 ' CE1' ' CD2' ' A' ' 47' ' ' PHE . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.27000000000000002 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 0.28999999999999998 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 0.85999999999999999 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26000000000000001 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 1.54 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.3 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 0.97999999999999998 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 0.29999999999999999 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 1.96 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 0.47999999999999998 116.688 -162.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.1100000000000001 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.72999999999999998 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 1.76 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 0.54000000000000004 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.34999999999999998 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 1.96 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 94' ' ' PHE . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 0.25 109.063 154.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 0.28000000000000003 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 0.17999999999999999 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.52000000000000002 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 0.23000000000000001 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.35999999999999999 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 2.7000000000000002 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 0.23000000000000001 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 0.23000000000000001 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 0.65000000000000002 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.8899999999999999 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 81' ' ' ALA . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26000000000000001 105.199 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.46000000000000002 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.8899999999999999 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.27000000000000002 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.35999999999999999 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 0.40000000000000002 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.24 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.6699999999999999 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 0.28000000000000003 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.68000000000000005 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.2999999999999998 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.27 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 0.59999999999999998 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 0.87 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.0699999999999998 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 0.27000000000000002 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 0.87 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 0.26000000000000001 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 0.27000000000000002 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.28999999999999998 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.20999999999999999 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 0.17000000000000001 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 0.27000000000000002 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.28999999999999998 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.0899999999999999 108.462 -166.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 0.89000000000000001 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.1299999999999999 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 1.76 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.0600000000000001 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 0.40999999999999998 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.01 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 40' ' ' VAL . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.35999999999999999 113.581 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 0.27000000000000002 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46000000000000002 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 0.72999999999999998 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.42999999999999999 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 0.96999999999999997 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.52 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.9199999999999999 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 1.8999999999999999 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.23999999999999999 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 2.54 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.6699999999999999 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.22 110.228 -166.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.0600000000000001 114.202 -176.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 1.8200000000000001 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 0.27000000000000002 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 18' ' ' MET . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.2 111.386 164.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.40000000000000002 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 0.38 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 0.70999999999999996 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.04 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 0.57999999999999996 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 0.28000000000000003 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.1899999999999999 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 0.40000000000000002 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.3999999999999999 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.0900000000000001 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 2.8399999999999999 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.5600000000000001 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 0.44 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 0.84999999999999998 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 0.39000000000000001 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.4099999999999999 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 2' ' ' PHE . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 0.20000000000000001 106.172 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.1499999999999999 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.1599999999999999 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.6799999999999999 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.3700000000000001 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.8500000000000001 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 3.9900000000000002 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 0.28999999999999998 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.28999999999999998 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.22 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.21 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.406 7.4 p90 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.83999999999999997 113.742 159.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 4.6 t-160 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 113.829 1.048 . . . . 1.1699999999999999 113.829 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 0.72999999999999998 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 0.68000000000000005 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.83999999999999997 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 0.82999999999999996 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.57999999999999996 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 0.28999999999999998 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 0.85999999999999999 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26000000000000001 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 1.54 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.3 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 0.97999999999999998 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 0.29999999999999999 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 1.96 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 0.47999999999999998 115.396 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.1100000000000001 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.72999999999999998 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 1.76 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 0.54000000000000004 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.34999999999999998 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 1.96 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 0.25 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 0.28000000000000003 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 0.17999999999999999 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.52000000000000002 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.23000000000000001 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.35999999999999999 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 2.7000000000000002 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 0.23000000000000001 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 0.23000000000000001 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 0.65000000000000002 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.8899999999999999 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26000000000000001 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.46000000000000002 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.8899999999999999 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' HG12 ' A' ' 114' ' ' ILE . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.26000000000000001 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.35999999999999999 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 0.40000000000000002 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.24 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.6699999999999999 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 0.28000000000000003 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 0.59999999999999998 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.68000000000000005 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.2999999999999998 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.27 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 0.59999999999999998 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 0.87 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.0699999999999998 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 0.27000000000000002 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 0.87 109.265 -150.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 0.26000000000000001 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.589 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 0.27000000000000002 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.20999999999999999 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 0.17000000000000001 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 0.27000000000000002 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 0.59999999999999998 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.0899999999999999 113.047 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 0.89000000000000001 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.1299999999999999 115.03 169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 1.76 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.0600000000000001 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 0.40999999999999998 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.01 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.35999999999999999 110.282 -161.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 0.27000000000000002 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46000000000000002 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' HD11 ' A' ' 126' ' ' LEU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 0.72999999999999998 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.42999999999999999 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 0.96999999999999997 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.557 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.52 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' CA ' ' HE ' ' A' ' 121' ' ' ARG . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.9199999999999999 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 1.8999999999999999 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.23999999999999999 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 2.54 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.6699999999999999 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.22 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB3' HD12 ' A' ' 23' ' ' ILE . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.0600000000000001 114.06 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 1.8200000000000001 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 0.27000000000000002 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.2 112.074 167.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.40000000000000002 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD13 ' HB ' ' A' ' 27' ' ' VAL . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 0.38 107.699 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 0.70999999999999996 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.04 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 23' ' ' ILE . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 0.57999999999999996 112.052 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 0.28000000000000003 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.1899999999999999 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 0.40000000000000002 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.3999999999999999 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.0900000000000001 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 2.8399999999999999 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.5600000000000001 108.521 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 0.44 119.555 166.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 0.84999999999999998 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 0.39000000000000001 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.4099999999999999 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 0.20000000000000001 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.1499999999999999 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.1599999999999999 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.6799999999999999 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.3700000000000001 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.8500000000000001 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 3.9900000000000002 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 0.28999999999999998 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.28999999999999998 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.22 109.909 -173.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.21 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 . . . . . 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.83999999999999997 115.783 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.1699999999999999 105.687 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 0.72999999999999998 110.327 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.1299999999999999 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 0.68000000000000005 105.797 -162.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.83999999999999997 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 0.82999999999999996 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.57999999999999996 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 0.28999999999999998 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 0.85999999999999999 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26000000000000001 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 1.54 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.3 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 0.97999999999999998 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 0.29999999999999999 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 1.96 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 0.47999999999999998 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.1100000000000001 112.616 164.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.72999999999999998 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 1.76 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 0.54000000000000004 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.34999999999999998 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 1.96 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 0.25 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 0.28000000000000003 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 0.17999999999999999 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.52000000000000002 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 0.23000000000000001 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.35999999999999999 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 2.7000000000000002 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 0.23000000000000001 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 0.23000000000000001 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 0.65000000000000002 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.8899999999999999 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26000000000000001 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.46000000000000002 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.8899999999999999 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE1' HD21 ' A' ' 21' ' ' LEU 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.26000000000000001 115.981 -177.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.35999999999999999 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 0.40000000000000002 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.24 112.653 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.6699999999999999 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 0.28000000000000003 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 0.59999999999999998 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.68000000000000005 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.2999999999999998 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.27 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 0.59999999999999998 108.488 -161.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 0.87 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.0699999999999998 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 0.27000000000000002 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 0.87 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 0.26000000000000001 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 0.27000000000000002 107.475 170.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.28999999999999998 119.952 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.20999999999999999 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 0.17000000000000001 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 0.27000000000000002 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 0.59999999999999998 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.52 ' HE ' ' CA ' ' A' ' 11' ' ' GLU . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.0899999999999999 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.557 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 0.89000000000000001 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.1299999999999999 110.728 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 1.76 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.0600000000000001 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.567 HD11 ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 0.40999999999999998 113.964 168.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.01 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.35999999999999999 114.347 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 0.27000000000000002 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46000000000000002 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 0.72999999999999998 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.42999999999999999 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.96999999999999997 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.52 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.9199999999999999 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 1.8999999999999999 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.23999999999999999 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 2.54 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.6699999999999999 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17000000000000001 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.0600000000000001 117.088 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 1.8200000000000001 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 0.27000000000000002 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.2 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.40000000000000002 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 0.38 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 0.70999999999999996 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.04 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 0.57999999999999996 114.03 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 0.28000000000000003 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.1899999999999999 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 0.40000000000000002 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.3999999999999999 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.0900000000000001 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78000000000000003 117.961 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.5600000000000001 116.794 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 0.44 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 0.84999999999999998 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 0.39000000000000001 114.76 -166.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.4099999999999999 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 0.20000000000000001 107.211 -168.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.1499999999999999 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.1599999999999999 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.6799999999999999 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.3700000000000001 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.8500000000000001 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 3.9900000000000002 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 0.28999999999999998 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.28999999999999998 106.727 167.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.22 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.21 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.83999999999999997 116.399 174.124 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--O 1.266 1.954 0 N-CA-C 106.117 -1.808 . . . . 1.1699999999999999 106.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 0.72999999999999998 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.1299999999999999 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 0.68000000000000005 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.83999999999999997 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 0.82999999999999996 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' CE1' ' CB ' ' A' ' 47' ' ' PHE . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.57999999999999996 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 0.28999999999999998 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 0.85999999999999999 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26000000000000001 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 1.54 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.3 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 0.97999999999999998 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 0.29999999999999999 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 1.96 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 0.47999999999999998 114.518 -163.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.1100000000000001 115.047 162.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.72999999999999998 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 1.76 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 0.54000000000000004 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.34999999999999998 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 1.96 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 0.25 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 0.28000000000000003 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.52000000000000002 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 0.23000000000000001 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.35999999999999999 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 2.7000000000000002 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 0.23000000000000001 112.423 -167.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 0.23000000000000001 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 0.65000000000000002 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.8899999999999999 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26000000000000001 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.46000000000000002 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.8899999999999999 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.857 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.26000000000000001 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.35999999999999999 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 0.40000000000000002 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.24 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.6699999999999999 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 0.28000000000000003 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 0.59999999999999998 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.68000000000000005 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.2999999999999998 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.27 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 0.59999999999999998 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 0.87 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.0699999999999998 110.978 169.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 0.27000000000000002 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 0.87 108.113 -161.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 0.26000000000000001 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.857 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 0.27000000000000002 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.28999999999999998 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.20999999999999999 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 0.17000000000000001 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 0.27000000000000002 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 0.59999999999999998 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.0899999999999999 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 0.89000000000000001 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.1299999999999999 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 1.76 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.0600000000000001 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 0.40999999999999998 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.01 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.35999999999999999 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 0.27000000000000002 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46000000000000002 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 0.72999999999999998 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.42999999999999999 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 0.96999999999999997 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.52 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.9199999999999999 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 1.8999999999999999 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.23999999999999999 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 2.54 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.6699999999999999 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.22 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.0600000000000001 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 1.8200000000000001 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 0.27000000000000002 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.2 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.40000000000000002 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 0.38 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 0.70999999999999996 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.04 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 0.57999999999999996 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 0.28000000000000003 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.1899999999999999 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 0.40000000000000002 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.3999999999999999 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.0900000000000001 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 2.8399999999999999 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.5600000000000001 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 0.44 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 0.84999999999999998 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 0.39000000000000001 114.542 -172.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.4099999999999999 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 0.20000000000000001 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.1499999999999999 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.1599999999999999 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.6799999999999999 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.3700000000000001 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.8500000000000001 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 3.9900000000000002 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 0.28999999999999998 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.442 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.28999999999999998 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.22 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.442 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.21 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.83999999999999997 106.238 161.212 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 CA--C 1.504 -0.82 0 CA-C-O 120.703 0.287 . . . . 1.1699999999999999 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 0.72999999999999998 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.1299999999999999 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 0.68000000000000005 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.83999999999999997 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 0.82999999999999996 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.57999999999999996 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 0.28999999999999998 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 0.85999999999999999 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26000000000000001 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 1.54 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.3 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 0.97999999999999998 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 0.29999999999999999 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 1.96 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 0.47999999999999998 115.002 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.1100000000000001 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.72999999999999998 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 1.76 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 0.54000000000000004 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.34999999999999998 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 1.96 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 0.25 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 0.28000000000000003 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.52000000000000002 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 0.23000000000000001 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.35999999999999999 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 2.7000000000000002 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 0.23000000000000001 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 0.23000000000000001 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 0.65000000000000002 107.41 160.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.8899999999999999 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26000000000000001 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.46000000000000002 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.8899999999999999 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.27000000000000002 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.35999999999999999 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 0.40000000000000002 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.24 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.6699999999999999 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 0.28000000000000003 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 0.59999999999999998 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.68000000000000005 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.2999999999999998 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.27 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 0.59999999999999998 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 0.87 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.0699999999999998 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 0.27000000000000002 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 0.87 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 0.26000000000000001 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 0.27000000000000002 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.28999999999999998 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.20999999999999999 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 0.17000000000000001 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 0.27000000000000002 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' A' ' 121' ' ' ARG . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 0.59999999999999998 111.166 164.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.407 ' HD3' ' CE2' ' A' ' 119' ' ' TYR . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.0899999999999999 111.986 -169.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 0.89000000000000001 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.1299999999999999 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 1.76 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.0600000000000001 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 0.40999999999999998 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.01 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.35999999999999999 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 0.27000000000000002 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46000000000000002 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 0.72999999999999998 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.42999999999999999 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 0.96999999999999997 112.882 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.52 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.9199999999999999 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 1.8999999999999999 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.23999999999999999 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.23999999999999999 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.6699999999999999 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 119' ' ' TYR . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.22 113.661 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.0600000000000001 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 1.8200000000000001 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 0.27000000000000002 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.2 111.735 165.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.40000000000000002 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 0.38 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 0.70999999999999996 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.04 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 0.57999999999999996 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 0.28000000000000003 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.1899999999999999 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 0.40000000000000002 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.3999999999999999 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.0900000000000001 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 2.8399999999999999 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.5600000000000001 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 0.44 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 0.84999999999999998 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 0.39000000000000001 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.4099999999999999 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 0.20000000000000001 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.1499999999999999 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.1599999999999999 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.6799999999999999 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.3700000000000001 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.8500000000000001 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 3.9900000000000002 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 0.28999999999999998 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.28999999999999998 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.22 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.21 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 11.6 p90 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67000000000000004 113.09 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 62.0 t-80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 122.936 1.351 . . . . 0.93999999999999995 111.158 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 0.72999999999999998 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.1299999999999999 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.68000000000000005 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.83999999999999997 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 0.82999999999999996 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.57999999999999996 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 0.28999999999999998 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 0.85999999999999999 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26000000000000001 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 1.54 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.3 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 0.97999999999999998 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 0.29999999999999999 109.318 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 1.96 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' LYS . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 0.47999999999999998 118.818 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.446 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.1100000000000001 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 113.81 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 73' ' ' THR . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 1.76 109.919 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 0.54000000000000004 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.34999999999999998 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 1.96 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 0.25 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 0.28000000000000003 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 0.17999999999999999 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.52000000000000002 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 0.23000000000000001 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.35999999999999999 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 2.7000000000000002 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 0.23000000000000001 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 0.23000000000000001 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 0.65000000000000002 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.8899999999999999 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26000000000000001 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.46000000000000002 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.8899999999999999 112.621 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CD1' HD11 ' A' ' 21' ' ' LEU . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.26000000000000001 113.687 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.35999999999999999 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 0.40000000000000002 117.955 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.24 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.6699999999999999 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 0.28000000000000003 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 0.59999999999999998 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.68000000000000005 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.2999999999999998 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.27 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 0.59999999999999998 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 0.87 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.0699999999999998 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 0.27000000000000002 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 0.87 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 0.26000000000000001 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 0.27000000000000002 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.28999999999999998 110.355 165.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.20999999999999999 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 0.17000000000000001 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 0.27000000000000002 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.419 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 0.59999999999999998 113.044 167.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.0899999999999999 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.609 ' H ' ' HB3' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 0.89000000000000001 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.1299999999999999 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 1.76 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.0600000000000001 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 0.40999999999999998 108.486 153.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 126' ' ' LEU . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.01 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.35999999999999999 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 0.27000000000000002 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46000000000000002 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.75 ' H ' ' HB2' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 0.72999999999999998 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.42999999999999999 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 0.96999999999999997 115.894 165.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.52 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.684 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.9199999999999999 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 1.8999999999999999 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.23999999999999999 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.684 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.23999999999999999 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.6699999999999999 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.22 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.0600000000000001 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 1.8200000000000001 109.859 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 0.27000000000000002 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.2 114.769 -166.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.40000000000000002 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 0.38 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 0.70999999999999996 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.04 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 0.57999999999999996 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 0.28000000000000003 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.1899999999999999 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 0.40000000000000002 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.3999999999999999 112.108 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.0900000000000001 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 2.8399999999999999 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.5600000000000001 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 0.44 109.938 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 0.84999999999999998 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 0.39000000000000001 116.653 -169.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.4099999999999999 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 0.20000000000000001 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.1499999999999999 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.1599999999999999 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.6799999999999999 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.3700000000000001 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.8500000000000001 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 3.9900000000000002 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 0.28999999999999998 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.28999999999999998 105.9 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.22 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.21 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67000000000000004 106.709 173.14 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 108.734 -0.839 . . . . 1.1699999999999999 108.734 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 0.72999999999999998 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.1299999999999999 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 0.68000000000000005 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.83999999999999997 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 0.82999999999999996 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.57999999999999996 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 0.28999999999999998 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 0.85999999999999999 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26000000000000001 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 1.54 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.3 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 0.97999999999999998 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 0.29999999999999999 107.531 -165.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 1.96 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 0.47999999999999998 113.833 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.1100000000000001 114.507 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.72999999999999998 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 1.76 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 0.54000000000000004 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.34999999999999998 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 1.96 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 0.25 108.613 167.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 0.28000000000000003 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 0.17999999999999999 110.184 168.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.52000000000000002 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 0.23000000000000001 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.35999999999999999 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 2.7000000000000002 106.999 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 0.23000000000000001 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 0.23000000000000001 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 0.65000000000000002 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.8899999999999999 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26000000000000001 109.368 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.46000000000000002 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.8899999999999999 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.27000000000000002 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.35999999999999999 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.40000000000000002 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.24 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.6699999999999999 116.755 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 0.59999999999999998 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.68000000000000005 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.2999999999999998 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.27 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 0.59999999999999998 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 0.87 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.0699999999999998 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 0.27000000000000002 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 0.87 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 0.26000000000000001 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 0.27000000000000002 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.28999999999999998 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.20999999999999999 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 0.17000000000000001 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 0.27000000000000002 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 0.59999999999999998 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.0899999999999999 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 0.89000000000000001 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.1299999999999999 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 1.76 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.0600000000000001 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 0.40999999999999998 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.75 ' HB2' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.01 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.35999999999999999 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 0.27000000000000002 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46000000000000002 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 0.72999999999999998 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.42999999999999999 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 0.96999999999999997 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.52 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.9199999999999999 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 1.8999999999999999 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.23999999999999999 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 2.54 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.6699999999999999 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.22 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 1.8200000000000001 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 0.27000000000000002 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.2 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.40000000000000002 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 0.38 108.537 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 0.70999999999999996 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.04 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 0.57999999999999996 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 0.28000000000000003 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.1899999999999999 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 0.40000000000000002 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.3999999999999999 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.0900000000000001 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 2.8399999999999999 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.5600000000000001 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 0.44 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 0.84999999999999998 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 0.39000000000000001 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.4099999999999999 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 0.20000000000000001 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.1499999999999999 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.1599999999999999 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.6799999999999999 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.3700000000000001 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.8500000000000001 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 3.9900000000000002 108.816 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 0.28999999999999998 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.28999999999999998 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.22 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.21 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.83999999999999997 106.918 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.347 -0.612 . . . . 1.1699999999999999 109.347 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 0.72999999999999998 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.1299999999999999 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 0.68000000000000005 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.83999999999999997 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 0.82999999999999996 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 83' ' ' VAL . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.57999999999999996 107.879 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 0.28999999999999998 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 0.85999999999999999 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26000000000000001 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 1.54 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.3 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 0.97999999999999998 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 0.29999999999999999 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 1.96 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.636 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 0.47999999999999998 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.1100000000000001 109.449 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.72999999999999998 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 1.76 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 0.54000000000000004 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.34999999999999998 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 1.96 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 0.25 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 0.28000000000000003 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 63' ' ' PHE . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 0.17999999999999999 111.344 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.52000000000000002 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 0.23000000000000001 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.35999999999999999 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 2.7000000000000002 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 0.23000000000000001 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 0.23000000000000001 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 0.65000000000000002 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.8899999999999999 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26000000000000001 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.46000000000000002 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.8899999999999999 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.27000000000000002 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.35999999999999999 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 0.40000000000000002 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.24 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.6699999999999999 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 0.28000000000000003 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 0.59999999999999998 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.68000000000000005 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.2999999999999998 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.27 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 0.59999999999999998 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 0.87 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.0699999999999998 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 0.27000000000000002 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 0.87 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 0.26000000000000001 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 0.27000000000000002 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.28999999999999998 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.20999999999999999 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 0.17000000000000001 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 0.27000000000000002 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 0.59999999999999998 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.0899999999999999 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 0.89000000000000001 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.1299999999999999 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 1.76 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.0600000000000001 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 0.40999999999999998 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.01 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.35999999999999999 117.196 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 0.27000000000000002 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46000000000000002 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 0.72999999999999998 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.42999999999999999 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 0.96999999999999997 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.52 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.9199999999999999 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 1.8999999999999999 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.23999999999999999 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 2.54 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.6699999999999999 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 114' ' ' ILE . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.22 108.96 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.0600000000000001 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 1.8200000000000001 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 0.27000000000000002 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.2 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.40000000000000002 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 0.38 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 0.70999999999999996 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.04 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 0.57999999999999996 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 0.28000000000000003 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.651 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.1899999999999999 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 0.40000000000000002 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.3999999999999999 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.0900000000000001 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 2.8399999999999999 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.5600000000000001 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 0.44 112.917 -166.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 0.84999999999999998 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 0.39000000000000001 110.338 -161.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.4099999999999999 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 0.20000000000000001 111.654 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.1499999999999999 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.1599999999999999 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.6799999999999999 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.3700000000000001 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.8500000000000001 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 3.9900000000000002 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 0.28999999999999998 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.546 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.28999999999999998 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.22 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.546 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.21 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.83999999999999997 105.55 154.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.431 -0.581 . . . . 1.1699999999999999 109.431 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 0.72999999999999998 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.1299999999999999 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 0.68000000000000005 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.83999999999999997 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 0.82999999999999996 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.57999999999999996 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 0.28999999999999998 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 0.85999999999999999 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 1.54 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.3 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 0.97999999999999998 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 0.29999999999999999 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 1.96 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 0.47999999999999998 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.1100000000000001 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.72999999999999998 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 1.76 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 0.54000000000000004 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.34999999999999998 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 1.96 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 0.25 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 0.28000000000000003 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 0.17999999999999999 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.52000000000000002 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 0.23000000000000001 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.35999999999999999 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 2.7000000000000002 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 0.23000000000000001 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 0.23000000000000001 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 0.65000000000000002 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.8899999999999999 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26000000000000001 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.46000000000000002 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.8899999999999999 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 21' ' ' LEU . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.26000000000000001 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.35999999999999999 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 0.40000000000000002 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.24 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.6699999999999999 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 0.28000000000000003 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 0.59999999999999998 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.68000000000000005 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.2999999999999998 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.27 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 0.59999999999999998 108.678 -154.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 0.87 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.0699999999999998 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 0.27000000000000002 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 0.87 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 0.26000000000000001 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 0.27000000000000002 107.636 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.28999999999999998 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.20999999999999999 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 0.17000000000000001 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 0.27000000000000002 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 0.59999999999999998 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.0899999999999999 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 0.89000000000000001 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.1299999999999999 110.012 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 1.76 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.0600000000000001 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 0.40999999999999998 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.496 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.01 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.35999999999999999 117.047 -160.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 0.27000000000000002 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46000000000000002 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 0.72999999999999998 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.42999999999999999 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 0.96999999999999997 113.946 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.52 113.985 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.9199999999999999 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 1.8999999999999999 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.23999999999999999 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 2.54 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.6699999999999999 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.22 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.0600000000000001 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 1.8200000000000001 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 0.27000000000000002 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.2 114.005 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.40000000000000002 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 0.38 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 0.70999999999999996 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.04 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 0.57999999999999996 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 0.28000000000000003 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.1899999999999999 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 0.40000000000000002 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.3999999999999999 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.0900000000000001 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 2.8399999999999999 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.5600000000000001 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 0.44 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 0.84999999999999998 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 0.39000000000000001 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.4099999999999999 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 0.20000000000000001 113.132 -163.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.1499999999999999 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.1599999999999999 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.6799999999999999 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.3700000000000001 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.8500000000000001 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 3.9900000000000002 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 0.28999999999999998 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.28999999999999998 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.22 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.21 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.83999999999999997 105.038 173.726 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.686 -0.197 . . . . 1.1699999999999999 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 0.72999999999999998 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.1299999999999999 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 0.68000000000000005 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.83999999999999997 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 0.82999999999999996 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.57999999999999996 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 0.28999999999999998 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 0.85999999999999999 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26000000000000001 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 1.54 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.3 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 0.97999999999999998 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 0.29999999999999999 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 1.96 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 0.47999999999999998 111.925 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.1100000000000001 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.72999999999999998 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 1.76 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 0.54000000000000004 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.34999999999999998 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 1.96 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 0.25 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 0.28000000000000003 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 0.17999999999999999 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.52000000000000002 109.992 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 0.23000000000000001 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.35999999999999999 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 2.7000000000000002 108.171 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 0.23000000000000001 109.61 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 0.23000000000000001 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 0.65000000000000002 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.8899999999999999 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26000000000000001 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.46000000000000002 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.8899999999999999 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.27000000000000002 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.35999999999999999 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.484 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 0.40000000000000002 108.163 161.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.24 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.6699999999999999 117.566 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 108' ' ' LEU . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 0.28000000000000003 107.622 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 0.59999999999999998 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.68000000000000005 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.2999999999999998 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' C ' HD22 ' A' ' 108' ' ' LEU . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.27 109.411 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 107' ' ' LYS 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 0.59999999999999998 105.104 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 0.87 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.0699999999999998 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 0.27000000000000002 109.037 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 0.87 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 0.26000000000000001 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 0.27000000000000002 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.28999999999999998 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.20999999999999999 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 0.17000000000000001 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 0.27000000000000002 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 0.59999999999999998 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.0899999999999999 107.111 164.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' A' ' 10' ' ' SER . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 0.89000000000000001 111.019 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.1299999999999999 112.498 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 1.76 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.0600000000000001 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 0.40999999999999998 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.01 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.549 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.35999999999999999 117.846 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 0.27000000000000002 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46000000000000002 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 0.72999999999999998 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.42999999999999999 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 0.96999999999999997 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.52 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.9199999999999999 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 1.8999999999999999 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.23999999999999999 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 2.54 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.6699999999999999 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.22 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.0600000000000001 114.504 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 1.8200000000000001 112.294 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 0.27000000000000002 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 21' ' ' LEU . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.2 112.448 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.40000000000000002 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 0.38 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 0.70999999999999996 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.04 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 0.57999999999999996 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 0.28000000000000003 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.1899999999999999 109.192 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 0.40000000000000002 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.3999999999999999 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.0900000000000001 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 2.8399999999999999 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.5600000000000001 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 36' ' ' ILE . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 0.44 117.559 -174.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 0.84999999999999998 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 0.39000000000000001 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.4099999999999999 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 0.20000000000000001 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.1499999999999999 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.1599999999999999 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.6799999999999999 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.3700000000000001 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.8500000000000001 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26000000000000001 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 0.28999999999999998 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.28999999999999998 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.22 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.455 HE21 ' H28' ' A' ' 201' ' ' GCH . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.21 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 1.308 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 -130.59 159.09 38.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67000000000000004 111.973 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m -23.72 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 120.797 3.628 . . . . 2.5699999999999998 120.797 -159.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.82 -2.32 84.36 Favored Glycine 0 CA--C 1.478 -2.242 0 CA-C-N 122.227 2.285 . . . . 2.4500000000000002 111.043 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.25 33.19 7.8 Favored Glycine 0 CA--C 1.476 -2.346 0 O-C-N 118.09 -3.006 . . . . 1.5600000000000001 106.153 164.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 1.308 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 -71.99 138.17 47.79 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 119.834 -1.98 . . . . 1.1699999999999999 109.615 160.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 0.72999999999999998 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.1299999999999999 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 0.68000000000000005 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.83999999999999997 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 0.82999999999999996 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.814 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.27000000000000002 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 0.28999999999999998 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 0.85999999999999999 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26000000000000001 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 1.54 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.3 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 0.97999999999999998 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 0.29999999999999999 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 1.96 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.427 ' HA ' H152 ' A' ' 202' ' ' CHO . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 0.47999999999999998 116.688 -162.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.1100000000000001 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.72999999999999998 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 1.76 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 0.54000000000000004 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.34999999999999998 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 1.96 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 94' ' ' PHE . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 0.25 109.063 154.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 0.28000000000000003 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 0.17999999999999999 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.52000000000000002 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 0.23000000000000001 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.35999999999999999 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 2.7000000000000002 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 0.23000000000000001 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 0.23000000000000001 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 0.65000000000000002 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.8899999999999999 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 81' ' ' ALA . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26000000000000001 105.199 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.46000000000000002 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.8899999999999999 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.27000000000000002 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.35999999999999999 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 0.40000000000000002 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.24 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.6699999999999999 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 0.28000000000000003 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.68000000000000005 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.2999999999999998 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.27 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 0.59999999999999998 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 0.87 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.0699999999999998 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 0.27000000000000002 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 0.87 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 0.26000000000000001 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 0.27000000000000002 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.28999999999999998 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.20999999999999999 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 0.17000000000000001 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 0.27000000000000002 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.28999999999999998 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.622 ' HD3' ' H31' ' A' ' 201' ' ' GCH . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.0899999999999999 108.462 -166.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 0.89000000000000001 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.1299999999999999 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 1.76 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.0600000000000001 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 0.40999999999999998 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.622 ' H31' ' HD3' ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.814 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.01 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 40' ' ' VAL . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.35999999999999999 113.581 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 0.27000000000000002 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46000000000000002 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 0.72999999999999998 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.42999999999999999 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 0.96999999999999997 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.52 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.9199999999999999 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 1.8999999999999999 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.23999999999999999 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 2.54 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.6699999999999999 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.22 110.228 -166.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.0600000000000001 114.202 -176.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 1.8200000000000001 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 0.27000000000000002 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 18' ' ' MET . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.2 111.386 164.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.40000000000000002 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 0.38 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 0.70999999999999996 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.04 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 0.57999999999999996 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 0.28000000000000003 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.1899999999999999 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 0.40000000000000002 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.3999999999999999 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.0900000000000001 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 2.8399999999999999 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.5600000000000001 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 0.44 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 0.84999999999999998 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 0.39000000000000001 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.4099999999999999 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 2' ' ' PHE . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 0.20000000000000001 106.172 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.1499999999999999 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.1599999999999999 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.6799999999999999 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.3700000000000001 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.8500000000000001 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 3.9900000000000002 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 0.28999999999999998 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.28999999999999998 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.22 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.21 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.406 7.4 p90 -70.19 103.11 2.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.83999999999999997 113.742 159.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.7 p 37.58 -123.75 0.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.759 2.503 . . . . 2.5699999999999998 117.759 -154.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.91 3.32 67.25 Favored Glycine 0 N--CA 1.481 1.64 0 O-C-N 119.397 -2.064 . . . . 2.4500000000000002 113.156 159.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.92 -52.23 52.32 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 128.43 2.919 . . . . 1.5600000000000001 115.806 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 4.6 t-160 -159.45 146.26 16.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 119.258 -2.319 . . . . 1.1699999999999999 113.829 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 0.72999999999999998 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 0.68000000000000005 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.83999999999999997 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 0.82999999999999996 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.57999999999999996 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 0.28999999999999998 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 0.85999999999999999 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26000000000000001 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 1.54 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.3 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 0.97999999999999998 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 0.29999999999999999 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 1.96 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 0.47999999999999998 115.396 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.1100000000000001 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.72999999999999998 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 1.76 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 0.54000000000000004 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.34999999999999998 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 1.96 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 0.25 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 0.28000000000000003 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 0.17999999999999999 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.52000000000000002 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.23000000000000001 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.35999999999999999 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 2.7000000000000002 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 0.23000000000000001 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 0.23000000000000001 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 0.65000000000000002 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.8899999999999999 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26000000000000001 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.46000000000000002 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.8899999999999999 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.858 ' OH ' ' C21' ' A' ' 202' ' ' CHO . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.26000000000000001 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.35999999999999999 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 0.40000000000000002 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.24 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.6699999999999999 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 0.28000000000000003 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 0.59999999999999998 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.68000000000000005 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.2999999999999998 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.27 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 0.59999999999999998 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 0.87 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.0699999999999998 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 0.27000000000000002 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 0.87 109.265 -150.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 0.26000000000000001 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.589 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 0.27000000000000002 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.20999999999999999 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 0.17000000000000001 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 0.27000000000000002 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 0.59999999999999998 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.743 ' HE ' ' H30' ' A' ' 201' ' ' GCH . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.0899999999999999 113.047 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 0.89000000000000001 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.516 ' CB ' ' H36' ' A' ' 201' ' ' GCH . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.1299999999999999 115.03 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 1.76 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.0600000000000001 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 0.40999999999999998 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.743 ' H30' ' HE ' ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.858 ' C21' ' OH ' ' A' ' 97' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.01 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB3' ' H2 ' ' A' ' 201' ' ' GCH . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.35999999999999999 110.282 -161.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 0.27000000000000002 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46000000000000002 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' HD11 ' A' ' 126' ' ' LEU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 0.72999999999999998 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.42999999999999999 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 0.96999999999999997 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.557 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.52 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' CA ' ' HE ' ' A' ' 121' ' ' ARG . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.9199999999999999 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 1.8999999999999999 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.23999999999999999 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 2.54 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.6699999999999999 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.22 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB3' HD12 ' A' ' 23' ' ' ILE . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.0600000000000001 114.06 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 1.8200000000000001 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 0.27000000000000002 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.2 112.074 167.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.40000000000000002 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 H232 ' A' ' 202' ' ' CHO . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 0.38 107.699 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 0.70999999999999996 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.04 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 23' ' ' ILE . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 0.57999999999999996 112.052 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 0.28000000000000003 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.1899999999999999 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 0.40000000000000002 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.3999999999999999 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.0900000000000001 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 2.8399999999999999 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.5600000000000001 108.521 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' C24' ' A' ' 201' ' ' GCH 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 0.44 119.555 166.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 0.84999999999999998 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 0.39000000000000001 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.4099999999999999 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 0.20000000000000001 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.1499999999999999 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.1599999999999999 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.6799999999999999 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.3700000000000001 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.8500000000000001 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 3.9900000000000002 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 0.28999999999999998 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.28999999999999998 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.22 109.909 -173.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.21 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 -65.61 103.54 0.88 Allowed 'General case' 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.83999999999999997 115.783 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.0 p 49.61 28.15 2.45 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 129.008 2.923 . . . . 2.5699999999999998 114.586 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.79 -3.98 47.22 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 121.357 3.303 . . . . 2.4500000000000002 121.357 -165.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.42 -25.23 48.21 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.021 -1.87 . . . . 1.5600000000000001 115.347 -170.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 -162.81 167.42 22.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.1699999999999999 105.687 172.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 0.72999999999999998 110.327 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.1299999999999999 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 0.68000000000000005 105.797 -162.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.83999999999999997 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 0.82999999999999996 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.57999999999999996 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 0.28999999999999998 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 0.85999999999999999 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26000000000000001 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 1.54 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.3 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 0.97999999999999998 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 0.29999999999999999 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 1.96 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 0.47999999999999998 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.562 ' H ' H162 ' A' ' 202' ' ' CHO . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.1100000000000001 112.616 164.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.72999999999999998 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 1.76 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 0.54000000000000004 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.34999999999999998 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 1.96 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 0.25 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 0.28000000000000003 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 0.17999999999999999 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.52000000000000002 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 0.23000000000000001 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.35999999999999999 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 2.7000000000000002 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 0.23000000000000001 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 0.23000000000000001 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 0.65000000000000002 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.8899999999999999 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26000000000000001 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.46000000000000002 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.8899999999999999 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE1' HD21 ' A' ' 21' ' ' LEU 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.26000000000000001 115.981 -177.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.35999999999999999 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.438 ' OE1' H122 ' A' ' 202' ' ' CHO . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 0.40000000000000002 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.49 ' HB3' ' H11' ' A' ' 201' ' ' GCH . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.24 112.653 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.6699999999999999 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 0.28000000000000003 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 0.59999999999999998 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.68000000000000005 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.2999999999999998 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.27 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.428 HD12 ' H7 ' ' A' ' 201' ' ' GCH . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 0.59999999999999998 108.488 -161.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 0.87 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.0699999999999998 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 0.27000000000000002 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 0.87 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 0.26000000000000001 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 0.27000000000000002 107.475 170.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.28999999999999998 119.952 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.20999999999999999 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 0.17000000000000001 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 0.27000000000000002 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 0.59999999999999998 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.52 ' HE ' ' CA ' ' A' ' 11' ' ' GLU . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.0899999999999999 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.557 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 0.89000000000000001 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.1299999999999999 110.728 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 1.76 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.0600000000000001 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.567 HD11 ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 0.40999999999999998 113.964 168.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.49 ' H11' ' HB3' ' A' ' 101' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.562 H162 ' H ' ' A' ' 74' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.01 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.35999999999999999 114.347 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 0.27000000000000002 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46000000000000002 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 0.72999999999999998 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.42999999999999999 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.96999999999999997 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.52 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.9199999999999999 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 1.8999999999999999 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.23999999999999999 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 2.54 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.6699999999999999 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17000000000000001 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.0600000000000001 117.088 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 1.8200000000000001 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 0.27000000000000002 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.2 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.40000000000000002 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 0.38 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 0.70999999999999996 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.04 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 0.57999999999999996 114.03 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 0.28000000000000003 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.1899999999999999 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 0.40000000000000002 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.3999999999999999 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.0900000000000001 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 54' ' ' SER . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78000000000000003 117.961 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HA ' ' O5 ' ' A' ' 201' ' ' GCH 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.5600000000000001 116.794 -175.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 0.44 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 0.84999999999999998 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.514 HG21 ' H42' ' A' ' 201' ' ' GCH . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 0.39000000000000001 114.76 -166.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.4099999999999999 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG21 ' C5 ' ' A' ' 201' ' ' GCH . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 0.20000000000000001 107.211 -168.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.1499999999999999 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.1599999999999999 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.6799999999999999 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.3700000000000001 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.8500000000000001 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 3.9900000000000002 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 0.28999999999999998 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.28999999999999998 106.727 167.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.22 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.21 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -63.88 65.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.83999999999999997 116.399 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.49 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . 82.7 p 59.22 8.33 1.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.223 2.209 . . . . 2.5699999999999998 115.018 -158.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.94 55.86 Favored Glycine 0 C--O 1.258 1.654 0 O-C-N 121.943 -0.473 . . . . 2.4500000000000002 114.071 -165.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.78 -16.12 68.79 Favored Glycine 0 C--N 1.364 2.121 0 O-C-N 117.942 -3.093 . . . . 1.5600000000000001 111.793 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -170.35 123.0 0.67 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-N 123.65 3.725 . . . . 1.1699999999999999 106.117 -167.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 0.72999999999999998 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.1299999999999999 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 0.68000000000000005 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.83999999999999997 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 0.82999999999999996 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.69 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.57999999999999996 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 0.28999999999999998 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 0.85999999999999999 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26000000000000001 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 1.54 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.3 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 0.97999999999999998 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 0.29999999999999999 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 1.96 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.462 ' HB ' ' N25' ' A' ' 202' ' ' CHO . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 0.47999999999999998 114.518 -163.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.441 ' SD ' H213 ' A' ' 202' ' ' CHO . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.1100000000000001 115.047 162.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.72999999999999998 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 1.76 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 0.54000000000000004 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.34999999999999998 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 1.96 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 0.25 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 0.28000000000000003 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.52000000000000002 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 0.23000000000000001 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.35999999999999999 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 2.7000000000000002 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.651 ' HB2' ' H22' ' A' ' 202' ' ' CHO . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 0.23000000000000001 112.423 -167.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 0.23000000000000001 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 0.65000000000000002 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.8899999999999999 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26000000000000001 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.46000000000000002 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.8899999999999999 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.857 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.26000000000000001 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.35999999999999999 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.479 ' HG2' ' C12' ' A' ' 202' ' ' CHO . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 0.40000000000000002 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.24 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.6699999999999999 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 0.28000000000000003 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 0.59999999999999998 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.68000000000000005 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.2999999999999998 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.27 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 0.59999999999999998 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 0.87 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.0699999999999998 110.978 169.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 0.27000000000000002 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.611 ' HG ' ' HH ' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 0.87 108.113 -161.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 0.26000000000000001 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.857 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 0.27000000000000002 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.28999999999999998 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.20999999999999999 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 0.17000000000000001 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 0.27000000000000002 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 0.59999999999999998 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.0899999999999999 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 0.89000000000000001 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.1299999999999999 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 1.76 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.0600000000000001 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 0.40999999999999998 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.611 ' C5 ' HG21 ' A' ' 40' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.69 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.01 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.35999999999999999 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 0.27000000000000002 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46000000000000002 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 0.72999999999999998 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.42999999999999999 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 0.96999999999999997 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.52 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.9199999999999999 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 1.8999999999999999 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.23999999999999999 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 2.54 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.6699999999999999 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.22 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.0600000000000001 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 1.8200000000000001 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 0.27000000000000002 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.2 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.40000000000000002 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 0.38 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 0.70999999999999996 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.04 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 0.57999999999999996 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 0.28000000000000003 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.1899999999999999 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 0.40000000000000002 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.3999999999999999 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.0900000000000001 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 2.8399999999999999 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.5600000000000001 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 0.44 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 0.84999999999999998 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.406 HG21 ' H41' ' A' ' 201' ' ' GCH . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 0.39000000000000001 114.542 -172.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.4099999999999999 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 0.20000000000000001 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.1499999999999999 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.1599999999999999 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.6799999999999999 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.3700000000000001 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.8500000000000001 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 3.9900000000000002 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 0.28999999999999998 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.442 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.28999999999999998 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.22 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.442 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.21 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -70.37 133.54 47.01 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.83999999999999997 106.238 161.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 m -67.1 100.27 0.75 Allowed 'General case' 0 C--O 1.253 1.276 0 CA-C-O 123.504 1.621 . . . . 2.5699999999999998 114.898 164.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.02 -8.02 4.79 Favored Glycine 0 CA--C 1.451 -3.925 0 N-CA-C 121.083 3.193 . . . . 2.4500000000000002 121.083 -162.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 91.15 2.14 Favored Glycine 0 N--CA 1.473 1.165 0 O-C-N 120.381 -1.658 . . . . 1.5600000000000001 114.171 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 171.54 143.59 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 129.214 3.006 . . . . 1.1699999999999999 110.732 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 0.72999999999999998 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.1299999999999999 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 0.68000000000000005 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.83999999999999997 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 0.82999999999999996 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.57999999999999996 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 0.28999999999999998 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 0.85999999999999999 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26000000000000001 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 1.54 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.3 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 0.97999999999999998 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 0.29999999999999999 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 1.96 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' H181 ' A' ' 202' ' ' CHO . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 0.47999999999999998 115.002 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.1100000000000001 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.72999999999999998 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 1.76 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 0.54000000000000004 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.34999999999999998 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 1.96 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 0.25 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 0.28000000000000003 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.52000000000000002 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 0.23000000000000001 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.35999999999999999 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 2.7000000000000002 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 0.23000000000000001 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 0.23000000000000001 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.515 HG22 ' H12' ' A' ' 202' ' ' CHO . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 0.65000000000000002 107.41 160.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.8899999999999999 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26000000000000001 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.46000000000000002 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.8899999999999999 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.27000000000000002 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.35999999999999999 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 0.40000000000000002 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.24 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.6699999999999999 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 0.28000000000000003 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 0.59999999999999998 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.68000000000000005 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.2999999999999998 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.27 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 0.59999999999999998 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 0.87 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.0699999999999998 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 0.27000000000000002 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 0.87 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 0.26000000000000001 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 0.27000000000000002 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.28999999999999998 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.20999999999999999 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 0.17000000000000001 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 0.27000000000000002 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' A' ' 121' ' ' ARG . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 0.59999999999999998 111.166 164.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.407 ' HD3' ' CE2' ' A' ' 119' ' ' TYR . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.0899999999999999 111.986 -169.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 0.89000000000000001 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.1299999999999999 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 1.76 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.0600000000000001 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 0.40999999999999998 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.636 ' H38' ' H20' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.515 ' H12' HG22 ' A' ' 92' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.01 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.35999999999999999 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 0.27000000000000002 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46000000000000002 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 0.72999999999999998 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.42999999999999999 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.516 ' SD ' ' H20' ' A' ' 201' ' ' GCH . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 0.96999999999999997 112.882 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.52 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.9199999999999999 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 1.8999999999999999 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.23999999999999999 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.23999999999999999 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.6699999999999999 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 119' ' ' TYR . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.22 113.661 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.0600000000000001 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 1.8200000000000001 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 0.27000000000000002 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.2 111.735 165.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.40000000000000002 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 0.38 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 0.70999999999999996 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.04 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 0.57999999999999996 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 0.28000000000000003 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.1899999999999999 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 0.40000000000000002 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.3999999999999999 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.0900000000000001 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 2.8399999999999999 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.5600000000000001 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 0.44 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 0.84999999999999998 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 0.39000000000000001 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.4099999999999999 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 0.20000000000000001 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.1499999999999999 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.1599999999999999 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.6799999999999999 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.3700000000000001 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.8500000000000001 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 3.9900000000000002 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 0.28999999999999998 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.28999999999999998 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.22 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.21 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 11.6 p90 -102.48 159.72 15.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67000000000000004 113.09 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -17.93 40.44 Favored 'General case' 0 N--CA 1.483 1.183 1 N-CA-C 122.061 4.097 . . . . 2.5699999999999998 122.061 -162.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.9 2.87 31.14 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 119.909 2.723 . . . . 2.4500000000000002 119.909 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.31 24.71 42.57 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 115.523 -2.821 . . . . 1.5600000000000001 112.939 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 62.0 t-80 -102.74 129.83 49.5 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.094 1.947 . . . . 0.93999999999999995 111.158 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 0.72999999999999998 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.1299999999999999 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.68000000000000005 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.83999999999999997 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 0.82999999999999996 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.57999999999999996 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 0.28999999999999998 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 0.85999999999999999 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26000000000000001 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 1.54 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.3 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 0.97999999999999998 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.41 HG23 H193 ' A' ' 202' ' ' CHO . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 0.29999999999999999 109.318 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 1.96 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.765 ' HA ' H181 ' A' ' 202' ' ' CHO . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 0.47999999999999998 118.818 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.446 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.1100000000000001 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' N ' ' OT1' ' A' ' 202' ' ' CHO . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 113.81 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 73' ' ' THR . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 1.76 109.919 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 0.54000000000000004 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.34999999999999998 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 1.96 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 0.25 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 0.28000000000000003 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 0.17999999999999999 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.52000000000000002 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 0.23000000000000001 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.35999999999999999 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 2.7000000000000002 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 0.23000000000000001 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 0.23000000000000001 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 0.65000000000000002 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.8899999999999999 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26000000000000001 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.46000000000000002 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.8899999999999999 112.621 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CD1' HD11 ' A' ' 21' ' ' LEU . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.26000000000000001 113.687 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.35999999999999999 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 0.40000000000000002 117.955 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.24 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.6699999999999999 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 0.28000000000000003 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 0.59999999999999998 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.68000000000000005 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.2999999999999998 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.27 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 0.59999999999999998 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 0.87 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.0699999999999998 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 0.27000000000000002 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 0.87 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 0.26000000000000001 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 0.27000000000000002 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.28999999999999998 110.355 165.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.20999999999999999 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 0.17000000000000001 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 0.27000000000000002 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 0.59999999999999998 113.044 167.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.0899999999999999 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.609 ' H ' ' HB3' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 0.89000000000000001 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.1299999999999999 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 1.76 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.0600000000000001 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 0.40999999999999998 108.486 153.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 126' ' ' LEU . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.516 ' H20' ' SD ' ' A' ' 8' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.765 H181 ' HA ' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.01 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.35999999999999999 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 0.27000000000000002 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46000000000000002 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.75 ' H ' ' HB2' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 0.72999999999999998 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.42999999999999999 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 0.96999999999999997 115.894 165.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.52 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.684 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.9199999999999999 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 1.8999999999999999 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.23999999999999999 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.684 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.23999999999999999 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.6699999999999999 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.22 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.0600000000000001 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 1.8200000000000001 109.859 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 0.27000000000000002 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 H231 ' A' ' 202' ' ' CHO 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.2 114.769 -166.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.40000000000000002 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 0.38 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 0.70999999999999996 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.04 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 0.57999999999999996 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 0.28000000000000003 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.1899999999999999 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 0.40000000000000002 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.3999999999999999 112.108 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.0900000000000001 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 2.8399999999999999 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.5600000000000001 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 HD12 ' H24' ' A' ' 201' ' ' GCH . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 0.44 109.938 -171.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 0.84999999999999998 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H41' ' A' ' 201' ' ' GCH . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 0.39000000000000001 116.653 -169.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.4099999999999999 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 0.20000000000000001 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.1499999999999999 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.1599999999999999 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.6799999999999999 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.3700000000000001 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.8500000000000001 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 3.9900000000000002 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 0.28999999999999998 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.28999999999999998 105.9 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.22 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.21 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -65.05 133.11 50.94 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67000000000000004 106.709 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -68.17 -26.06 65.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.548 0.739 . . . . 2.5699999999999998 112.848 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.78 -0.66 27.06 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.654 1.597 . . . . 2.4500000000000002 115.695 163.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.68 54.84 1.11 Allowed Glycine 0 CA--C 1.473 -2.569 0 N-CA-C 118.175 2.03 . . . . 1.5600000000000001 118.175 155.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -145.25 141.41 28.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.781 -1.423 . . . . 1.1699999999999999 108.734 162.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 0.72999999999999998 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.1299999999999999 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 0.68000000000000005 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.83999999999999997 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 0.82999999999999996 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.57999999999999996 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 0.28999999999999998 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 0.85999999999999999 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26000000000000001 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 1.54 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.3 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 0.97999999999999998 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 H191 ' A' ' 202' ' ' CHO . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 0.29999999999999999 107.531 -165.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 1.96 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 0.47999999999999998 113.833 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.432 ' HB2' H222 ' A' ' 202' ' ' CHO . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.1100000000000001 114.507 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.72999999999999998 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 1.76 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 0.54000000000000004 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.34999999999999998 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 1.96 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 0.25 108.613 167.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 0.28000000000000003 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.479 HG22 H192 ' A' ' 202' ' ' CHO . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 0.17999999999999999 110.184 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.52000000000000002 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 0.23000000000000001 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.35999999999999999 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 2.7000000000000002 106.999 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 0.23000000000000001 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 0.23000000000000001 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 0.65000000000000002 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.8899999999999999 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26000000000000001 109.368 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.46000000000000002 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.8899999999999999 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.27000000000000002 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.35999999999999999 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.40000000000000002 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.24 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.6699999999999999 116.755 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 0.59999999999999998 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.68000000000000005 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.2999999999999998 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.27 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 0.59999999999999998 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 0.87 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.0699999999999998 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 0.27000000000000002 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 0.87 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 0.26000000000000001 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 0.27000000000000002 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.28999999999999998 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.20999999999999999 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 0.17000000000000001 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 0.27000000000000002 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 0.59999999999999998 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.0899999999999999 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 0.89000000000000001 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.1299999999999999 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 1.76 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.0600000000000001 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 0.40999999999999998 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.75 ' HB2' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.65 ' H41' HG21 ' A' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.614 H191 HG23 ' A' ' 71' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.01 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.35999999999999999 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 0.27000000000000002 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46000000000000002 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 0.72999999999999998 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.42999999999999999 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 0.96999999999999997 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.52 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.9199999999999999 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 1.8999999999999999 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.23999999999999999 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 2.54 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.6699999999999999 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.22 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 1.8200000000000001 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 0.27000000000000002 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.2 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.40000000000000002 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.539 HD11 ' HN ' ' A' ' 202' ' ' CHO . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 0.38 108.537 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 0.70999999999999996 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.04 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 0.57999999999999996 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 0.28000000000000003 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.1899999999999999 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 0.40000000000000002 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.3999999999999999 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.0900000000000001 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 2.8399999999999999 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.5600000000000001 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 0.44 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 0.84999999999999998 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 0.39000000000000001 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.4099999999999999 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 0.20000000000000001 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.1499999999999999 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.1599999999999999 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.6799999999999999 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.3700000000000001 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.8500000000000001 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.418 ' HE2' ' H2 ' ' A' ' 201' ' ' GCH . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 3.9900000000000002 108.816 -167.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 0.28999999999999998 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.28999999999999998 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.22 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.21 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 -59.24 132.56 54.37 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.83999999999999997 106.918 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -75.58 6.99 4.07 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 126.46 3.028 . . . . 2.5699999999999998 115.445 164.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.18 -7.54 88.33 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 119.021 -2.3 . . . . 2.4500000000000002 115.665 159.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.56 47.83 2.27 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 121.161 2.48 . . . . 1.5600000000000001 116.39 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 -154.06 162.9 40.87 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.755 1.277 . . . . 1.1699999999999999 109.347 170.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 0.72999999999999998 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.1299999999999999 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 0.68000000000000005 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.83999999999999997 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 0.82999999999999996 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 83' ' ' VAL . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.57999999999999996 107.879 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 0.28999999999999998 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 0.85999999999999999 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26000000000000001 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 1.54 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.3 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 0.97999999999999998 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 0.29999999999999999 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 1.96 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.636 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 0.47999999999999998 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.44 ' H ' H162 ' A' ' 202' ' ' CHO . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.1100000000000001 109.449 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.72999999999999998 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 1.76 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 0.54000000000000004 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.34999999999999998 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 1.96 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 0.25 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 0.28000000000000003 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 63' ' ' PHE . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 0.17999999999999999 111.344 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.52000000000000002 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 0.23000000000000001 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.35999999999999999 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 2.7000000000000002 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 0.23000000000000001 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 0.23000000000000001 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 0.65000000000000002 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.8899999999999999 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26000000000000001 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.46000000000000002 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.8899999999999999 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.27000000000000002 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.35999999999999999 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 0.40000000000000002 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.24 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.6699999999999999 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 0.28000000000000003 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 0.59999999999999998 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.68000000000000005 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.2999999999999998 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.27 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 0.59999999999999998 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 0.87 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.0699999999999998 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 0.27000000000000002 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 0.87 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 0.26000000000000001 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 0.27000000000000002 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.28999999999999998 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.20999999999999999 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 0.17000000000000001 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 0.27000000000000002 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 0.59999999999999998 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.0899999999999999 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 0.89000000000000001 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.1299999999999999 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 1.76 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.0600000000000001 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 0.40999999999999998 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.43 ' C24' HH11 ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.539 ' HN ' HD11 ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.01 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' H9 ' ' A' ' 201' ' ' GCH . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.35999999999999999 117.196 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 0.27000000000000002 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46000000000000002 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 0.72999999999999998 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.42999999999999999 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 0.96999999999999997 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.52 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.9199999999999999 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 1.8999999999999999 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.23999999999999999 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 2.54 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.6699999999999999 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 114' ' ' ILE . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.22 108.96 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.0600000000000001 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 1.8200000000000001 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 0.27000000000000002 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.2 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.40000000000000002 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 0.38 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 0.70999999999999996 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.04 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 0.57999999999999996 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 0.28000000000000003 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.651 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.1899999999999999 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 0.40000000000000002 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.3999999999999999 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.0900000000000001 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 2.8399999999999999 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.5600000000000001 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 0.44 112.917 -166.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 0.84999999999999998 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.659 ' CG2' ' H41' ' A' ' 201' ' ' GCH 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 0.39000000000000001 110.338 -161.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.4099999999999999 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.48 HG22 ' H5 ' ' A' ' 201' ' ' GCH . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 0.20000000000000001 111.654 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.1499999999999999 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.1599999999999999 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.6799999999999999 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.3700000000000001 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.8500000000000001 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 3.9900000000000002 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 0.28999999999999998 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.747 ' CH2' ' H14' ' A' ' 202' ' ' CHO . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.28999999999999998 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.22 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.546 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.21 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 -58.07 121.38 10.49 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.83999999999999997 105.55 154.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -58.26 124.34 19.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.856 -0.794 . . . . 2.5699999999999998 108.856 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.6 -5.68 54.64 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.022 -1.432 . . . . 2.4500000000000002 116.225 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.21 69.32 0.63 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 119.95 1.875 . . . . 1.5600000000000001 116.314 158.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.66 155.17 40.69 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.599 -1.53 . . . . 1.1699999999999999 109.431 158.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 0.72999999999999998 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.1299999999999999 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 0.68000000000000005 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.83999999999999997 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 0.82999999999999996 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.57999999999999996 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 0.28999999999999998 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 0.85999999999999999 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 1.54 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.3 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 0.97999999999999998 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 0.29999999999999999 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 1.96 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 0.47999999999999998 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.1100000000000001 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.72999999999999998 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 1.76 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 0.54000000000000004 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.34999999999999998 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 1.96 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 0.25 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 0.28000000000000003 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 0.17999999999999999 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.52000000000000002 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 0.23000000000000001 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.35999999999999999 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 2.7000000000000002 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 0.23000000000000001 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 0.23000000000000001 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 0.65000000000000002 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.8899999999999999 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26000000000000001 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.46000000000000002 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.8899999999999999 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 21' ' ' LEU . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.26000000000000001 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.35999999999999999 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.495 ' CD ' H112 ' A' ' 202' ' ' CHO . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 0.40000000000000002 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.24 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.6699999999999999 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 0.28000000000000003 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 0.59999999999999998 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.68000000000000005 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.2999999999999998 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.27 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.804 HD21 ' H37' ' A' ' 201' ' ' GCH . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 0.59999999999999998 108.678 -154.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 0.87 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.0699999999999998 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 0.27000000000000002 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 0.87 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 0.26000000000000001 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 0.27000000000000002 107.636 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.28999999999999998 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.20999999999999999 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 0.17000000000000001 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 0.27000000000000002 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 0.59999999999999998 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.0899999999999999 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 0.89000000000000001 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.1299999999999999 110.012 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 1.76 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.0600000000000001 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 0.40999999999999998 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.804 ' H37' HD21 ' A' ' 108' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.747 ' H14' ' CH2' ' A' ' 49' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.01 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.476 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.35999999999999999 117.047 -160.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 0.27000000000000002 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46000000000000002 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 0.72999999999999998 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.42999999999999999 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.58 ' HB2' ' H27' ' A' ' 201' ' ' GCH 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 0.96999999999999997 113.946 176.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.52 113.985 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.9199999999999999 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 1.8999999999999999 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.23999999999999999 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 2.54 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.6699999999999999 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.22 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.0600000000000001 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 1.8200000000000001 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 0.27000000000000002 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD23 ' O24' ' A' ' 202' ' ' CHO . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.2 114.005 -172.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.40000000000000002 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 0.38 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 0.70999999999999996 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.04 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 0.57999999999999996 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 0.28000000000000003 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.1899999999999999 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 0.40000000000000002 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.3999999999999999 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.0900000000000001 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 2.8399999999999999 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.5600000000000001 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 0.44 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 0.84999999999999998 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 0.39000000000000001 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.4099999999999999 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.435 HG21 ' H4 ' ' A' ' 201' ' ' GCH . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 0.20000000000000001 113.132 -163.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.1499999999999999 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.1599999999999999 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.6799999999999999 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.3700000000000001 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.8500000000000001 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 3.9900000000000002 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 0.28999999999999998 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.28999999999999998 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.22 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.21 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -62.35 151.97 35.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.83999999999999997 105.038 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -63.88 -18.93 64.68 Favored 'General case' 0 N--CA 1.518 2.928 0 O-C-N 121.788 -0.57 . . . . 2.5699999999999998 110.066 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.71 3.48 63.96 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 117.639 1.816 . . . . 2.4500000000000002 117.639 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.16 33.81 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.628 -2.101 . . . . 1.5600000000000001 116.329 167.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -114.33 145.45 41.78 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.952 1.376 . . . . 1.1699999999999999 111.183 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 0.72999999999999998 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.1299999999999999 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 0.68000000000000005 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.83999999999999997 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 0.82999999999999996 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.57999999999999996 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 0.28999999999999998 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 0.85999999999999999 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26000000000000001 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 1.54 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.3 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 0.97999999999999998 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 0.29999999999999999 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 1.96 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.862 ' HB ' ' C27' ' A' ' 202' ' ' CHO . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 0.47999999999999998 111.925 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.1100000000000001 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.72999999999999998 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 1.76 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 0.54000000000000004 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.34999999999999998 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 1.96 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 0.25 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 0.28000000000000003 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 0.17999999999999999 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.52000000000000002 109.992 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 0.23000000000000001 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.35999999999999999 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 2.7000000000000002 108.171 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 0.23000000000000001 109.61 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 0.23000000000000001 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 0.65000000000000002 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.8899999999999999 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26000000000000001 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.46000000000000002 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.8899999999999999 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.27000000000000002 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.35999999999999999 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.484 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 0.40000000000000002 108.163 161.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.24 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.6699999999999999 117.566 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 108' ' ' LEU . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 0.28000000000000003 107.622 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 0.59999999999999998 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.68000000000000005 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.2999999999999998 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' C ' HD22 ' A' ' 108' ' ' LEU . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.27 109.411 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' H15' ' A' ' 201' ' ' GCH 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 0.59999999999999998 105.104 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 0.87 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.0699999999999998 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 0.27000000000000002 109.037 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 0.87 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 0.26000000000000001 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 0.27000000000000002 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.28999999999999998 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.20999999999999999 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 0.17000000000000001 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 0.27000000000000002 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 0.59999999999999998 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.642 ' HD3' ' H26' ' A' ' 201' ' ' GCH . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.0899999999999999 107.111 164.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' A' ' 10' ' ' SER . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 0.89000000000000001 111.019 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.109 ' CB ' ' H32' ' A' ' 201' ' ' GCH . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.1299999999999999 112.498 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 1.76 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.0600000000000001 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 0.40999999999999998 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 1.109 ' H32' ' CB ' ' A' ' 123' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.862 ' C27' ' HB ' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.01 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.35999999999999999 117.846 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 0.27000000000000002 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46000000000000002 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 0.72999999999999998 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.42999999999999999 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 0.96999999999999997 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.52 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.9199999999999999 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 1.8999999999999999 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.23999999999999999 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 2.54 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.6699999999999999 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.22 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.0600000000000001 114.504 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 1.8200000000000001 112.294 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 0.27000000000000002 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 21' ' ' LEU . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.2 112.448 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.40000000000000002 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 0.38 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 0.70999999999999996 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.04 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 0.57999999999999996 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 0.28000000000000003 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.1899999999999999 109.192 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 0.40000000000000002 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.3999999999999999 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.0900000000000001 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 2.8399999999999999 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.5600000000000001 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 36' ' ' ILE . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 0.44 117.559 -174.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 0.84999999999999998 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 0.39000000000000001 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.4099999999999999 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 0.20000000000000001 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.1499999999999999 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.1599999999999999 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.6799999999999999 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.3700000000000001 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.8500000000000001 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26000000000000001 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 0.28999999999999998 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.28999999999999998 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.22 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.21 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 1.308 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 . . . . . 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67000000000000004 111.973 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 1.308 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.615 -0.513 . . . . 1.1699999999999999 109.615 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 0.72999999999999998 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.1299999999999999 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 0.68000000000000005 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.83999999999999997 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 0.82999999999999996 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.791 ' CE1' ' CD2' ' A' ' 47' ' ' PHE . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.27000000000000002 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 0.28999999999999998 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 0.85999999999999999 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26000000000000001 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 1.54 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.3 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 0.97999999999999998 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 0.29999999999999999 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 1.96 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 0.47999999999999998 116.688 -162.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.1100000000000001 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.72999999999999998 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 1.76 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 0.54000000000000004 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.34999999999999998 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 1.96 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 94' ' ' PHE . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 0.25 109.063 154.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 0.28000000000000003 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 0.17999999999999999 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.52000000000000002 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 0.23000000000000001 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.35999999999999999 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 2.7000000000000002 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 0.23000000000000001 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 0.23000000000000001 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 0.65000000000000002 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.8899999999999999 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 81' ' ' ALA . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26000000000000001 105.199 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.46000000000000002 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.8899999999999999 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.27000000000000002 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.35999999999999999 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 0.40000000000000002 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.24 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.6699999999999999 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 0.28000000000000003 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.68000000000000005 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.2999999999999998 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.27 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 0.59999999999999998 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 0.87 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.0699999999999998 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 0.27000000000000002 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 0.87 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 0.26000000000000001 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 0.27000000000000002 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.28999999999999998 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.20999999999999999 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 0.17000000000000001 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 0.27000000000000002 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.28999999999999998 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.0899999999999999 108.462 -166.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 0.89000000000000001 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.1299999999999999 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 1.76 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.0600000000000001 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 0.40999999999999998 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.01 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 40' ' ' VAL . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.35999999999999999 113.581 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 0.27000000000000002 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46000000000000002 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 0.72999999999999998 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.42999999999999999 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 0.96999999999999997 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.52 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.9199999999999999 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 1.8999999999999999 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.23999999999999999 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 2.54 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.6699999999999999 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.22 110.228 -166.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.0600000000000001 114.202 -176.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 1.8200000000000001 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 0.27000000000000002 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 18' ' ' MET . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.2 111.386 164.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.40000000000000002 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 0.38 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 0.70999999999999996 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.04 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 0.57999999999999996 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 0.28000000000000003 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.1899999999999999 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 0.40000000000000002 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.3999999999999999 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.0900000000000001 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 2.8399999999999999 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.5600000000000001 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 0.44 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 0.84999999999999998 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 0.39000000000000001 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.4099999999999999 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 2' ' ' PHE . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 0.20000000000000001 106.172 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.1499999999999999 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.1599999999999999 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.6799999999999999 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.3700000000000001 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.8500000000000001 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 3.9900000000000002 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 0.28999999999999998 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.28999999999999998 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.22 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.21 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.406 7.4 p90 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.83999999999999997 113.742 159.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 4.6 t-160 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 113.829 1.048 . . . . 1.1699999999999999 113.829 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 0.72999999999999998 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 0.68000000000000005 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.83999999999999997 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 0.82999999999999996 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.57999999999999996 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 0.28999999999999998 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 0.85999999999999999 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26000000000000001 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 1.54 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.3 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 0.97999999999999998 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 0.29999999999999999 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 1.96 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 0.47999999999999998 115.396 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.1100000000000001 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.72999999999999998 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 1.76 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 0.54000000000000004 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.34999999999999998 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 1.96 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 0.25 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 0.28000000000000003 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 0.17999999999999999 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.52000000000000002 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.23000000000000001 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.35999999999999999 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 2.7000000000000002 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 0.23000000000000001 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 0.23000000000000001 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 0.65000000000000002 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.8899999999999999 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26000000000000001 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.46000000000000002 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.8899999999999999 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' HG12 ' A' ' 114' ' ' ILE . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.26000000000000001 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.35999999999999999 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 0.40000000000000002 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.24 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.6699999999999999 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 0.28000000000000003 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 0.59999999999999998 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.68000000000000005 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.2999999999999998 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.27 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 0.59999999999999998 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 0.87 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.0699999999999998 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 0.27000000000000002 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 0.87 109.265 -150.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 0.26000000000000001 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.589 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 0.27000000000000002 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.20999999999999999 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 0.17000000000000001 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 0.27000000000000002 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 0.59999999999999998 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.0899999999999999 113.047 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 0.89000000000000001 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.1299999999999999 115.03 169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 1.76 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.0600000000000001 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 0.40999999999999998 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.01 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.35999999999999999 110.282 -161.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 0.27000000000000002 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46000000000000002 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' HD11 ' A' ' 126' ' ' LEU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 0.72999999999999998 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.42999999999999999 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 0.96999999999999997 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.557 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.52 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' CA ' ' HE ' ' A' ' 121' ' ' ARG . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.9199999999999999 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 1.8999999999999999 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.23999999999999999 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 2.54 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.6699999999999999 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.22 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB3' HD12 ' A' ' 23' ' ' ILE . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.0600000000000001 114.06 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 1.8200000000000001 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 0.27000000000000002 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.2 112.074 167.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.40000000000000002 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD13 ' HB ' ' A' ' 27' ' ' VAL . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 0.38 107.699 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 0.70999999999999996 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.04 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 23' ' ' ILE . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 0.57999999999999996 112.052 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 0.28000000000000003 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.1899999999999999 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 0.40000000000000002 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.3999999999999999 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.0900000000000001 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 2.8399999999999999 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.5600000000000001 108.521 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 0.44 119.555 166.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 0.84999999999999998 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 0.39000000000000001 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.4099999999999999 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 0.20000000000000001 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.1499999999999999 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.1599999999999999 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.6799999999999999 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.3700000000000001 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.8500000000000001 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 3.9900000000000002 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 0.28999999999999998 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.28999999999999998 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.22 109.909 -173.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.21 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 . . . . . 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.83999999999999997 115.783 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.1699999999999999 105.687 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 0.72999999999999998 110.327 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.1299999999999999 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 0.68000000000000005 105.797 -162.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.83999999999999997 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 0.82999999999999996 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.57999999999999996 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 0.28999999999999998 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 0.85999999999999999 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26000000000000001 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 1.54 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.3 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 0.97999999999999998 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 0.29999999999999999 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 1.96 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 0.47999999999999998 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.1100000000000001 112.616 164.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.72999999999999998 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 1.76 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 0.54000000000000004 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.34999999999999998 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 1.96 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 0.25 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 0.28000000000000003 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 0.17999999999999999 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.52000000000000002 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 0.23000000000000001 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.35999999999999999 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 2.7000000000000002 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 0.23000000000000001 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 0.23000000000000001 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 0.65000000000000002 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.8899999999999999 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26000000000000001 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.46000000000000002 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.8899999999999999 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE1' HD21 ' A' ' 21' ' ' LEU 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.26000000000000001 115.981 -177.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.35999999999999999 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 0.40000000000000002 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.24 112.653 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.6699999999999999 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 0.28000000000000003 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 0.59999999999999998 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.68000000000000005 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.2999999999999998 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.27 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 0.59999999999999998 108.488 -161.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 0.87 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.0699999999999998 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 0.27000000000000002 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 0.87 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 0.26000000000000001 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 0.27000000000000002 107.475 170.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.28999999999999998 119.952 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.20999999999999999 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 0.17000000000000001 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 0.27000000000000002 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 0.59999999999999998 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.52 ' HE ' ' CA ' ' A' ' 11' ' ' GLU . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.0899999999999999 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.557 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 0.89000000000000001 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.1299999999999999 110.728 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 1.76 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.0600000000000001 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.567 HD11 ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 0.40999999999999998 113.964 168.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.01 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.35999999999999999 114.347 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 0.27000000000000002 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46000000000000002 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 0.72999999999999998 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.42999999999999999 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.96999999999999997 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.52 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.9199999999999999 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 1.8999999999999999 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.23999999999999999 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 2.54 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.6699999999999999 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17000000000000001 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.0600000000000001 117.088 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 1.8200000000000001 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 0.27000000000000002 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.2 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.40000000000000002 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 0.38 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 0.70999999999999996 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.04 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 0.57999999999999996 114.03 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 0.28000000000000003 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.1899999999999999 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 0.40000000000000002 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.3999999999999999 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.0900000000000001 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78000000000000003 117.961 -170.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.5600000000000001 116.794 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 0.44 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 0.84999999999999998 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 0.39000000000000001 114.76 -166.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.4099999999999999 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 0.20000000000000001 107.211 -168.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.1499999999999999 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.1599999999999999 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.6799999999999999 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.3700000000000001 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.8500000000000001 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 3.9900000000000002 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 0.28999999999999998 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.28999999999999998 106.727 167.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.22 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.21 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.83999999999999997 116.399 174.124 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--O 1.266 1.954 0 N-CA-C 106.117 -1.808 . . . . 1.1699999999999999 106.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 0.72999999999999998 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.1299999999999999 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 0.68000000000000005 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.83999999999999997 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 0.82999999999999996 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' CE1' ' CB ' ' A' ' 47' ' ' PHE . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.57999999999999996 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 0.28999999999999998 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 0.85999999999999999 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26000000000000001 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 1.54 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.3 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 0.97999999999999998 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 0.29999999999999999 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 1.96 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 0.47999999999999998 114.518 -163.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.1100000000000001 115.047 162.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.72999999999999998 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 1.76 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 0.54000000000000004 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.34999999999999998 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 1.96 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 0.25 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 0.28000000000000003 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.52000000000000002 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 0.23000000000000001 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.35999999999999999 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 2.7000000000000002 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 0.23000000000000001 112.423 -167.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 0.23000000000000001 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 0.65000000000000002 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.8899999999999999 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26000000000000001 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.46000000000000002 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.8899999999999999 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.857 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.26000000000000001 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.35999999999999999 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 0.40000000000000002 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.24 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.6699999999999999 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 0.28000000000000003 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 0.59999999999999998 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.68000000000000005 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.2999999999999998 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.27 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 0.59999999999999998 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 0.87 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.0699999999999998 110.978 169.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 0.27000000000000002 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 0.87 108.113 -161.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 0.26000000000000001 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.857 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 0.27000000000000002 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.28999999999999998 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.20999999999999999 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 0.17000000000000001 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 0.27000000000000002 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 0.59999999999999998 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.0899999999999999 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 0.89000000000000001 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.1299999999999999 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 1.76 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.0600000000000001 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 0.40999999999999998 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.01 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.35999999999999999 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 0.27000000000000002 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46000000000000002 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 0.72999999999999998 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.42999999999999999 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 0.96999999999999997 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.52 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.9199999999999999 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 1.8999999999999999 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.23999999999999999 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 2.54 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.6699999999999999 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.22 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.0600000000000001 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 1.8200000000000001 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 0.27000000000000002 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.2 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.40000000000000002 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 0.38 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 0.70999999999999996 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.04 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 0.57999999999999996 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 0.28000000000000003 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.1899999999999999 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 0.40000000000000002 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.3999999999999999 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.0900000000000001 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 2.8399999999999999 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.5600000000000001 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 0.44 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 0.84999999999999998 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 0.39000000000000001 114.542 -172.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.4099999999999999 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 0.20000000000000001 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.1499999999999999 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.1599999999999999 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.6799999999999999 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.3700000000000001 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.8500000000000001 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 3.9900000000000002 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 0.28999999999999998 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.442 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.28999999999999998 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.22 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.442 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.21 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.83999999999999997 106.238 161.212 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 CA--C 1.504 -0.82 0 CA-C-O 120.703 0.287 . . . . 1.1699999999999999 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 0.72999999999999998 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.1299999999999999 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 0.68000000000000005 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.83999999999999997 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 0.82999999999999996 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.57999999999999996 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 0.28999999999999998 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 0.85999999999999999 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26000000000000001 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 1.54 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.3 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 0.97999999999999998 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 0.29999999999999999 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 1.96 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 0.47999999999999998 115.002 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.1100000000000001 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.72999999999999998 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 1.76 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 0.54000000000000004 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.34999999999999998 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 1.96 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 0.25 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 0.28000000000000003 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.52000000000000002 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 0.23000000000000001 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.35999999999999999 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 2.7000000000000002 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 0.23000000000000001 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 0.23000000000000001 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 0.65000000000000002 107.41 160.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.8899999999999999 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26000000000000001 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.46000000000000002 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.8899999999999999 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.27000000000000002 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.35999999999999999 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 0.40000000000000002 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.24 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.6699999999999999 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 0.28000000000000003 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 0.59999999999999998 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.68000000000000005 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.2999999999999998 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.27 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 0.59999999999999998 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 0.87 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.0699999999999998 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 0.27000000000000002 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 0.87 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 0.26000000000000001 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 0.27000000000000002 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.28999999999999998 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.20999999999999999 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 0.17000000000000001 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 0.27000000000000002 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' A' ' 121' ' ' ARG . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 0.59999999999999998 111.166 164.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.407 ' HD3' ' CE2' ' A' ' 119' ' ' TYR . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.0899999999999999 111.986 -169.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 0.89000000000000001 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.1299999999999999 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 1.76 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.0600000000000001 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 0.40999999999999998 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.01 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.35999999999999999 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 0.27000000000000002 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46000000000000002 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 0.72999999999999998 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.42999999999999999 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 0.96999999999999997 112.882 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.52 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.9199999999999999 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 1.8999999999999999 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.23999999999999999 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.23999999999999999 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.6699999999999999 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 119' ' ' TYR . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.22 113.661 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.0600000000000001 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 1.8200000000000001 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 0.27000000000000002 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.2 111.735 165.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.40000000000000002 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 0.38 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 0.70999999999999996 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.04 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 0.57999999999999996 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 0.28000000000000003 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.1899999999999999 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 0.40000000000000002 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.3999999999999999 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.0900000000000001 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 2.8399999999999999 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.5600000000000001 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 0.44 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 0.84999999999999998 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 0.39000000000000001 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.4099999999999999 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 0.20000000000000001 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.1499999999999999 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.1599999999999999 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.6799999999999999 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.3700000000000001 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.8500000000000001 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 3.9900000000000002 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 0.28999999999999998 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.28999999999999998 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.22 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.21 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 11.6 p90 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67000000000000004 113.09 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 62.0 t-80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 122.936 1.351 . . . . 0.93999999999999995 111.158 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 0.72999999999999998 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.1299999999999999 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.68000000000000005 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.83999999999999997 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 0.82999999999999996 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.57999999999999996 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 0.28999999999999998 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 0.85999999999999999 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26000000000000001 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 1.54 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.3 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 0.97999999999999998 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 0.29999999999999999 109.318 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 1.96 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' LYS . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 0.47999999999999998 118.818 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.446 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.1100000000000001 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 113.81 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 73' ' ' THR . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 1.76 109.919 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 0.54000000000000004 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.34999999999999998 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 1.96 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 0.25 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 0.28000000000000003 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 0.17999999999999999 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.52000000000000002 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 0.23000000000000001 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.35999999999999999 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 2.7000000000000002 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 0.23000000000000001 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 0.23000000000000001 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 0.65000000000000002 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.8899999999999999 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26000000000000001 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.46000000000000002 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.8899999999999999 112.621 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CD1' HD11 ' A' ' 21' ' ' LEU . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.26000000000000001 113.687 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.35999999999999999 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.422 HE21 ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.422 ' N ' HE21 ' A' ' 99' ' ' GLN . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 0.40000000000000002 117.955 178.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.24 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.6699999999999999 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 0.28000000000000003 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 0.59999999999999998 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.68000000000000005 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.2999999999999998 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.27 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 0.59999999999999998 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 0.87 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.0699999999999998 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 0.27000000000000002 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 0.87 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 0.26000000000000001 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 0.27000000000000002 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.28999999999999998 110.355 165.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.20999999999999999 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 0.17000000000000001 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 0.27000000000000002 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.419 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 0.59999999999999998 113.044 167.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.0899999999999999 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.609 ' H ' ' HB3' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 0.89000000000000001 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.1299999999999999 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 1.76 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.0600000000000001 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 0.40999999999999998 108.486 153.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 126' ' ' LEU . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.01 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.35999999999999999 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 0.27000000000000002 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46000000000000002 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.75 ' H ' ' HB2' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 0.72999999999999998 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.42999999999999999 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 0.96999999999999997 115.894 165.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.52 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.684 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.9199999999999999 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 1.8999999999999999 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.23999999999999999 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.684 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.23999999999999999 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.6699999999999999 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.22 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.0600000000000001 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 1.8200000000000001 109.859 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 0.27000000000000002 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.2 114.769 -166.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.40000000000000002 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 0.38 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 0.70999999999999996 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.04 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 0.57999999999999996 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 0.28000000000000003 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.1899999999999999 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 0.40000000000000002 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.3999999999999999 112.108 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.0900000000000001 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 2.8399999999999999 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.5600000000000001 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 0.44 109.938 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 0.84999999999999998 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 0.39000000000000001 116.653 -169.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.4099999999999999 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 0.20000000000000001 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.1499999999999999 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.1599999999999999 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.6799999999999999 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.3700000000000001 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.8500000000000001 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 3.9900000000000002 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 0.28999999999999998 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.28999999999999998 105.9 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.22 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.21 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67000000000000004 106.709 173.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 108.734 -0.839 . . . . 1.1699999999999999 108.734 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 0.72999999999999998 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.1299999999999999 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 0.68000000000000005 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.83999999999999997 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 0.82999999999999996 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.57999999999999996 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 0.28999999999999998 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 0.85999999999999999 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26000000000000001 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 1.54 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.3 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 0.97999999999999998 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 0.29999999999999999 107.531 -165.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 1.96 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 0.47999999999999998 113.833 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.1100000000000001 114.507 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.72999999999999998 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 1.76 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 0.54000000000000004 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.34999999999999998 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 1.96 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 0.25 108.613 167.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 0.28000000000000003 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 0.17999999999999999 110.184 168.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.52000000000000002 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 0.23000000000000001 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.35999999999999999 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 2.7000000000000002 106.999 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 0.23000000000000001 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 0.23000000000000001 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 0.65000000000000002 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.8899999999999999 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26000000000000001 109.368 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.46000000000000002 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.8899999999999999 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.27000000000000002 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.35999999999999999 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.40000000000000002 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.24 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.6699999999999999 116.755 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 0.59999999999999998 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.68000000000000005 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.2999999999999998 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.27 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 0.59999999999999998 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 0.87 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.0699999999999998 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 0.27000000000000002 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 0.87 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 0.26000000000000001 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 0.27000000000000002 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.28999999999999998 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.20999999999999999 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 0.17000000000000001 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 0.27000000000000002 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 0.59999999999999998 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.0899999999999999 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 0.89000000000000001 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.1299999999999999 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 1.76 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.0600000000000001 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 0.40999999999999998 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.75 ' HB2' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.01 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.35999999999999999 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 0.27000000000000002 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46000000000000002 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 0.72999999999999998 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.42999999999999999 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 0.96999999999999997 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.52 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.9199999999999999 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 1.8999999999999999 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.23999999999999999 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 2.54 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.6699999999999999 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.22 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 1.8200000000000001 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 0.27000000000000002 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.2 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.40000000000000002 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 0.38 108.537 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 0.70999999999999996 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.04 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 0.57999999999999996 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 0.28000000000000003 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.1899999999999999 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 0.40000000000000002 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.3999999999999999 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.0900000000000001 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 2.8399999999999999 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.5600000000000001 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 0.44 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 0.84999999999999998 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 0.39000000000000001 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.4099999999999999 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 0.20000000000000001 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.1499999999999999 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.1599999999999999 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.6799999999999999 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.3700000000000001 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.8500000000000001 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 3.9900000000000002 108.816 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 0.28999999999999998 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.28999999999999998 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.22 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.21 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.83999999999999997 106.918 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.347 -0.612 . . . . 1.1699999999999999 109.347 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 0.72999999999999998 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.1299999999999999 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 0.68000000000000005 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.83999999999999997 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 0.82999999999999996 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 83' ' ' VAL . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.57999999999999996 107.879 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 0.28999999999999998 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 0.85999999999999999 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26000000000000001 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 1.54 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.3 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 0.97999999999999998 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 0.29999999999999999 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 1.96 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.636 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 0.47999999999999998 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.1100000000000001 109.449 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.72999999999999998 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 1.76 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 0.54000000000000004 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.34999999999999998 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 1.96 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 0.25 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 0.28000000000000003 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 63' ' ' PHE . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 0.17999999999999999 111.344 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.52000000000000002 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 0.23000000000000001 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.35999999999999999 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 2.7000000000000002 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 0.23000000000000001 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 0.23000000000000001 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 0.65000000000000002 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.8899999999999999 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26000000000000001 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.46000000000000002 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.8899999999999999 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.27000000000000002 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.35999999999999999 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 0.40000000000000002 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.24 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.6699999999999999 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 0.28000000000000003 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 0.59999999999999998 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.68000000000000005 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.2999999999999998 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.27 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 0.59999999999999998 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 0.87 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.0699999999999998 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 0.27000000000000002 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 0.87 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 0.26000000000000001 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 0.27000000000000002 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.28999999999999998 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.20999999999999999 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 0.17000000000000001 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 0.27000000000000002 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 0.59999999999999998 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.0899999999999999 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 0.89000000000000001 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.1299999999999999 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 1.76 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.0600000000000001 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 0.40999999999999998 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.01 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.35999999999999999 117.196 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 0.27000000000000002 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46000000000000002 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 0.72999999999999998 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.42999999999999999 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 0.96999999999999997 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.52 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.9199999999999999 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 1.8999999999999999 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 t30 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.23999999999999999 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 2.54 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.6699999999999999 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 114' ' ' ILE . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.22 108.96 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.0600000000000001 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 1.8200000000000001 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 0.27000000000000002 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.2 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.40000000000000002 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 0.38 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 0.70999999999999996 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.04 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 0.57999999999999996 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 0.28000000000000003 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.651 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.1899999999999999 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 0.40000000000000002 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.3999999999999999 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.0900000000000001 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 2.8399999999999999 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.5600000000000001 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 0.44 112.917 -166.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 0.84999999999999998 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 0.39000000000000001 110.338 -161.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.4099999999999999 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 0.20000000000000001 111.654 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.1499999999999999 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.1599999999999999 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.6799999999999999 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.3700000000000001 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.8500000000000001 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 3.9900000000000002 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 0.28999999999999998 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.546 ' HE1' ' NE2' ' A' ' 51' ' ' GLN . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.28999999999999998 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.22 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.546 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.21 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.83999999999999997 105.55 154.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.431 -0.581 . . . . 1.1699999999999999 109.431 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 0.72999999999999998 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.1299999999999999 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 0.68000000000000005 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.83999999999999997 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 0.82999999999999996 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.57999999999999996 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 0.28999999999999998 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 0.85999999999999999 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 1.54 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.3 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 0.97999999999999998 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 0.29999999999999999 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 1.96 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 0.47999999999999998 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.1100000000000001 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.72999999999999998 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 1.76 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 0.54000000000000004 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.34999999999999998 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 1.96 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 0.25 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 0.28000000000000003 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 0.17999999999999999 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.52000000000000002 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 0.23000000000000001 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.35999999999999999 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 2.7000000000000002 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 0.23000000000000001 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 0.23000000000000001 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 0.65000000000000002 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.8899999999999999 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26000000000000001 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.46000000000000002 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.8899999999999999 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 21' ' ' LEU . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.26000000000000001 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.35999999999999999 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 0.40000000000000002 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.24 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.6699999999999999 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 0.28000000000000003 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 0.59999999999999998 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.68000000000000005 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.2999999999999998 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.27 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 0.59999999999999998 108.678 -154.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 0.87 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.0699999999999998 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 0.27000000000000002 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 0.87 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 0.26000000000000001 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 0.27000000000000002 107.636 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.28999999999999998 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.20999999999999999 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 0.17000000000000001 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 0.27000000000000002 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 0.59999999999999998 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.0899999999999999 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 0.89000000000000001 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.1299999999999999 110.012 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 1.76 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.0600000000000001 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 0.40999999999999998 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.496 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.01 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.35999999999999999 117.047 -160.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 0.27000000000000002 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46000000000000002 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 0.72999999999999998 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.42999999999999999 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 0.96999999999999997 113.946 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.52 113.985 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.9199999999999999 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 1.8999999999999999 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.23999999999999999 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 2.54 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.6699999999999999 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.22 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.0600000000000001 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 1.8200000000000001 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 0.27000000000000002 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.2 114.005 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.40000000000000002 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 0.38 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 0.70999999999999996 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.04 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 0.57999999999999996 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 0.28000000000000003 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.1899999999999999 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 0.40000000000000002 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.3999999999999999 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.0900000000000001 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 2.8399999999999999 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.5600000000000001 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 0.44 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 0.84999999999999998 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 0.39000000000000001 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.4099999999999999 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 0.20000000000000001 113.132 -163.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.1499999999999999 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.1599999999999999 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.6799999999999999 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.3700000000000001 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.8500000000000001 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 3.9900000000000002 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 0.28999999999999998 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.28999999999999998 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.22 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.21 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.83999999999999997 105.038 173.726 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.686 -0.197 . . . . 1.1699999999999999 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 0.72999999999999998 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.1299999999999999 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 0.68000000000000005 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.83999999999999997 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 0.82999999999999996 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.57999999999999996 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 0.28999999999999998 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 0.85999999999999999 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26000000000000001 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 1.54 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.3 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 0.97999999999999998 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 0.29999999999999999 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 1.96 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 0.47999999999999998 111.925 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.1100000000000001 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.72999999999999998 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 1.76 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 0.54000000000000004 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.34999999999999998 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 1.96 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 0.25 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 0.28000000000000003 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 0.17999999999999999 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.52000000000000002 109.992 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 0.23000000000000001 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.35999999999999999 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 2.7000000000000002 108.171 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 0.23000000000000001 109.61 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 0.23000000000000001 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 0.65000000000000002 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.8899999999999999 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26000000000000001 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.46000000000000002 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.8899999999999999 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.27000000000000002 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.35999999999999999 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.484 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 0.40000000000000002 108.163 161.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.24 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.6699999999999999 117.566 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 108' ' ' LEU . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 0.28000000000000003 107.622 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 0.59999999999999998 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.68000000000000005 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.2999999999999998 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' C ' HD22 ' A' ' 108' ' ' LEU . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.27 109.411 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 107' ' ' LYS 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 0.59999999999999998 105.104 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 0.87 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.0699999999999998 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 0.27000000000000002 109.037 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 0.87 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 0.26000000000000001 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 0.27000000000000002 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.28999999999999998 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.20999999999999999 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 0.17000000000000001 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 0.27000000000000002 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 0.59999999999999998 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.0899999999999999 107.111 164.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' A' ' 10' ' ' SER . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 0.89000000000000001 111.019 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.1299999999999999 112.498 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 1.76 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.0600000000000001 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 0.40999999999999998 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 108.142 -1.058 . . . . 1.01 108.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.549 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 62.7 m-85 -86.74 0.14 55.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 117.846 2.535 . . . . 0.35999999999999999 117.846 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 m -49.9 142.03 9.62 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.371 1.989 . . . . 0.27000000000000002 116.371 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.05 -169.25 31.37 Favored Glycine 0 CA--C 1.457 -3.539 0 CA-C-O 114.734 -3.259 . . . . 0.46000000000000002 114.152 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 129.64 56.64 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.23 2.015 . . . . 0.72999999999999998 107.556 171.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -136.18 137.23 40.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.094 -1.447 . . . . 0.42999999999999999 107.094 -169.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -105.6 133.08 50.92 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 112.798 0.666 . . . . 1.98 112.798 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 ttp -89.63 148.17 23.48 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 116.667 -3.771 . . . . 0.96999999999999997 112.721 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -157.48 67.1 0.5 Allowed 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 111.507 -2.588 . . . . 2.75 111.756 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -177.83 126.77 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.039 1.336 . . . . 2.52 108.533 165.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -137.03 116.57 12.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 C-N-CA 125.992 1.717 . . . . 1.9199999999999999 111.974 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.6 113.04 16.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.977 -1.077 . . . . 1.8999999999999999 110.547 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 73.33 20.8 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.132 1.773 . . . . 0.23999999999999999 114.769 -169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -56.93 -52.93 63.24 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 130.763 3.625 . . . . 2.54 115.839 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.26 -38.42 91.1 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.074 1.138 . . . . 1.6699999999999999 114.074 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.22 -44.05 26.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.831 1.048 . . . . 1.0 113.831 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 119' ' ' TYR . 54.5 t80 -55.91 -45.02 78.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.18 0.807 . . . . 0.22 113.18 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.09 -30.61 43.96 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 117.815 -1.554 . . . . 1.0600000000000001 114.504 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -60.16 -49.4 77.8 Favored 'General case' 0 C--N 1.38 1.926 0 CA-C-N 113.664 -1.607 . . . . 1.8200000000000001 112.294 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.38 -31.26 71.9 Favored 'General case' 0 CA--C 1.473 -2.01 0 O-C-N 119.953 -1.717 . . . . 0.27000000000000002 110.315 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 21' ' ' LEU . 9.1 mt -77.73 -28.73 50.87 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.802 0.81 . . . . 1.2 112.448 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.17 37.09 0.58 Allowed Glycine 0 C--N 1.354 1.532 0 CA-C-O 116.416 -2.324 . . . . 0.40000000000000002 110.635 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.9 121.65 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.169 1.984 . . . . 0.38 108.811 164.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -65.65 -58.6 5.33 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-O 124.568 2.127 . . . . 0.70999999999999996 115.9 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -156.55 -16.51 0.1 Allowed 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.725 -2.489 . . . . 1.04 109.219 168.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 31.0 t0 -58.47 -55.76 30.83 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 119.594 -1.941 . . . . 1.29 115.665 -162.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.01 -34.08 14.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 121.106 1.776 . . . . 0.57999999999999996 111.902 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -39.38 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.467 1.107 . . . . 0.28000000000000003 113.329 -172.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.34 -34.17 68.5 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.799 -1.188 . . . . 1.48 112.371 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 42.4 mmtm -82.82 -41.82 18.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.226 1.41 . . . . 1.1899999999999999 109.192 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.59 80.08 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 117.102 2.26 . . . . 0.40000000000000002 117.102 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -56.24 -41.12 75.22 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.211 2.434 . . . . 2.3999999999999999 112.867 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -90.33 -55.55 3.55 Favored 'General case' 0 C--O 1.259 1.595 0 O-C-N 117.646 -3.159 . . . . 1.0900000000000001 112.62 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.67 -27.04 21.53 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 117.799 2.518 . . . . 2.8399999999999999 117.799 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER 51.37 106.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.24 2.616 . . . . 2.5600000000000001 114.885 -172.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 36' ' ' ILE . 3.5 mm -34.21 150.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.575 1 C-N-CA 132.461 4.305 . . . . 0.44 117.559 -174.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -115.21 165.96 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 O-C-N 117.781 -3.074 . . . . 0.84999999999999998 105.798 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -149.8 157.48 43.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 118.535 -2.603 . . . . 0.39000000000000001 116.411 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -127.07 115.25 18.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.603 1.961 . . . . 1.4099999999999999 108.114 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.63 150.06 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.92 1.288 . . . . 0.20000000000000001 109.957 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 118.67 7.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.647 -1.242 . . . . 2.1499999999999999 107.647 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -121.73 128.1 51.42 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 117.376 -1.297 . . . . 1.1599999999999999 110.298 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -121.81 73.97 1.11 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.98 -1.489 . . . . 1.6799999999999999 106.98 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.0 -105.98 1.51 Allowed Glycine 0 C--N 1.367 2.263 0 C-N-CA 126.34 1.924 . . . . 1.24 112.118 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -71.28 -37.41 71.88 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 116.669 2.1 . . . . 1.3700000000000001 116.669 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -74.63 140.8 44.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.303 1.223 . . . . 1.8500000000000001 114.303 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 85.0 t80 -137.92 145.29 41.89 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 115.093 -2.384 . . . . 0.26000000000000001 110.734 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -143.87 128.54 18.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 127.904 3.252 . . . . 0.28999999999999998 106.038 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.84 144.52 43.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.159 0.98 . . . . 0.28999999999999998 109.546 151.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -117.4 124.74 49.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.485 -1.302 . . . . 1.22 107.485 166.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.455 HE21 ' H28' ' A' ' 201' ' ' GCH . 44.6 mt-30 -110.94 151.87 27.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.124 1.37 . . . . 1.5 109.91 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -133.62 138.57 46.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.249 1.02 . . . . 2.21 111.029 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 1.308 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 44.0 p90 -130.59 159.09 38.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.837 1.255 . . . . 0.67000000000000004 111.973 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 m -23.72 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 120.797 3.628 . . . . 2.5699999999999998 120.797 -159.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.82 -2.32 84.36 Favored Glycine 0 CA--C 1.478 -2.242 0 CA-C-N 122.227 2.285 . . . . 2.4500000000000002 111.043 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.25 33.19 7.8 Favored Glycine 0 CA--C 1.476 -2.346 0 O-C-N 118.09 -3.006 . . . . 1.5600000000000001 106.153 164.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 1.308 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 4.1 t-80 -71.99 138.17 47.79 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 119.834 -1.98 . . . . 1.1699999999999999 109.615 160.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -89.26 141.95 28.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.189 1.396 . . . . 0.72999999999999998 111.904 167.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ptt? -136.04 126.05 26.04 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-O 117.097 -1.43 . . . . 1.1299999999999999 107.804 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 p -119.08 164.28 15.76 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 124.963 2.316 . . . . 0.68000000000000005 111.144 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.36 148.11 34.3 Favored 'General case' 0 C--O 1.188 -2.139 1 O-C-N 113.132 -5.98 . . . . 0.83999999999999997 106.192 157.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -131.94 112.69 12.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.793 1.237 . . . . 0.82999999999999996 109.808 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.814 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 14.2 p90 -138.85 168.56 19.55 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-N 118.703 0.683 . . . . 0.27000000000000002 111.324 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 m -103.86 117.85 35.32 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 102.588 -3.116 . . . . 0.28999999999999998 102.588 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -59.87 132.0 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 118.179 -2.826 . . . . 0.85999999999999999 113.292 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.27 4.26 86.45 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.038 1.175 . . . . 0.26000000000000001 116.038 -170.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -119.65 166.63 12.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.78 2.032 . . . . 1.54 110.981 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -130.03 158.97 38.14 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 124.049 0.94 . . . . 0.62 110.426 -161.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 t 69.39 21.61 6.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.704 2.402 . . . . 1.3 117.315 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -122.23 -0.48 9.37 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.971 1.309 . . . . 0.97999999999999998 113.683 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 133.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.628 1.571 . . . . 0.29999999999999999 109.753 -162.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -145.47 160.25 41.88 Favored 'General case' 0 C--O 1.262 1.73 0 CA-C-N 121.256 1.844 . . . . 1.96 110.571 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.427 ' HA ' H152 ' A' ' 202' ' ' CHO . 24.9 p -77.93 -177.49 4.99 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.688 2.107 . . . . 0.47999999999999998 116.688 -162.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 mmt -56.23 -35.43 67.35 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 126.048 2.832 . . . . 1.1100000000000001 114.722 161.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.73 -6.5 89.01 Favored Glycine 0 CA--C 1.477 -2.314 0 O-C-N 117.844 -3.035 . . . . 0.72999999999999998 119.075 168.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.9 38.28 49.22 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 119.542 2.577 . . . . 0.63 119.542 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -94.7 122.66 37.54 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-O 117.329 -1.319 . . . . 1.76 108.75 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 138.31 52.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.683 2.038 . . . . 0.54000000000000004 115.262 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -127.7 168.23 15.35 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.765 1.765 . . . . 0.34999999999999998 115.765 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -114.21 107.99 16.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.074 1.35 . . . . 1.96 108.652 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 94' ' ' PHE . . . -159.3 -176.02 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.715 0.806 . . . . 0.25 109.063 154.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 m -103.97 108.3 19.58 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.641 -1.615 . . . . 0.28000000000000003 106.641 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 63' ' ' PHE . 2.8 t -76.86 133.55 30.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.746 -1.181 . . . . 0.17999999999999999 110.904 171.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.02 142.6 51.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.427 0.691 . . . . 0.52000000000000002 110.888 -169.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.5 mtp -95.75 129.29 43.02 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.671 -0.681 . . . . 0.23000000000000001 109.803 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -141.81 108.63 5.4 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.096 0.95 . . . . 1.53 111.828 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 16.02 78.55 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 115.659 1.024 . . . . 1.05 115.659 -165.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.55 50.96 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 116.89 -2.061 . . . . 0.35999999999999999 113.959 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -123.54 133.1 54.04 Favored 'General case' 0 C--O 1.255 1.367 0 N-CA-C 105.6 -2.0 . . . . 2.7000000000000002 105.6 -167.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.5 140.54 29.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.253 1.388 . . . . 0.23000000000000001 111.83 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.3 144.42 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.81 -0.811 . . . . 0.23000000000000001 108.81 -173.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.74 155.52 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.802 -1.184 . . . . 0.65000000000000002 107.802 159.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -125.31 137.39 54.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.592 1.557 . . . . 1.8899999999999999 109.328 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 81' ' ' ALA . 94.0 m-85 -146.49 165.82 18.71 Favored Pre-proline 0 C--O 1.196 -1.716 0 C-N-CA 127.423 2.289 . . . . 0.26000000000000001 105.199 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.47 -46.59 31.17 Favored 'Trans proline' 0 CA--C 1.476 -2.383 1 C-N-CA 127.087 5.191 . . . . 0.46000000000000002 116.125 158.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.21 -12.03 29.08 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.814 -1.179 . . . . 1.8899999999999999 111.63 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -140.33 156.63 46.36 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.781 1.401 . . . . 0.27000000000000002 114.781 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -157.76 149.11 21.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.08 1.752 . . . . 0.35999999999999999 106.996 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -159.43 -179.11 7.64 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 116.675 -2.01 . . . . 1.48 110.911 160.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.4 144.98 24.17 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.223 1.409 . . . . 0.40000000000000002 107.419 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.65 122.22 11.77 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 127.476 2.31 . . . . 1.24 107.185 -162.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.87 167.39 27.65 Favored 'General case' 0 C--N 1.375 1.711 0 N-CA-C 116.652 2.093 . . . . 1.6699999999999999 116.652 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.08 126.52 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.281 -1.748 . . . . 0.28000000000000003 106.281 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.14 119.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 109.753 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.85 -108.44 2.55 Favored Glycine 0 C--N 1.366 2.231 0 C-N-CA 119.687 -1.244 . . . . 0.68000000000000005 111.385 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -119.39 0.01 11.02 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 124.214 1.959 . . . . 2.2999999999999998 114.453 162.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -104.33 152.38 22.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 126.282 2.944 . . . . 2.27 110.513 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.5 125.58 51.95 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 118.255 -2.778 . . . . 0.59999999999999998 109.538 -167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.42 125.72 32.94 Favored 'Isoleucine or valine' 0 C--O 1.271 2.236 0 C-N-CA 123.54 0.736 . . . . 0.87 109.074 -156.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -132.63 136.22 46.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.245 -0.91 . . . . 2.0699999999999998 111.03 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.99 125.56 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.966 0.791 . . . . 0.27000000000000002 111.793 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.8 m -134.4 156.6 48.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.122 -1.611 . . . . 0.87 110.517 -161.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.2 m -141.75 120.14 12.34 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.998 2.119 . . . . 0.26000000000000001 110.298 -172.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.18 132.73 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 120.32 1.418 . . . . 0.27000000000000002 108.037 168.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 58.56 30.35 65.2 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 109.145 -1.582 . . . . 0.28999999999999998 109.145 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.84 12.45 74.72 Favored Glycine 0 CA--C 1.468 -2.888 0 N-CA-C 121.267 3.267 . . . . 0.20999999999999999 121.267 -168.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.265 0.4 OUTLIER -120.13 140.65 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.955 2.378 . . . . 0.17000000000000001 114.979 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.3 m -100.12 147.9 25.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.916 0.486 . . . . 0.27000000000000002 112.135 -153.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 78.6 t80 -132.01 149.33 52.45 Favored 'General case' 0 C--O 1.194 -1.825 0 CA-C-O 124.453 2.073 . . . . 0.28999999999999998 110.973 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -147.91 150.46 34.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 117.14 -3.475 . . . . 0.88 108.994 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.622 ' HD3' ' H31' ' A' ' 201' ' ' GCH . 37.1 ttm180 -149.92 149.98 31.21 Favored 'General case' 0 CA--C 1.457 -2.604 0 C-N-CA 125.238 1.415 . . . . 6.0899999999999999 108.462 -166.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -141.56 142.04 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.113 1.365 . . . . 0.89000000000000001 112.153 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -151.98 152.52 32.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.124 1.44 . . . . 1.1299999999999999 112.751 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -114.01 137.12 52.13 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.854 2.461 . . . . 1.76 111.685 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -95.69 147.49 23.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.744 1.156 . . . . 2.0600000000000001 113.451 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.86 41.34 0.76 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 122.891 1.329 . . . . 0.40999999999999998 112.299 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 125.963 1.705 . . . . 30.0 110.889 167.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.622 ' H31' ' HD3' ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.814 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.129 -0.693 . . . . 1.01 109.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 40' ' ' VAL . 83.0 m-85 -119.81 16.46 12.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.655 1.582 . . . . 0.35999999999999999 113.581 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 m -54.99 132.44 46.99 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.749 2.42 . . . . 0.27000000000000002 114.397 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -166.93 33.91 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-O 118.615 -1.103 . . . . 0.46000000000000002 112.949 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -144.14 127.81 17.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 119.494 1.647 . . . . 0.72999999999999998 108.376 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.96 147.56 42.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.344 1.457 . . . . 0.42999999999999999 107.388 -150.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -138.73 116.31 11.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.502 1.521 . . . . 1.98 110.054 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.3 ttp -86.91 144.84 26.79 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.651 1.58 . . . . 0.96999999999999997 111.793 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.49 97.22 3.31 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.262 -2.866 . . . . 2.75 103.262 156.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -161.25 169.71 21.66 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 116.86 -1.543 . . . . 2.52 108.721 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -173.52 46.61 0.02 OUTLIER 'General case' 0 C--N 1.381 1.94 0 O-C-N 127.984 3.303 . . . . 1.9199999999999999 114.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -95.84 112.84 24.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.146 1.794 . . . . 1.8999999999999999 111.622 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t30 69.78 19.55 7.13 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 128.502 2.721 . . . . 0.23999999999999999 113.324 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -53.63 -50.0 66.67 Favored 'General case' 0 C--N 1.386 2.17 0 O-C-N 119.054 -2.279 . . . . 2.54 112.93 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.81 -46.02 89.93 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 115.278 1.585 . . . . 1.6699999999999999 115.278 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.16 -45.77 90.14 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 119.505 -1.997 . . . . 1.0 115.161 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 31.0 t80 -74.26 -44.25 53.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.291 0.496 . . . . 0.22 110.228 -166.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -75.43 -23.98 57.02 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.509 -1.369 . . . . 1.0600000000000001 114.202 -176.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -64.42 -43.76 93.35 Favored 'General case' 0 CA--C 1.579 2.078 0 O-C-N 121.303 -0.873 . . . . 1.8200000000000001 111.241 160.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -20.74 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.82 1.415 . . . . 0.27000000000000002 114.82 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 18' ' ' MET . 7.7 mp -54.09 -43.82 70.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.439 1.496 . . . . 1.2 111.386 164.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.26 22.7 4.76 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 125.9 1.714 . . . . 0.40000000000000002 111.583 -165.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.63 133.54 42.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 O-C-N 119.365 -2.256 . . . . 0.38 109.007 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.2 m -82.92 -52.81 6.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 118.756 -2.465 . . . . 0.70999999999999996 113.932 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.4 t -155.88 -22.03 0.11 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 126.17 1.788 . . . . 1.04 113.766 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.79 -41.32 81.86 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 116.653 -1.642 . . . . 1.29 113.336 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.35 -36.85 14.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.711 0 C-N-CA 116.269 -2.172 . . . . 0.57999999999999996 110.417 168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mt -66.03 -37.22 79.31 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 O-C-N 125.419 1.699 . . . . 0.28000000000000003 110.529 -159.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -72.66 -29.58 63.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 119.484 -2.01 . . . . 1.48 112.808 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -72.94 -51.82 16.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.41 -1.33 . . . . 1.1899999999999999 107.41 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.699 1.999 . . . . 0.40000000000000002 112.623 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -65.87 -34.99 79.4 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.166 0.894 . . . . 2.3999999999999999 112.337 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -84.82 -36.34 21.71 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.401 1.63 . . . . 1.0900000000000001 115.401 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.357 14.7 p90 -132.57 -8.36 3.24 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 118.84 2.904 . . . . 2.8399999999999999 118.84 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.2 160.99 0.12 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 125.436 2.541 . . . . 2.5600000000000001 111.883 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.31 153.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 117.415 -3.303 . . . . 0.44 111.13 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.18 142.55 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.073 1.749 . . . . 0.84999999999999998 112.551 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.9 m -145.76 138.74 25.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.693 1.235 . . . . 0.39000000000000001 112.901 -165.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.52 146.59 31.63 Favored 'General case' 0 N--CA 1.428 -1.555 1 C-N-CA 134.102 4.961 . . . . 1.4099999999999999 106.238 175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 2' ' ' PHE . 93.3 t -141.3 153.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.172 -1.788 . . . . 0.20000000000000001 106.172 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 148.97 40.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.275 1.83 . . . . 2.1499999999999999 107.885 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 65.0 tt0 -155.17 123.02 5.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.905 -1.122 . . . . 1.1599999999999999 110.253 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -105.93 98.13 7.86 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 102.972 -2.973 . . . . 1.6799999999999999 102.972 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 -106.71 1.77 Allowed Glycine 0 N--CA 1.503 3.149 0 C-N-CA 118.121 -1.99 . . . . 1.24 114.915 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -92.29 -12.13 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.561 -1.319 . . . . 1.3700000000000001 113.883 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -103.05 114.18 28.26 Favored 'General case' 0 C--O 1.188 -2.172 0 N-CA-C 113.665 0.987 . . . . 1.8500000000000001 113.665 -174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -118.99 147.83 43.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 119.957 -1.714 . . . . 3.9900000000000002 106.903 -161.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m -136.37 132.01 34.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 126.948 2.655 . . . . 0.28999999999999998 109.284 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.08 128.22 52.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.488 1.915 . . . . 0.28999999999999998 111.526 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -132.68 110.47 10.43 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-O 117.826 -1.083 . . . . 1.22 113.888 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.63 163.29 13.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.566 1.546 . . . . 1.5 109.923 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -146.41 122.37 10.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.966 0.906 . . . . 2.21 110.47 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.406 7.4 p90 -70.19 103.11 2.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.091 -1.044 . . . . 0.83999999999999997 113.742 159.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.7 p 37.58 -123.75 0.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.759 2.503 . . . . 2.5699999999999998 117.759 -154.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.91 3.32 67.25 Favored Glycine 0 N--CA 1.481 1.64 0 O-C-N 119.397 -2.064 . . . . 2.4500000000000002 113.156 159.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.92 -52.23 52.32 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 128.43 2.919 . . . . 1.5600000000000001 115.806 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 4.6 t-160 -159.45 146.26 16.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 119.258 -2.319 . . . . 1.1699999999999999 113.829 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.9 m -102.46 138.02 39.93 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 126.743 2.017 . . . . 0.72999999999999998 109.247 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.3 132.75 54.56 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.55 -1.344 . . . . 1.1299999999999999 108.422 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.36 0.3 OUTLIER -128.36 133.28 48.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.737 1.384 . . . . 0.68000000000000005 114.737 176.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.55 117.63 20.74 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.87 -1.53 . . . . 0.83999999999999997 106.87 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -128.63 111.94 13.73 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.08 1.352 . . . . 0.82999999999999996 109.829 -166.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -157.2 165.98 34.46 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 118.687 -2.508 . . . . 0.57999999999999996 110.218 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -100.04 130.16 46.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.237 -0.892 . . . . 0.28999999999999998 112.056 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.94 135.87 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.664 0.987 . . . . 0.85999999999999999 113.664 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.63 2.25 84.81 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.085 -1.397 . . . . 0.26000000000000001 114.767 -168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -112.06 158.05 20.03 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 124.841 1.257 . . . . 1.54 109.076 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 168.26 14.34 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 127.232 3.396 . . . . 0.62 112.401 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m 60.41 44.01 12.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 117.564 -3.21 . . . . 1.3 117.935 -170.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -149.13 3.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 118.55 -2.594 . . . . 0.97999999999999998 115.866 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.45 124.64 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.977 1.311 . . . . 0.29999999999999999 109.208 -174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -113.0 164.11 13.86 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 116.45 -1.738 . . . . 1.96 107.777 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 p -102.94 -173.55 2.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.396 1.628 . . . . 0.47999999999999998 115.396 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.4 mtt -59.27 -43.37 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.254 1.421 . . . . 1.1100000000000001 114.265 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 -20.64 61.87 Favored Glycine 0 CA--C 1.487 -1.668 0 CA-C-O 116.847 -2.085 . . . . 0.72999999999999998 110.182 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.84 28.95 6.36 Favored Glycine 0 N--CA 1.496 2.669 0 CA-C-N 119.825 1.812 . . . . 0.63 112.107 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HE3' ' CD2' ' A' ' 79' ' ' PHE . 30.9 ttpt -70.36 113.87 7.93 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 128.633 2.773 . . . . 1.76 109.361 166.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -74.37 123.87 25.45 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.463 1.102 . . . . 0.54000000000000004 108.432 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD2' ' HE3' ' A' ' 77' ' ' LYS 0.372 0.0 OUTLIER -134.24 160.09 38.95 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.523 2.045 . . . . 0.34999999999999998 116.523 169.492 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 107.57 19.89 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.834 0.854 . . . . 1.96 111.485 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.27 155.01 38.89 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.564 0.745 . . . . 0.25 110.184 164.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 m -67.8 135.25 52.32 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.39 1.476 . . . . 0.28000000000000003 112.11 162.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.24 126.93 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 101.104 -3.665 . . . . 0.17999999999999999 101.104 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.59 162.45 29.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.479 1.112 . . . . 0.52000000000000002 109.808 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 73.4 mtp -128.14 127.6 43.28 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.23000000000000001 110.32 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -115.18 115.18 26.31 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 122.143 0.973 . . . . 1.53 109.283 166.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -74.01 0.39 Allowed Glycine 0 C--O 1.265 2.09 0 C-N-CA 126.376 1.941 . . . . 1.05 110.107 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.9 36.82 0.46 Allowed Glycine 0 N--CA 1.509 3.527 0 O-C-N 116.876 -3.72 . . . . 0.35999999999999999 112.972 -164.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -140.45 152.87 46.01 Favored 'General case' 0 N--CA 1.519 3.013 0 O-C-N 117.849 -3.147 . . . . 2.7000000000000002 111.472 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.1 mt -113.72 142.01 46.56 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 119.378 -2.076 . . . . 0.23000000000000001 111.268 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.22 137.9 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.495 -1.298 . . . . 0.23000000000000001 107.495 -167.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.28 159.63 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.602 1.191 . . . . 0.65000000000000002 108.965 161.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.04 133.92 39.87 Favored 'General case' 0 C--O 1.187 -2.194 0 CA-C-O 125.46 2.552 . . . . 1.8899999999999999 108.033 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -139.4 172.68 6.09 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 118.611 -2.555 . . . . 0.26000000000000001 108.831 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -66.86 -19.91 52.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.697 1.285 . . . . 0.46000000000000002 113.826 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.08 -53.9 2.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.748 1.619 . . . . 1.8899999999999999 112.456 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.858 ' OH ' ' C21' ' A' ' 202' ' ' CHO . 56.6 t80 -90.78 146.07 24.27 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.451 1.278 . . . . 0.26000000000000001 114.451 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -147.34 152.41 38.17 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.382 -1.449 . . . . 0.35999999999999999 111.289 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 164.4 29.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.839 -1.163 . . . . 1.48 110.988 168.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -161.11 147.85 14.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.431 3.092 . . . . 0.40000000000000002 107.795 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 126.8 1.4 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 117.272 -3.392 . . . . 1.24 114.615 -160.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.65 161.75 39.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.624 1.713 . . . . 1.6699999999999999 115.624 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.65 136.3 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.796 -1.187 . . . . 0.28000000000000003 107.796 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 t -126.59 107.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 104.372 -2.455 . . . . 0.59999999999999998 104.372 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.38 -116.18 8.98 Favored Glycine 0 N--CA 1.511 3.678 0 C-N-CA 128.294 2.854 . . . . 0.68000000000000005 108.605 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.13 -8.27 57.98 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.888 2.181 . . . . 2.2999999999999998 116.888 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -112.72 150.54 31.4 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.201 -1.562 . . . . 2.27 109.52 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.19 125.69 29.98 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.573 0.624 . . . . 0.59999999999999998 112.643 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.08 126.26 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 O-C-N 119.949 -1.72 . . . . 0.87 107.347 -157.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -112.34 135.89 52.47 Favored 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 107.957 -1.127 . . . . 2.0699999999999998 107.957 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.4 135.02 46.98 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-O 124.193 1.949 . . . . 0.27000000000000002 106.154 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.2 OUTLIER -150.23 140.86 22.59 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.298 -1.334 . . . . 0.87 109.265 -150.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -138.72 130.84 28.27 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-N 121.552 1.978 . . . . 0.26000000000000001 110.325 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.589 HG12 ' CD1' ' A' ' 97' ' ' TYR . 97.5 mt -128.42 116.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.692 1.133 . . . . 0.27000000000000002 110.151 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.81 21.99 59.24 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 113.202 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.11 9.23 59.61 Favored Glycine 0 N--CA 1.5 2.953 0 CA-C-O 115.232 -2.982 . . . . 0.20999999999999999 117.331 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.21 130.38 66.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 128.643 3.202 . . . . 0.17000000000000001 105.565 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.38 149.2 27.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 117.321 2.341 . . . . 0.27000000000000002 117.321 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -133.43 145.01 49.87 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 127.549 2.34 . . . . 0.59999999999999998 111.649 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -141.32 147.4 38.08 Favored 'General case' 0 C--O 1.273 2.302 0 N-CA-C 106.803 -1.555 . . . . 0.88 106.803 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.743 ' HE ' ' H30' ' A' ' 201' ' ' GCH . 23.5 ptt-85 -156.73 156.57 33.58 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.851 -1.156 . . . . 6.0899999999999999 113.047 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.45 147.55 27.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 104.808 -2.293 . . . . 0.89000000000000001 104.808 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.516 ' CB ' ' H36' ' A' ' 201' ' ' GCH . 28.1 t -137.46 156.41 48.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.03 1.492 . . . . 1.1299999999999999 115.03 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.77 134.81 42.13 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.887 1.675 . . . . 1.76 111.643 166.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -72.3 146.07 47.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 126.51 1.924 . . . . 2.0600000000000001 113.164 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -149.05 22.68 0.96 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.716 0.806 . . . . 0.40999999999999998 112.67 170.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.577 1.992 0 O-C-N 120.727 -1.233 . . . . 30.0 109.205 166.312 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.743 ' H30' ' HE ' ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.858 ' C21' ' OH ' ' A' ' 97' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.191 -2.005 0 CA-C-O 123.025 1.393 . . . . 1.01 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB3' ' H2 ' ' A' ' 201' ' ' GCH . 28.4 m-85 -126.57 -1.4 6.8 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 118.811 -2.43 . . . . 0.35999999999999999 110.282 -161.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 m -52.19 130.53 30.69 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.442 2.386 . . . . 0.27000000000000002 117.442 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.24 -145.7 11.85 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 107.01 -2.436 . . . . 0.46000000000000002 107.01 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' HD11 ' A' ' 126' ' ' LEU . 1.9 tmmm? -136.5 139.8 42.56 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.924 2.489 . . . . 0.72999999999999998 110.346 171.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -140.8 141.91 34.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.25 2.62 . . . . 0.42999999999999999 107.172 -164.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -130.45 119.37 22.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 128.444 3.974 . . . . 1.98 109.869 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -99.25 143.61 29.32 Favored 'General case' 0 N--CA 1.479 1.01 1 O-C-N 113.198 -5.938 . . . . 0.96999999999999997 113.811 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.58 66.74 1.17 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 127.72 2.408 . . . . 2.75 107.505 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.557 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 2.2 t -168.37 90.89 0.28 Allowed 'General case' 0 N--CA 1.398 -3.072 1 O-C-N 113.264 -5.897 . . . . 2.52 115.154 -151.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' CA ' ' HE ' ' A' ' 121' ' ' ARG . 2.2 mp0 -135.8 124.49 23.81 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 117.1 -1.429 . . . . 1.9199999999999999 113.969 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -153.5 126.64 8.47 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 100.716 -3.809 . . . . 1.8999999999999999 100.716 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 t30 55.67 19.14 3.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.37 1.619 . . . . 0.23999999999999999 115.37 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -61.2 -38.09 85.31 Favored 'General case' 0 CA--C 1.481 -1.7 0 C-N-CA 129.707 3.203 . . . . 2.54 110.343 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -43.92 55.89 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 118.473 -2.642 . . . . 1.6699999999999999 111.984 -165.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -72.46 -39.31 67.87 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 115.692 -2.099 . . . . 1.0 112.103 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 119' ' ' TYR . 63.6 t80 -59.05 -53.33 59.62 Favored 'General case' 0 N--CA 1.425 -1.707 0 O-C-N 126.485 2.366 . . . . 0.22 114.565 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB3' HD12 ' A' ' 23' ' ' ILE . 23.8 mmt -67.84 -36.81 80.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.06 1.133 . . . . 1.0600000000000001 114.06 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -58.27 -55.38 35.67 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 124.047 1.88 . . . . 1.8200000000000001 114.298 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.31 -26.85 65.35 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.53 -1.981 . . . . 0.27000000000000002 114.836 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -62.95 -33.63 75.78 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.122 -0.942 . . . . 1.2 112.074 167.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.99 -6.52 5.43 Favored Glycine 0 CA--C 1.457 -3.579 0 CA-C-O 125.048 2.471 . . . . 0.40000000000000002 112.616 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 H232 ' A' ' 202' ' ' CHO . 22.7 mt -68.17 143.91 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 117.441 -3.388 . . . . 0.38 107.699 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -97.32 -53.33 3.5 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 117.407 -1.717 . . . . 0.70999999999999996 110.43 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 m -146.84 -24.86 0.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 118.989 -2.319 . . . . 1.04 113.674 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.36 -63.73 1.04 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.376 1.621 . . . . 1.29 115.376 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 23' ' ' ILE . 50.3 t -70.33 -28.33 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.299 1.409 . . . . 0.57999999999999996 112.052 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.48 -46.12 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 123.68 1.705 . . . . 0.28000000000000003 112.607 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.97 -46.44 85.14 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.645 1.978 . . . . 1.48 114.345 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -55.76 -45.77 78.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.637 -0.665 . . . . 1.1899999999999999 109.551 171.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.96 71.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.792 -1.193 . . . . 0.40000000000000002 112.378 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -76.75 -7.99 56.43 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 116.865 2.172 . . . . 2.3999999999999999 116.865 -171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.15 -84.91 0.49 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 125.141 1.376 . . . . 1.0900000000000001 110.755 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.358 9.1 p90 -96.41 -13.16 23.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 118.741 2.867 . . . . 2.8399999999999999 118.741 -165.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.65 127.28 0.02 OUTLIER 'General case' 0 C--O 1.251 1.133 0 CA-C-O 125.524 2.583 . . . . 2.5600000000000001 108.521 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' C24' ' A' ' 201' ' ' GCH 0.265 90.7 mt -50.05 140.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 119.555 3.168 . . . . 0.44 119.555 166.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.28 130.81 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.003 1.321 . . . . 0.84999999999999998 109.831 165.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 m -117.07 147.29 42.5 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.088 -1.449 . . . . 0.39000000000000001 107.088 -161.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.58 143.35 45.46 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.312 2.006 . . . . 1.4099999999999999 110.245 161.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.56 149.44 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 O-C-N 118.096 -2.877 . . . . 0.20000000000000001 108.045 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.99 110.03 5.6 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.932 -1.032 . . . . 2.1499999999999999 108.642 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -121.79 135.62 54.92 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 119.525 1.057 . . . . 1.1599999999999999 108.298 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.05 91.09 3.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.497 1.919 . . . . 1.6799999999999999 114.721 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.97 -112.59 3.96 Favored Glycine 0 N--CA 1.421 -2.333 0 CA-C-O 125.569 2.76 . . . . 1.24 115.852 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -72.56 -34.57 67.59 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 112.352 -1.924 . . . . 1.3700000000000001 114.333 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 75.8 m-20 -76.34 149.74 36.97 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 118.476 -2.64 . . . . 1.8500000000000001 116.965 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -151.84 143.42 23.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 116.443 2.016 . . . . 3.9900000000000002 116.443 -169.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -135.03 120.1 18.72 Favored 'General case' 0 C--O 1.187 -2.206 0 C-N-CA 128.388 2.675 . . . . 0.28999999999999998 109.027 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.49 107.4 14.25 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 118.414 -2.679 . . . . 0.28999999999999998 109.358 163.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 14.6 t -108.43 124.63 50.7 Favored 'General case' 0 C--O 1.187 -2.234 0 O-C-N 121.073 -1.017 . . . . 1.22 109.909 -173.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.94 129.86 56.8 Favored 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 126.067 2.842 . . . . 1.5 105.309 -163.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.93 103.19 8.18 Favored 'General case' 0 C--O 1.247 0.97 0 O-C-N 118.47 -2.644 . . . . 2.21 112.527 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 57' ' ' HIS 0.37 3.7 p90 -65.61 103.54 0.88 Allowed 'General case' 0 N--CA 1.484 1.26 0 O-C-N 117.599 -3.188 . . . . 0.83999999999999997 115.783 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.0 p 49.61 28.15 2.45 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 129.008 2.923 . . . . 2.5699999999999998 114.586 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.79 -3.98 47.22 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 121.357 3.303 . . . . 2.4500000000000002 121.357 -165.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.42 -25.23 48.21 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.021 -1.87 . . . . 1.5600000000000001 115.347 -170.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR 0.253 14.6 t-80 -162.81 167.42 22.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.687 -1.968 . . . . 1.1699999999999999 105.687 172.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.8 m -132.98 132.17 41.6 Favored 'General case' 0 N--CA 1.415 -2.225 0 O-C-N 129.023 3.952 . . . . 0.72999999999999998 110.327 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -125.92 164.09 21.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.201 -1.407 . . . . 1.1299999999999999 107.201 161.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 25.7 p -144.13 145.0 31.84 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-O 125.257 2.456 . . . . 0.68000000000000005 105.797 -162.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.38 117.38 22.09 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 117.218 -3.427 . . . . 0.83999999999999997 109.594 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -131.23 127.01 36.97 Favored 'General case' 0 C--N 1.375 1.69 0 O-C-N 120.837 -1.164 . . . . 0.82999999999999996 109.975 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.06 162.27 41.36 Favored 'General case' 0 C--O 1.266 1.967 0 C-N-CA 128.15 2.58 . . . . 0.57999999999999996 113.616 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 m -104.03 128.19 51.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.48 1.112 . . . . 0.28999999999999998 111.249 164.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.01 138.38 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-O 124.33 2.014 . . . . 0.85999999999999999 109.844 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.93 82.07 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 119.959 -1.713 . . . . 0.26000000000000001 114.816 -164.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -121.23 153.38 37.7 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.309 1.554 . . . . 1.54 112.876 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -108.48 152.27 24.94 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-O 122.08 0.943 . . . . 0.62 111.131 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.74 41.18 28.58 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 118.114 2.635 . . . . 1.3 118.114 173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.77 -8.99 9.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.278 -1.328 . . . . 0.97999999999999998 110.967 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.19 136.25 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.262 1.425 . . . . 0.29999999999999999 110.675 -153.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -115.3 158.49 22.29 Favored 'General case' 0 C--O 1.253 1.285 0 C-N-CA 125.137 1.375 . . . . 1.96 114.381 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -82.14 173.48 12.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.27 2.228 . . . . 0.47999999999999998 112.345 167.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.562 ' H ' H162 ' A' ' 202' ' ' CHO . 14.9 mtm -74.37 -18.2 60.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.292 -1.337 . . . . 1.1100000000000001 112.616 164.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.9 -0.15 89.13 Favored Glycine 0 N--CA 1.4 -3.757 0 CA-C-N 120.481 1.491 . . . . 0.72999999999999998 109.929 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.37 76.86 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 118.51 -2.759 . . . . 0.63 117.154 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -78.46 131.84 37.04 Favored 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 115.51 1.67 . . . . 1.76 115.51 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -80.74 134.94 35.91 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.821 -1.174 . . . . 0.54000000000000004 111.059 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.6 161.99 36.17 Favored 'General case' 0 C--O 1.292 3.304 0 N-CA-C 115.644 1.72 . . . . 0.34999999999999998 115.644 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 94.75 5.23 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 116.633 -1.651 . . . . 1.96 115.327 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.12 164.57 28.81 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 126.119 2.137 . . . . 0.25 107.778 165.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.7 m -99.11 109.99 22.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.006 0.922 . . . . 0.28000000000000003 108.521 174.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.72 147.84 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.075 0.95 . . . . 0.17999999999999999 111.822 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -126.05 158.22 35.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.539 1.063 . . . . 0.52000000000000002 111.919 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 69.1 mtp -100.32 131.28 46.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.342 0.657 . . . . 0.23000000000000001 111.341 159.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -127.64 67.35 1.32 Allowed 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 127.379 2.271 . . . . 1.53 108.671 -170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.44 -5.38 54.92 Favored Glycine 0 C--O 1.293 3.8 0 O-C-N 117.843 -3.036 . . . . 1.05 114.751 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.34 -23.41 11.29 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 116.095 -2.503 . . . . 0.35999999999999999 111.117 -157.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -76.32 154.32 35.14 Favored 'General case' 0 C--O 1.196 -1.727 0 CA-C-N 120.071 1.935 . . . . 2.7000000000000002 115.054 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 mt -115.73 133.22 56.25 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-O 117.224 -1.37 . . . . 0.23000000000000001 109.692 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 140.79 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 122.036 2.198 . . . . 0.23000000000000001 116.639 -162.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.84 156.42 41.38 Favored 'Isoleucine or valine' 0 C--O 1.257 1.487 0 O-C-N 117.978 -2.951 . . . . 0.65000000000000002 110.074 163.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -140.58 100.17 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.245 2.218 . . . . 1.8899999999999999 109.378 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.88 175.35 1.91 Allowed Pre-proline 0 N--CA 1.408 -2.568 0 C-N-CA 127.822 2.449 . . . . 0.26000000000000001 107.068 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -75.24 -30.12 7.15 Favored 'Trans proline' 0 C--O 1.261 1.66 0 CA-C-O 115.183 -2.09 . . . . 0.46000000000000002 113.86 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -123.08 23.87 9.09 Favored 'General case' 0 C--N 1.373 1.601 0 CA-C-N 123.867 3.03 . . . . 1.8899999999999999 112.802 156.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE1' HD21 ' A' ' 21' ' ' LEU 0.301 45.5 t80 -136.02 135.33 39.38 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 115.981 1.845 . . . . 0.26000000000000001 115.981 -177.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -146.96 151.39 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.82 -0.807 . . . . 0.35999999999999999 108.82 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.438 ' OE1' H122 ' A' ' 202' ' ' CHO . 8.4 pt20 -151.79 171.25 18.01 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 119.477 -0.889 . . . . 1.48 111.748 150.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.7 m -135.54 139.76 44.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.031 2.132 . . . . 0.40000000000000002 107.454 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.49 ' HB3' ' H11' ' A' ' 201' ' ' GCH . 58.7 m -129.37 141.6 51.02 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.194 1.361 . . . . 1.24 112.653 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -150.14 153.4 36.27 Favored 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 116.471 2.026 . . . . 1.6699999999999999 116.471 -164.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.0 tt -116.57 114.62 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 O-C-N 118.215 -2.803 . . . . 0.28000000000000003 111.056 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.5 t -126.56 113.66 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 106.057 -1.831 . . . . 0.59999999999999998 106.057 -168.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.79 -107.12 2.01 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-N 114.204 -1.362 . . . . 0.68000000000000005 112.358 -173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -118.06 -6.97 10.9 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 126.636 1.974 . . . . 2.2999999999999998 113.135 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -102.02 155.12 18.38 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 127.796 2.438 . . . . 2.27 109.493 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.428 HD12 ' H7 ' ' A' ' 201' ' ' GCH . 2.4 mm? -129.14 115.99 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.406 -1.27 . . . . 0.59999999999999998 108.488 -161.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.05 144.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.818 0 C-N-CA 124.356 1.062 . . . . 0.87 109.09 -156.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 161.44 33.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 119.543 -1.973 . . . . 2.0699999999999998 111.688 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.82 99.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.588 0.755 . . . . 0.27000000000000002 109.091 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 11.0 m -100.49 172.63 7.0 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 109.417 -0.586 . . . . 0.87 109.417 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -152.37 130.16 11.66 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.778 2.431 . . . . 0.26000000000000001 110.97 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -129.14 128.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.475 -1.306 . . . . 0.27000000000000002 107.475 170.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 59.44 17.92 41.76 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 115.854 -3.07 . . . . 0.28999999999999998 119.952 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.84 20.76 67.42 Favored Glycine 0 C--O 1.181 -3.187 0 CA-C-O 113.594 -3.892 . . . . 0.20999999999999999 115.657 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.5 131.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 127.872 2.748 . . . . 0.17000000000000001 110.57 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.64 144.97 29.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.264 1.95 . . . . 0.27000000000000002 116.264 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 47.0 t80 -134.54 137.49 43.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.1 2.56 . . . . 0.59999999999999998 109.117 165.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -157.9 72.86 0.66 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 124.04 3.109 . . . . 0.88 115.166 -160.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.52 ' HE ' ' CA ' ' A' ' 11' ' ' GLU . 9.4 mmm180 -112.62 156.61 22.43 Favored 'General case' 0 N--CA 1.485 1.28 1 O-C-N 113.505 -5.747 . . . . 6.0899999999999999 114.62 -154.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.557 ' H ' ' CB ' ' A' ' 10' ' ' SER . 2.3 t -121.89 147.22 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 C-N-CA 126.219 1.808 . . . . 0.89000000000000001 114.585 -165.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -153.3 168.66 25.3 Favored 'General case' 0 CA--C 1.478 -1.799 0 CA-C-O 123.099 1.428 . . . . 1.1299999999999999 110.728 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -126.46 121.34 32.11 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.561 -2.108 . . . . 1.76 110.764 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -70.35 152.86 43.65 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.851 1.344 . . . . 2.0600000000000001 110.83 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.567 HD11 ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -157.97 17.21 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.964 1.098 . . . . 0.40999999999999998 113.964 168.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.431 -1.322 . . . . 30.0 107.431 168.516 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.49 ' H11' ' HB3' ' A' ' 101' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.562 H162 ' H ' ' A' ' 74' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.531 3.58 0 N-CA-C 108.633 -0.877 . . . . 1.01 108.633 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 19.7 m-85 -99.56 5.84 45.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.115 1.366 . . . . 0.35999999999999999 114.347 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -29.52 144.64 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.481 0 N-CA-C 116.981 2.215 . . . . 0.27000000000000002 116.981 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.49 -161.54 23.26 Favored Glycine 0 CA--C 1.468 -2.846 0 O-C-N 125.71 1.881 . . . . 0.46000000000000002 112.491 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.21 131.11 56.4 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.47 2.308 . . . . 0.72999999999999998 107.956 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.11 146.14 51.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.278 1.431 . . . . 0.42999999999999999 109.548 -170.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.7 113.49 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.025 0.93 . . . . 1.98 109.779 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpt -72.02 128.45 35.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.96999999999999997 108.628 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -119.33 7.37 11.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.439 0.903 . . . . 2.75 113.439 -172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -155.61 134.29 11.87 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 117.284 -3.385 . . . . 2.52 115.597 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -96.61 143.19 27.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.678 1.991 . . . . 1.9199999999999999 113.766 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -161.24 124.58 3.26 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.768 -1.208 . . . . 1.8999999999999999 112.038 152.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 67.64 1.73 2.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.747 2.419 . . . . 0.23999999999999999 115.206 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -57.93 -29.51 65.2 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.966 -1.084 . . . . 2.54 112.605 -160.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.85 -63.79 1.01 Allowed 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 126.978 2.111 . . . . 1.6699999999999999 105.416 -167.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -61.57 -32.39 72.48 Favored 'General case' 0 N--CA 1.4 -2.946 0 C-N-CA 125.712 1.605 . . . . 1.0 112.459 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -74.3 -53.39 9.81 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 117.768 -1.11 . . . . 0.17000000000000001 111.166 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.8 mtp -63.71 -32.85 74.47 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 122.193 2.27 . . . . 1.0600000000000001 117.088 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -53.46 -45.77 69.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 118.302 -2.748 . . . . 1.8200000000000001 117.808 160.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.55 -23.91 63.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.052 0.941 . . . . 0.27000000000000002 112.765 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 97' ' ' TYR . 79.1 mt -68.5 -47.5 66.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.29 0.95 . . . . 1.2 111.691 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.81 6.11 0.98 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-O 116.659 -2.189 . . . . 0.40000000000000002 111.703 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.1 121.12 63.95 Favored 'Isoleucine or valine' 0 C--O 1.285 2.939 0 CA-C-N 119.776 1.788 . . . . 0.38 108.744 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 m -78.38 -51.48 10.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.14 -0.933 . . . . 0.70999999999999996 112.363 -173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -146.26 -32.72 0.33 Allowed 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 114.262 1.208 . . . . 1.04 114.262 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.295 19.3 t70 -59.83 -40.69 89.32 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.941 2.201 . . . . 1.29 116.941 -166.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.89 -25.08 11.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 120.683 1.583 . . . . 0.57999999999999996 114.03 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.11 -44.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.074 0.852 . . . . 0.28000000000000003 111.39 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.1 -31.85 71.53 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 126.168 1.787 . . . . 1.48 109.962 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -82.51 -45.06 15.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.234 -2.166 . . . . 1.1899999999999999 111.618 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.6 91.02 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 116.157 1.91 . . . . 0.40000000000000002 116.157 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -72.38 -34.63 68.09 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.404 1.082 . . . . 2.3999999999999999 112.478 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -79.48 -42.8 24.48 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.246 1.202 . . . . 1.0900000000000001 114.246 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 54' ' ' SER . 11.7 p90 -140.9 -8.5 1.05 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.961 2.578 . . . . 0.78000000000000003 117.961 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HA ' ' O5 ' ' A' ' 201' ' ' GCH 0.266 2.2 mptp? 68.07 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.671 2.389 . . . . 2.5600000000000001 116.794 -175.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.27 152.11 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 O-C-N 119.762 -1.836 . . . . 0.44 112.407 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.59 147.63 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 119.605 -1.935 . . . . 0.84999999999999998 112.497 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.514 HG21 ' H42' ' A' ' 201' ' ' GCH . 31.9 m -137.97 139.44 39.7 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-O 124.151 1.929 . . . . 0.39000000000000001 114.76 -166.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -112.44 131.73 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 127.566 2.346 . . . . 1.4099999999999999 113.017 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG21 ' C5 ' ' A' ' 201' ' ' GCH . 46.5 t -124.7 143.14 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 107.211 -1.403 . . . . 0.20000000000000001 107.211 -168.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -144.52 135.55 25.11 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 104.87 -2.27 . . . . 2.1499999999999999 104.87 162.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -144.57 138.58 27.57 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.058 -1.651 . . . . 1.1599999999999999 110.775 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -139.42 120.14 14.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.408 1.099 . . . . 1.6799999999999999 111.253 169.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.13 5.15 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 120.796 -1.19 . . . . 1.24 114.174 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -94.1 1.67 56.11 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-O 114.835 -2.507 . . . . 1.3700000000000001 107.667 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -104.64 131.4 52.1 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 123.98 3.082 . . . . 1.8500000000000001 115.626 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CB ' ' CE1' ' A' ' 63' ' ' PHE . 8.0 m-85 -128.27 150.97 49.82 Favored 'General case' 0 CA--C 1.444 -3.131 0 N-CA-C 114.404 1.261 . . . . 3.9900000000000002 114.404 -170.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -146.24 131.58 18.57 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 128.254 3.471 . . . . 0.28999999999999998 106.906 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.26 129.55 52.33 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 119.347 -2.095 . . . . 0.28999999999999998 106.727 167.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -131.9 110.68 10.97 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 121.201 1.819 . . . . 1.22 108.135 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -76.52 152.46 36.04 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 125.137 2.399 . . . . 1.5 116.199 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -137.93 121.19 16.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.488 1.915 . . . . 2.21 107.783 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -63.88 65.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 116.399 2.0 . . . . 0.83999999999999997 116.399 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.49 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . 82.7 p 59.22 8.33 1.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.223 2.209 . . . . 2.5699999999999998 115.018 -158.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.94 55.86 Favored Glycine 0 C--O 1.258 1.654 0 O-C-N 121.943 -0.473 . . . . 2.4500000000000002 114.071 -165.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.78 -16.12 68.79 Favored Glycine 0 C--N 1.364 2.121 0 O-C-N 117.942 -3.093 . . . . 1.5600000000000001 111.793 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -170.35 123.0 0.67 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-N 123.65 3.725 . . . . 1.1699999999999999 106.117 -167.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -91.8 152.75 19.99 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.295 -1.503 . . . . 0.72999999999999998 109.904 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.6 mtm -140.77 155.63 46.37 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 103.47 -2.789 . . . . 1.1299999999999999 103.47 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -144.73 117.13 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 104.887 -2.264 . . . . 0.68000000000000005 104.887 -160.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -120.95 82.59 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 118.007 -2.933 . . . . 0.83999999999999997 110.286 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -109.34 136.47 48.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.907 -1.044 . . . . 0.82999999999999996 112.299 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.69 ' CZ ' ' H5 ' ' A' ' 202' ' ' CHO . 30.3 p90 -163.18 173.15 13.79 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.291 1.036 . . . . 0.57999999999999996 108.225 -165.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.4 m -113.5 130.16 56.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.064 1.746 . . . . 0.28999999999999998 107.744 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.04 139.68 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.541 0.686 . . . . 0.85999999999999999 110.522 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.21 14.16 82.86 Favored Glycine 0 N--CA 1.484 1.875 0 O-C-N 117.809 -3.057 . . . . 0.26000000000000001 115.457 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -126.4 165.15 19.58 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 129.041 2.937 . . . . 1.54 107.345 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -106.62 167.51 9.81 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 128.172 2.589 . . . . 0.62 114.011 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 78.6 p 62.03 20.4 11.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 126.751 2.02 . . . . 1.3 116.181 160.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.11 2.87 10.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.701 1.2 . . . . 0.97999999999999998 110.431 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -82.86 135.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 120.866 -1.146 . . . . 0.29999999999999999 109.281 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.36 160.32 27.01 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 107.705 -1.221 . . . . 1.96 107.705 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.462 ' HB ' ' N25' ' A' ' 202' ' ' CHO . 23.2 p -108.09 179.07 4.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 120.16 -1.588 . . . . 0.47999999999999998 114.518 -163.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.441 ' SD ' H213 ' A' ' 202' ' ' CHO . 42.5 mtt -63.57 7.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.86 2.064 . . . . 1.1100000000000001 115.047 162.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.8 1.16 6.32 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 122.984 1.325 . . . . 0.72999999999999998 113.331 159.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.16 75.13 Favored Glycine 0 C--O 1.261 1.8 0 N-CA-C 118.834 2.294 . . . . 0.63 118.834 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.18 135.46 35.77 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 118.165 0.983 . . . . 1.76 109.851 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -88.4 127.68 35.5 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 115.326 -2.274 . . . . 0.54000000000000004 112.993 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -142.15 167.94 20.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 122.3 2.318 . . . . 0.34999999999999998 116.735 178.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.98 116.55 29.4 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 116.103 -1.903 . . . . 1.96 113.031 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.51 24.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.801 -0.815 . . . . 0.25 108.801 153.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 m -95.39 115.07 26.93 Favored 'General case' 0 CA--C 1.459 -2.528 0 C-N-CA 124.395 1.078 . . . . 0.28000000000000003 108.558 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.86 118.36 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 111.405 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -95.5 142.05 28.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.705 0.684 . . . . 0.52000000000000002 110.797 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.26 114.58 28.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.685 1.707 . . . . 0.23000000000000001 106.828 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.76 78.95 1.66 Allowed 'General case' 0 C--O 1.26 1.616 0 CA-C-O 124.597 2.142 . . . . 1.53 108.625 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.26 30.69 56.61 Favored Glycine 0 CA--C 1.562 3.031 0 O-C-N 118.356 -2.715 . . . . 1.05 117.105 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.37 35.57 17.0 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 119.6 2.6 . . . . 0.35999999999999999 119.6 -173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -150.44 146.23 26.53 Favored 'General case' 0 CA--C 1.479 -1.762 0 C-N-CA 126.858 2.063 . . . . 2.7000000000000002 108.517 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.651 ' HB2' ' H22' ' A' ' 202' ' ' CHO . 2.7 mp -122.27 143.34 49.66 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.573 -0.705 . . . . 0.23000000000000001 112.423 -167.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.87 146.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.092 -1.077 . . . . 0.23000000000000001 108.092 -158.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.84 166.84 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.562 1.945 . . . . 0.65000000000000002 108.503 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -144.15 129.43 18.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.115 2.166 . . . . 1.8899999999999999 108.413 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.56 160.89 59.65 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 126.836 2.055 . . . . 0.26000000000000001 106.914 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -56.15 -33.63 90.86 Favored 'Trans proline' 0 C--O 1.271 2.146 0 CA-C-N 119.99 1.032 . . . . 0.46000000000000002 111.717 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.63 -17.65 17.7 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 116.247 -1.835 . . . . 1.8899999999999999 114.368 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.857 ' CD1' HG12 ' A' ' 114' ' ' ILE . 38.4 t80 -140.72 142.32 34.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.791 1.774 . . . . 0.26000000000000001 115.791 -158.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -146.7 149.62 33.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.424 1.49 . . . . 0.35999999999999999 110.763 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.479 ' HG2' ' C12' ' A' ' 202' ' ' CHO . 7.3 tp-100 -135.71 162.5 32.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.443 1.497 . . . . 1.48 107.553 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 m -167.54 118.91 0.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.851 -3.018 . . . . 0.40000000000000002 102.851 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.1 p -141.99 135.21 29.07 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.598 -1.313 . . . . 1.24 114.345 -171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.28 170.12 16.3 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 118.15 2.648 . . . . 1.6699999999999999 118.15 -150.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.1 mt -109.54 124.17 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.665 1.698 . . . . 0.28000000000000003 107.583 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.24 97.23 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 118.832 -2.417 . . . . 0.59999999999999998 109.312 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.73 -106.16 0.11 Allowed Glycine 0 CA--C 1.56 2.867 0 O-C-N 117.158 -3.464 . . . . 0.68000000000000005 114.629 -165.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -100.31 0.24 39.75 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.819 2.31 . . . . 2.2999999999999998 113.795 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -111.99 154.72 24.89 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 125.014 2.34 . . . . 2.27 104.857 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.45 135.24 53.39 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 118.4 -2.688 . . . . 0.59999999999999998 107.558 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.94 122.63 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.25 0 N-CA-C 105.095 -2.187 . . . . 0.87 105.095 -167.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.2 147.54 24.5 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 119.016 -2.302 . . . . 2.0699999999999998 110.978 169.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.15 111.85 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-O 123.729 1.728 . . . . 0.27000000000000002 110.14 164.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.611 ' HG ' ' HH ' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -127.75 143.81 51.12 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.567 -1.958 . . . . 0.87 108.113 -161.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.0 m -143.88 127.24 16.79 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 118.997 -2.314 . . . . 0.26000000000000001 113.079 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.857 HG12 ' CD1' ' A' ' 97' ' ' TYR . 5.3 mt -119.38 128.27 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.08 -1.638 . . . . 0.27000000000000002 108.235 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.33 63.56 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.482 1.037 . . . . 0.28999999999999998 115.353 164.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.18 65.42 Favored Glycine 0 CA--C 1.457 -3.539 1 C-N-CA 131.265 4.269 . . . . 0.20999999999999999 122.66 -163.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 p -101.64 138.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 118.82 -2.576 . . . . 0.17000000000000001 111.905 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 m -107.5 153.31 23.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.147 1.536 . . . . 0.27000000000000002 115.147 -166.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.62 132.43 42.47 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.883 1.673 . . . . 0.59999999999999998 110.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -152.43 120.02 6.05 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 116.769 -1.973 . . . . 0.88 106.806 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -157.3 156.06 31.76 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.863 2.744 . . . . 6.0899999999999999 111.061 -164.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.33 141.47 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.831 2.053 . . . . 0.89000000000000001 112.576 -163.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.9 t -135.51 144.36 46.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 123.776 1.75 . . . . 1.1299999999999999 108.015 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -87.49 147.98 25.13 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.349 -1.47 . . . . 1.76 111.233 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -104.54 143.44 33.05 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 118.459 -0.781 . . . . 2.0600000000000001 109.021 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.99 25.46 0.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.832 1.419 . . . . 0.40999999999999998 114.832 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 O-C-N 120.552 -1.343 . . . . 30.0 112.049 170.246 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.611 ' C5 ' HG21 ' A' ' 40' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.69 ' H5 ' ' CZ ' ' A' ' 63' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.535 -3.876 . . . . 1.01 100.535 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -81.21 -3.98 54.03 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.558 2.058 . . . . 0.35999999999999999 116.558 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.1 m -24.19 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.326 2.651 . . . . 0.27000000000000002 116.743 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.21 -177.02 19.47 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 114.674 -3.292 . . . . 0.46000000000000002 108.735 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.75 132.34 53.38 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 122.894 3.347 . . . . 0.72999999999999998 108.607 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -130.06 136.17 49.07 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 120.273 -1.517 . . . . 0.42999999999999999 109.791 -162.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -112.26 128.08 56.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 125.297 2.475 . . . . 1.98 108.658 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.9 ttp -83.38 146.16 28.61 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 115.552 1.686 . . . . 0.96999999999999997 115.552 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.09 104.33 7.27 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 118.904 -2.372 . . . . 2.75 108.871 152.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -168.31 105.12 0.46 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.771 1.169 . . . . 2.52 112.64 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.61 124.89 48.98 Favored 'General case' 0 C--O 1.192 -1.936 0 N-CA-C 102.957 -2.979 . . . . 1.9199999999999999 102.957 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -158.17 76.07 0.76 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.674 1.19 . . . . 1.8999999999999999 111.193 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 t30 66.08 27.71 10.49 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.401 1.26 . . . . 0.23999999999999999 114.401 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -61.67 -37.24 83.33 Favored 'General case' 0 N--CA 1.419 -2.025 0 C-N-CA 128.215 2.606 . . . . 2.54 109.631 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -63.85 -39.22 93.7 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 116.952 -3.593 . . . . 1.6699999999999999 113.821 -168.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.63 -34.46 58.32 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.343 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -70.53 -51.22 30.19 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.44 -1.412 . . . . 0.22 107.619 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.29 -30.03 65.77 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.101 -1.624 . . . . 1.0600000000000001 112.967 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -58.6 -45.23 89.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.851 2.061 . . . . 1.8200000000000001 113.711 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.98 -12.47 50.29 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.42 1.088 . . . . 0.27000000000000002 109.054 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 tp -98.45 -6.78 29.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.519 -1.363 . . . . 1.2 113.613 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.46 10.28 10.64 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 127.0 2.238 . . . . 0.40000000000000002 115.442 157.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.76 151.02 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 114.083 -2.865 . . . . 0.38 108.993 162.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -96.45 -51.22 4.44 Favored 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 122.692 2.496 . . . . 0.70999999999999996 114.747 160.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m -132.37 -34.47 1.22 Allowed 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 115.065 -2.398 . . . . 1.04 110.0 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -35.37 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 115.992 -1.956 . . . . 1.29 112.871 -164.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -79.67 -19.95 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.122 1.783 . . . . 0.57999999999999996 113.84 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.72 -42.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.313 -2.117 . . . . 0.28000000000000003 112.882 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.26 -27.12 53.07 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 114.14 1.163 . . . . 1.48 114.14 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -78.33 -40.28 37.02 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.168 0.987 . . . . 1.1899999999999999 111.998 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.01 53.04 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 114.608 1.336 . . . . 0.40000000000000002 114.608 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -70.39 -24.74 63.0 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.185 1.357 . . . . 2.3999999999999999 113.847 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -77.17 -51.54 10.81 Favored 'General case' 0 CA--C 1.447 -3.019 0 N-CA-C 117.886 2.55 . . . . 1.0900000000000001 117.886 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.81 -90.58 0.48 Allowed 'General case' 0 C--O 1.222 -0.348 0 O-C-N 120.558 -1.339 . . . . 2.8399999999999999 109.351 -162.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.77 177.28 0.06 Allowed 'General case' 0 C--O 1.237 0.413 1 C-N-CA 132.916 4.486 . . . . 2.5600000000000001 104.387 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.7 mm -123.12 154.02 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.485 -0.931 . . . . 0.44 108.485 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.0 147.14 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.327 1.051 . . . . 0.84999999999999998 112.25 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.406 HG21 ' H41' ' A' ' 201' ' ' GCH . 8.6 m -132.73 145.43 51.02 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.542 1.312 . . . . 0.39000000000000001 114.542 -172.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.87 137.27 52.32 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 128.515 2.726 . . . . 1.4099999999999999 107.318 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.69 139.78 50.97 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 O-C-N 119.991 -1.693 . . . . 0.20000000000000001 110.896 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -141.13 136.76 32.22 Favored 'General case' 0 CA--C 1.589 2.447 0 N-CA-C 104.607 -2.368 . . . . 2.1499999999999999 104.607 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -144.91 157.35 44.18 Favored 'General case' 0 N--CA 1.398 -3.058 0 N-CA-C 107.814 -1.18 . . . . 1.1599999999999999 107.814 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -159.9 140.66 12.18 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.0 -1.688 . . . . 1.6799999999999999 108.084 152.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.7 -116.4 5.35 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.627 0.632 . . . . 1.24 113.493 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -93.28 -11.63 32.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.436 3.494 . . . . 1.3700000000000001 107.158 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.284 40.4 m-20 -106.05 130.79 53.9 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.953 2.161 . . . . 1.8500000000000001 116.602 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.13 123.99 35.8 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.121 1.156 . . . . 3.9900000000000002 114.121 -162.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.6 m -112.94 114.5 27.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.094 0.95 . . . . 0.28999999999999998 110.697 164.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.442 ' HE1' ' CD ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -107.85 99.0 8.51 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.243 2.617 . . . . 0.28999999999999998 107.902 167.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.6 m -114.49 125.41 53.78 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 119.616 -1.928 . . . . 1.22 114.257 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.442 ' CD ' ' HE1' ' A' ' 49' ' ' TRP . 6.7 mt-30 -122.06 152.37 39.89 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 127.241 2.216 . . . . 1.5 113.338 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -130.83 136.85 49.06 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 117.796 -3.065 . . . . 2.21 111.301 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -70.37 133.54 47.01 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 106.238 -1.764 . . . . 0.83999999999999997 106.238 161.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 m -67.1 100.27 0.75 Allowed 'General case' 0 C--O 1.253 1.276 0 CA-C-O 123.504 1.621 . . . . 2.5699999999999998 114.898 164.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.02 -8.02 4.79 Favored Glycine 0 CA--C 1.451 -3.925 0 N-CA-C 121.083 3.193 . . . . 2.4500000000000002 121.083 -162.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.01 91.15 2.14 Favored Glycine 0 N--CA 1.473 1.165 0 O-C-N 120.381 -1.658 . . . . 1.5600000000000001 114.171 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 171.54 143.59 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 129.214 3.006 . . . . 1.1699999999999999 110.732 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.7 m -121.7 138.95 54.14 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.592 1.808 . . . . 0.72999999999999998 110.983 -165.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.8 107.12 11.95 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 103.803 -2.666 . . . . 1.1299999999999999 103.803 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.265 1.4 p -101.84 134.11 45.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.077 1.308 . . . . 0.68000000000000005 114.494 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -127.07 96.74 4.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.12 -1.437 . . . . 0.83999999999999997 107.12 -173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -86.55 151.35 23.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.203 -0.936 . . . . 0.82999999999999996 108.624 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.95 170.77 21.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.567 1.147 . . . . 0.57999999999999996 110.891 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -124.86 108.04 11.51 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 101.838 -3.393 . . . . 0.28999999999999998 101.838 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.16 140.96 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 121.447 -0.783 . . . . 0.85999999999999999 111.619 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.46 78.15 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.083 -1.01 . . . . 0.26000000000000001 112.551 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.93 133.65 53.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 127.108 3.337 . . . . 1.54 110.204 -166.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -74.48 157.67 35.16 Favored 'General case' 0 N--CA 1.405 -2.685 0 O-C-N 118.39 -2.694 . . . . 0.62 115.513 171.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m 69.43 15.56 8.35 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.614 2.365 . . . . 1.3 117.366 165.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -129.26 32.64 4.66 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.3 -1.36 . . . . 0.97999999999999998 107.863 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.75 126.03 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 116.334 -1.793 . . . . 0.29999999999999999 111.48 -161.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -116.67 155.18 29.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 127.638 3.086 . . . . 1.96 113.854 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' H181 ' A' ' 202' ' ' CHO . 27.9 p -85.49 -178.99 6.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.352 3.061 . . . . 0.47999999999999998 115.002 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.3 mmt -56.3 -34.15 66.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.237 1.015 . . . . 1.1100000000000001 113.223 167.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 -12.72 83.88 Favored Glycine 0 C--O 1.187 -2.84 0 C-N-CA 126.192 1.853 . . . . 0.72999999999999998 113.927 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.13 68.08 Favored Glycine 0 CA--C 1.482 -2.024 0 CA-C-O 117.542 -1.699 . . . . 0.63 112.71 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -84.8 114.1 21.82 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 122.827 3.314 . . . . 1.76 107.398 -169.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -62.43 133.11 54.57 Favored 'General case' 0 CA--C 1.584 2.267 0 O-C-N 118.132 -2.855 . . . . 0.54000000000000004 109.955 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.325 0.0 OUTLIER -134.48 177.74 7.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.033 1.288 . . . . 0.34999999999999998 114.394 170.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.26 105.07 10.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.877 1.271 . . . . 1.96 109.405 -173.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.55 159.7 38.79 Favored 'General case' 0 C--O 1.183 -2.402 0 N-CA-C 107.465 -1.309 . . . . 0.25 107.465 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.9 m -88.52 105.8 17.87 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 118.896 -2.378 . . . . 0.28000000000000003 111.274 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.98 133.62 29.27 Favored 'Isoleucine or valine' 0 C--O 1.262 1.762 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.45 162.7 29.6 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.646 -1.284 . . . . 0.52000000000000002 112.789 -164.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.6 mtp -117.09 62.22 0.73 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.234 1.938 . . . . 0.23000000000000001 116.234 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.94 96.19 0.75 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.659 -1.275 . . . . 1.53 114.028 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.88 13.62 57.17 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 118.468 -2.645 . . . . 1.05 115.057 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.66 -10.29 23.61 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 126.654 2.074 . . . . 0.35999999999999999 115.454 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -69.81 144.82 52.52 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.011 2.124 . . . . 2.7000000000000002 111.415 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -102.65 120.02 39.83 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 114.796 1.406 . . . . 0.23000000000000001 114.796 167.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.72 139.31 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 118.491 0.587 . . . . 0.23000000000000001 110.66 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.515 HG22 ' H12' ' A' ' 202' ' ' CHO . 2.2 m -116.39 163.51 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.41 -1.33 . . . . 0.65000000000000002 107.41 160.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -129.25 136.68 50.41 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 112.091 -2.322 . . . . 1.8899999999999999 109.234 160.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.83 174.2 4.95 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 130.463 3.505 . . . . 0.26000000000000001 111.533 173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -56.05 -33.44 89.72 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.377 2.052 . . . . 0.46000000000000002 115.664 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -124.2 -28.87 3.64 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 120.098 1.317 . . . . 1.8899999999999999 108.275 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.24 141.05 29.29 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-O 126.365 2.983 . . . . 0.27000000000000002 109.006 -171.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -142.89 152.77 42.44 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.329 -2.107 . . . . 0.35999999999999999 109.294 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -151.61 179.98 7.92 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.038 1.125 . . . . 1.48 114.038 152.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.66 138.85 17.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 128.03 2.532 . . . . 0.40000000000000002 105.717 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.1 p -147.42 136.73 22.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.283 1.586 . . . . 1.24 115.283 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.24 146.78 26.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.982 2.113 . . . . 1.6699999999999999 113.382 -157.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.09 140.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.156 1.382 . . . . 0.28000000000000003 108.625 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.8 t -130.29 101.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.974 -1.491 . . . . 0.59999999999999998 106.974 163.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.22 -104.0 0.82 Allowed Glycine 0 C--N 1.275 -2.828 0 O-C-N 120.205 -1.56 . . . . 0.68000000000000005 113.865 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -103.22 -15.31 16.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.353 2.261 . . . . 2.2999999999999998 113.792 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -96.14 162.4 13.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.572 1.149 . . . . 2.27 109.984 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -144.08 103.8 4.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.44 -0.578 . . . . 0.59999999999999998 109.44 -168.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.7 137.5 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.287 0 C-N-CA 128.59 2.756 . . . . 0.87 116.54 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.56 144.56 44.21 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 119.18 -2.2 . . . . 2.0699999999999998 110.59 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.04 130.57 61.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.52 1.528 . . . . 0.27000000000000002 110.365 162.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -137.57 161.32 36.73 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 102.665 -3.087 . . . . 0.87 102.665 -164.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.6 m -150.21 137.41 19.55 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.534 1.933 . . . . 0.26000000000000001 107.36 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.3 mt -125.21 113.44 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 O-C-N 119.315 -2.116 . . . . 0.27000000000000002 105.799 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.52 29.15 57.09 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 117.103 -3.498 . . . . 0.28999999999999998 121.612 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -4.55 61.46 Favored Glycine 0 CA--C 1.478 -2.254 0 O-C-N 117.018 -3.637 . . . . 0.20999999999999999 113.394 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.08 143.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 122.338 3.069 . . . . 0.17000000000000001 113.785 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -112.97 143.39 44.35 Favored 'General case' 0 CA--C 1.47 -2.118 0 CA-C-O 123.854 1.788 . . . . 0.27000000000000002 111.387 -163.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' A' ' 121' ' ' ARG . 4.0 t80 -123.01 134.3 54.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.64 1.976 . . . . 0.59999999999999998 111.166 164.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.55 127.92 43.28 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 125.728 1.611 . . . . 0.88 107.16 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.407 ' HD3' ' CE2' ' A' ' 119' ' ' TYR . 19.3 ptt180 -147.48 127.94 14.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.911 -1.743 . . . . 6.0899999999999999 111.986 -169.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.6 t -115.75 139.56 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.086 0 C-N-CA 127.086 2.154 . . . . 0.89000000000000001 108.194 -165.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.8 t -137.26 148.59 46.54 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 118.591 -2.568 . . . . 1.1299999999999999 114.542 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -110.44 133.4 53.32 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.881 2.128 . . . . 1.76 112.123 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -78.59 145.34 34.82 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.005 0.821 . . . . 2.0600000000000001 112.145 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 9.78 0.65 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.223 1.564 . . . . 0.40999999999999998 115.223 174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 O-C-N 120.262 -1.524 . . . . 30.0 110.879 168.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.636 ' H38' ' H20' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.515 ' H12' HG22 ' A' ' 92' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.444 -3.12 0 N-CA-C 105.937 -1.875 . . . . 1.01 105.937 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -105.1 15.2 27.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.842 1.257 . . . . 0.35999999999999999 113.418 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -48.42 124.42 8.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.948 1.699 . . . . 0.27000000000000002 114.208 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.09 33.4 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.213 1.387 . . . . 0.46000000000000002 112.348 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.92 119.23 21.83 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 117.945 0.873 . . . . 0.72999999999999998 109.022 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -118.9 147.43 44.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.917 -1.114 . . . . 0.42999999999999999 110.048 -168.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -117.47 124.31 48.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.747 -0.644 . . . . 1.98 110.89 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.516 ' SD ' ' H20' ' A' ' 201' ' ' GCH . 63.4 ttp -75.91 146.09 39.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.742 2.065 . . . . 0.96999999999999997 112.882 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -160.71 69.4 0.37 Allowed 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 124.154 1.93 . . . . 2.75 109.97 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 122' ' ' VAL . 8.0 t -167.41 107.82 0.6 Allowed 'General case' 0 C--N 1.334 -0.101 0 O-C-N 120.28 -1.512 . . . . 2.52 109.485 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -104.9 119.35 38.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.397 1.079 . . . . 1.9199999999999999 109.584 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -152.25 96.06 2.13 Favored 'General case' 0 C--O 1.213 -0.833 1 CA-C-O 128.991 4.234 . . . . 1.8999999999999999 112.457 165.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 93.82 26.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 O-C-N 113.348 -5.845 . . . . 0.23999999999999999 108.601 159.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -66.85 -29.19 69.04 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 117.919 -1.039 . . . . 0.23999999999999999 112.756 -166.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.22 -50.86 64.21 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 125.475 2.559 . . . . 1.6699999999999999 112.437 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -69.56 -40.45 76.78 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.557 -1.965 . . . . 1.0 114.27 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.419 ' CD1' ' HD2' ' A' ' 119' ' ' TYR . 15.5 t80 -61.44 -50.03 74.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.828 -1.078 . . . . 0.22 113.661 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.1 mmm -67.8 -32.93 73.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 117.684 -1.151 . . . . 1.0600000000000001 111.946 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -66.86 -45.25 78.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.525 1.057 . . . . 1.8200000000000001 113.841 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.88 -25.64 56.32 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 125.147 2.403 . . . . 0.27000000000000002 112.076 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -69.52 -33.67 73.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 117.316 -3.365 . . . . 1.2 111.735 165.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.77 13.79 5.45 Favored Glycine 0 CA--C 1.55 2.269 0 C-N-CA 120.532 -0.842 . . . . 0.40000000000000002 111.285 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mp -79.13 117.89 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 119.532 -2.158 . . . . 0.38 106.879 165.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.2 m -81.67 -39.65 24.04 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.1 1.519 . . . . 0.70999999999999996 115.1 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -152.87 -33.18 0.12 Allowed 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 124.571 2.129 . . . . 1.04 113.877 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -55.13 -56.2 22.58 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 118.303 -2.748 . . . . 1.29 111.697 -159.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.28 -40.61 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 118.014 -0.993 . . . . 0.57999999999999996 112.807 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -42.91 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.023 0.829 . . . . 0.28000000000000003 112.738 -176.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 117.595 2.443 . . . . 1.48 117.595 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -86.76 -29.37 22.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 117.626 -1.178 . . . . 1.1899999999999999 110.009 163.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.91 66.0 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.709 1.204 . . . . 0.40000000000000002 113.925 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -56.26 -49.87 72.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 C-N-CA 128.0 2.52 . . . . 2.3999999999999999 109.72 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -75.53 -62.54 1.54 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 115.231 1.567 . . . . 1.0900000000000001 115.231 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -84.21 -37.7 21.5 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 116.01 1.855 . . . . 2.8399999999999999 116.01 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 56.98 125.81 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 1 CA-C-O 129.767 4.603 . . . . 2.5600000000000001 113.133 -161.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.77 155.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 1 O-C-N 114.106 -5.371 . . . . 0.44 113.119 -152.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.35 154.57 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.02 0 N-CA-C 114.485 1.291 . . . . 0.84999999999999998 114.485 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -137.72 127.45 25.34 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.546 -1.346 . . . . 0.39000000000000001 112.168 -164.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -88.27 126.17 35.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.151 1.78 . . . . 1.4099999999999999 110.43 160.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.53 138.5 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 124.243 1.017 . . . . 0.20000000000000001 109.8 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -148.33 128.2 13.48 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 124.428 2.061 . . . . 2.1499999999999999 112.344 158.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -142.36 150.12 40.31 Favored 'General case' 0 C--O 1.271 2.236 0 CA-C-O 125.231 2.443 . . . . 1.1599999999999999 109.307 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -159.23 125.29 4.41 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 113.081 -1.872 . . . . 1.6799999999999999 112.177 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.13 -120.54 21.41 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 119.233 -2.167 . . . . 1.24 112.665 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -91.21 -10.62 40.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.856 1.263 . . . . 1.3700000000000001 112.283 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -94.89 118.17 31.34 Favored 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 129.525 3.13 . . . . 1.8500000000000001 109.057 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -118.81 120.48 37.49 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 119.593 -1.942 . . . . 3.9900000000000002 116.179 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -106.26 130.74 54.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.931 -1.731 . . . . 0.28999999999999998 113.336 162.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -143.01 99.37 3.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.828 1.651 . . . . 0.28999999999999998 107.405 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -122.6 137.84 54.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.595 -1.315 . . . . 1.22 114.533 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 2.6 mp0 -106.67 150.24 26.44 Favored 'General case' 0 CA--C 1.45 -2.878 0 CA-C-N 113.168 -1.833 . . . . 1.5 113.325 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -131.24 111.2 11.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.817 1.647 . . . . 2.21 108.969 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 11.6 p90 -102.48 159.72 15.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.09 0.774 . . . . 0.67000000000000004 113.09 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -17.93 40.44 Favored 'General case' 0 N--CA 1.483 1.183 1 N-CA-C 122.061 4.097 . . . . 2.5699999999999998 122.061 -162.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.9 2.87 31.14 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 119.909 2.723 . . . . 2.4500000000000002 119.909 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.31 24.71 42.57 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 115.523 -2.821 . . . . 1.5600000000000001 112.939 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 62.0 t-80 -102.74 129.83 49.5 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.094 1.947 . . . . 0.93999999999999995 111.158 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.1 m -99.42 131.95 45.08 Favored 'General case' 0 C--O 1.2 -1.504 1 C-N-CA 131.737 4.015 . . . . 0.72999999999999998 107.053 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 74' ' ' MET . 1.2 ptm -134.44 114.56 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 119.262 -2.149 . . . . 1.1299999999999999 109.304 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.3 p -90.08 142.57 27.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.68000000000000005 110.518 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -128.13 98.47 5.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.802 -1.185 . . . . 0.83999999999999997 107.802 166.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -104.05 125.77 50.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.49 -0.756 . . . . 0.82999999999999996 111.254 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.4 153.29 38.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.541 1.163 . . . . 0.57999999999999996 111.724 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -90.58 122.09 33.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.743 -1.117 . . . . 0.28999999999999998 112.659 160.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.61 137.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.377 0.51 . . . . 0.85999999999999999 112.377 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.04 79.6 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.098 -1.001 . . . . 0.26000000000000001 112.972 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -129.19 166.88 18.49 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-O 125.701 2.667 . . . . 1.54 104.268 -170.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.71 159.09 40.67 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 111.33 -2.668 . . . . 0.62 110.47 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.259 74.4 m 68.65 40.54 1.82 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.701 2.8 . . . . 1.3 115.756 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -152.55 21.67 0.62 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.078 0.951 . . . . 0.97999999999999998 110.975 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.41 HG23 H193 ' A' ' 202' ' ' CHO . 28.3 mt -99.96 113.31 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 127.832 2.453 . . . . 0.29999999999999999 109.318 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -108.38 138.77 44.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.575 1.15 . . . . 1.96 112.095 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.765 ' HA ' H181 ' A' ' 202' ' ' CHO . 10.6 p -78.47 173.43 12.37 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.818 2.896 . . . . 0.47999999999999998 118.818 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.446 ' HA ' ' SD ' ' A' ' 59' ' ' MET . 12.6 mmt -59.79 -35.8 75.41 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.493 1.117 . . . . 1.1100000000000001 112.95 165.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' N ' ' OT1' ' A' ' 202' ' ' CHO . . . -87.87 -5.12 78.05 Favored Glycine 0 N--CA 1.48 1.606 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 113.81 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.71 17.2 26.64 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 120.604 3.002 . . . . 0.63 120.604 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 73' ' ' THR . 37.6 ttpt -95.4 132.12 40.8 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 118.562 -2.728 . . . . 1.76 109.919 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -85.31 131.36 34.42 Favored 'General case' 0 N--CA 1.512 2.639 0 C-N-CA 126.164 1.786 . . . . 0.54000000000000004 109.573 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.342 0.1 OUTLIER -141.27 -173.45 3.75 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.974 -1.079 . . . . 0.34999999999999998 112.05 170.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 117.3 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.55 -0.719 . . . . 1.96 111.716 -168.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.65 169.18 25.25 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 127.432 2.293 . . . . 0.25 109.882 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.9 m -84.59 111.46 19.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 119.967 -1.708 . . . . 0.28000000000000003 106.43 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.46 111.12 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 108.135 -1.061 . . . . 0.17999999999999999 108.135 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.76 156.38 16.7 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-O 123.1 1.429 . . . . 0.52000000000000002 111.541 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 ttt -137.99 118.82 14.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.187 -1.571 . . . . 0.23000000000000001 112.066 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -143.24 103.47 4.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.626 0.194 . . . . 1.53 111.277 -164.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.41 83.32 Favored Glycine 0 N--CA 1.494 2.513 0 CA-C-O 124.741 2.301 . . . . 1.05 111.799 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.55 19.91 36.43 Favored Glycine 0 N--CA 1.401 -3.655 0 O-C-N 118.318 -2.872 . . . . 0.35999999999999999 110.747 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -96.63 147.55 23.77 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 116.648 -3.854 . . . . 2.7000000000000002 109.128 161.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.2 138.6 44.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.603 1.161 . . . . 0.23000000000000001 110.954 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.35 146.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.43 0.692 . . . . 0.23000000000000001 110.753 -158.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.87 154.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.084 0 CA-C-O 122.787 1.28 . . . . 0.65000000000000002 110.558 165.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -131.13 121.77 25.48 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 126.062 2.839 . . . . 1.8899999999999999 107.999 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -113.09 166.03 11.95 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 116.771 -3.706 . . . . 0.26000000000000001 105.498 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -50.17 -38.97 51.93 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 CA-C-O 114.614 -2.327 . . . . 0.46000000000000002 114.923 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.53 -30.45 10.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 O-C-N 127.006 2.691 . . . . 1.8899999999999999 112.621 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CD1' HD11 ' A' ' 21' ' ' LEU . 54.4 t80 -107.05 137.93 44.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.042 -1.661 . . . . 0.26000000000000001 113.687 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -134.17 132.29 39.64 Favored 'General case' 0 C--O 1.207 -1.135 0 O-C-N 120.32 -1.488 . . . . 0.35999999999999999 112.351 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.422 HE21 ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -121.73 154.58 36.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 117.257 -3.402 . . . . 1.48 110.411 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.422 ' N ' HE21 ' A' ' 99' ' ' GLN . 0.0 OUTLIER -162.2 115.7 1.79 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 117.955 2.576 . . . . 0.40000000000000002 117.955 178.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.0 m -135.83 132.09 36.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.213 -1.554 . . . . 1.24 112.357 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -157.81 160.27 37.59 Favored 'General case' 0 CA--C 1.444 -3.1 0 N-CA-C 117.758 2.503 . . . . 1.6699999999999999 117.758 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.79 14.65 Favored 'Isoleucine or valine' 0 C--O 1.256 1.415 0 O-C-N 117.206 -3.434 . . . . 0.28000000000000003 112.501 -174.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.01 113.92 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.004 -1.85 . . . . 0.59999999999999998 106.004 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 59.55 -100.89 0.21 Allowed Glycine 0 CA--C 1.46 -3.348 0 O-C-N 118.176 -2.827 . . . . 0.68000000000000005 116.702 -167.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.0 -9.55 12.98 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.332 -2.275 . . . . 2.2999999999999998 109.123 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -90.79 151.39 21.21 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.745 2.212 . . . . 2.27 109.049 -171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.268 5.8 tp -126.62 112.1 15.11 Favored 'General case' 0 C--N 1.32 -0.693 1 O-C-N 115.872 -4.268 . . . . 0.59999999999999998 112.295 -166.097 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.07 152.45 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 126.662 3.125 . . . . 0.87 110.293 -150.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -145.13 148.96 34.19 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.386 -2.071 . . . . 2.0699999999999998 111.726 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.8 134.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 C-N-CA 127.193 2.197 . . . . 0.27000000000000002 106.212 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.3 m -147.43 166.45 27.18 Favored 'General case' 0 N--CA 1.526 3.351 0 CA-C-O 118.527 -0.749 . . . . 0.87 109.088 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.2 m -152.58 133.88 14.35 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 122.06 2.209 . . . . 0.26000000000000001 112.02 -163.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.58 131.02 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.448 1.931 . . . . 0.27000000000000002 108.97 163.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.8 60.89 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 115.673 -2.737 . . . . 0.28999999999999998 110.355 165.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.48 -8.11 76.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.506 -2.274 . . . . 0.20999999999999999 115.456 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.7 145.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 122.479 3.14 . . . . 0.17000000000000001 114.046 159.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.9 m -123.83 149.67 45.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.576 1.55 . . . . 0.27000000000000002 111.538 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -129.54 121.42 27.13 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.04 2.136 . . . . 0.59999999999999998 113.044 167.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.27 149.66 29.84 Favored 'General case' 0 CA--C 1.453 -2.788 0 N-CA-C 104.605 -2.369 . . . . 0.88 104.605 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 147.24 13.45 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 118.893 -2.379 . . . . 6.0899999999999999 114.529 -169.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.609 ' H ' ' HB3' ' A' ' 10' ' ' SER . 46.4 t -120.21 135.88 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.023 1.729 . . . . 0.89000000000000001 111.673 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 m -119.92 139.29 52.65 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 125.226 1.41 . . . . 1.1299999999999999 112.842 168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.42 133.1 46.56 Favored 'General case' 0 CA--C 1.582 2.205 0 O-C-N 120.702 -1.249 . . . . 1.76 111.831 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -69.83 149.84 47.47 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 122.955 1.36 . . . . 2.0600000000000001 110.867 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -154.35 -10.97 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 O-C-N 120.637 -1.289 . . . . 0.40999999999999998 108.486 153.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 126' ' ' LEU . . . . . . . . 0 C--O 1.268 2.059 0 N-CA-C 119.902 3.297 . . . . 30.0 119.902 162.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.516 ' H20' ' SD ' ' A' ' 8' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.765 H181 ' HA ' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.55 -0.738 . . . . 1.01 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.66 -5.5 35.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.101 1.76 . . . . 0.35999999999999999 111.296 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 m -35.92 135.33 0.32 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 130.33 3.452 . . . . 0.27000000000000002 113.341 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.92 -161.24 28.26 Favored Glycine 0 N--CA 1.478 1.492 0 O-C-N 120.371 -1.455 . . . . 0.46000000000000002 114.952 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.75 ' H ' ' HB2' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -129.36 137.93 51.24 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.286 1.543 . . . . 0.72999999999999998 107.999 172.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -144.22 155.81 44.04 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 108.253 -1.017 . . . . 0.42999999999999999 108.253 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -125.39 119.22 27.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 115.405 -2.236 . . . . 1.98 109.914 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.7 ttp -84.12 144.56 28.94 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-N 121.823 2.101 . . . . 0.96999999999999997 115.894 165.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -148.82 50.58 0.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.345 -1.472 . . . . 2.75 108.347 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -157.49 162.44 38.88 Favored 'General case' 0 C--O 1.277 2.514 0 O-C-N 119.27 -2.144 . . . . 2.52 109.595 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.684 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 2.5 mp0 -138.27 160.01 40.58 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.269 1.033 . . . . 1.9199999999999999 110.631 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -161.7 111.99 1.62 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.502 -0.761 . . . . 1.8999999999999999 109.197 168.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.3 t30 60.94 14.17 5.07 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 114.071 1.137 . . . . 0.23999999999999999 114.071 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.684 ' CD1' ' HB3' ' A' ' 11' ' ' GLU . 55.7 p90 -62.34 -37.32 85.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.692 1.997 . . . . 0.23999999999999999 112.747 -163.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 1.4 p30 -66.66 -49.09 67.31 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.48 1.512 . . . . 1.6699999999999999 114.196 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.794 0.665 . . . . 1.0 112.794 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -77.32 -46.33 23.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 117.562 -1.209 . . . . 0.22 111.253 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -28.21 61.41 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-O 114.919 -2.467 . . . . 1.0600000000000001 113.344 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.65 -43.02 84.62 Favored 'General case' 0 C--O 1.289 3.173 0 CA-C-N 121.602 2.001 . . . . 1.8200000000000001 109.859 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.71 -33.9 73.14 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 122.974 2.625 . . . . 0.27000000000000002 113.927 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 H231 ' A' ' 202' ' ' CHO 0.267 7.3 tp -87.51 -19.56 27.76 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 118.062 -2.899 . . . . 1.2 114.769 -166.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.6 25.85 0.06 OUTLIER Glycine 0 C--O 1.265 2.07 0 CA-C-O 118.522 -1.155 . . . . 0.40000000000000002 113.12 155.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.86 122.62 62.44 Favored 'Isoleucine or valine' 0 C--N 1.379 1.862 0 O-C-N 124.452 0.736 . . . . 0.38 111.808 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -73.84 -64.7 0.95 Allowed 'General case' 0 C--O 1.264 1.852 0 O-C-N 118.512 -2.618 . . . . 0.70999999999999996 115.627 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.4 m -145.55 -24.29 0.47 Allowed 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 120.993 -1.067 . . . . 1.04 111.47 -170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -58.89 -59.33 5.62 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 117.32 2.341 . . . . 1.29 117.32 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.59 -44.14 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 116.745 -3.722 . . . . 0.57999999999999996 111.954 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.53 -41.06 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 C-N-CA 128.859 2.864 . . . . 0.28000000000000003 115.515 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -73.96 -39.16 63.92 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.717 1.246 . . . . 1.48 108.424 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -79.99 -21.2 43.93 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.079 -2.263 . . . . 1.1899999999999999 112.431 -176.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.34 -50.26 34.1 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 131.174 3.79 . . . . 0.40000000000000002 110.315 169.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -63.95 -35.2 79.89 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-O 122.582 1.182 . . . . 2.3999999999999999 112.108 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -71.45 -83.39 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.826 1.25 . . . . 1.0900000000000001 113.013 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 30' ' ' LYS . 3.3 p90 -98.03 -14.77 20.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 118.495 2.776 . . . . 2.8399999999999999 118.495 -163.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.78 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.053 2.141 . . . . 2.5600000000000001 115.694 -171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 HD12 ' H24' ' A' ' 201' ' ' GCH . 68.4 mt -82.75 134.5 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.184 1.394 . . . . 0.44 109.938 -171.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.46 165.52 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 122.706 1.241 . . . . 0.84999999999999998 108.276 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H41' ' A' ' 201' ' ' GCH . 0.2 OUTLIER -118.02 139.09 51.7 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.653 2.094 . . . . 0.39000000000000001 116.653 -169.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -123.85 133.58 53.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.271 1.428 . . . . 1.4099999999999999 108.088 163.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 139.24 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.425 -1.422 . . . . 0.20000000000000001 113.159 -167.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -145.62 135.1 23.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.983 1.313 . . . . 2.1499999999999999 110.583 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -129.76 151.61 50.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.047 1.339 . . . . 1.1599999999999999 109.131 158.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.69 135.37 27.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.434 -1.321 . . . . 1.6799999999999999 107.434 150.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 -113.34 1.16 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-O 124.464 2.147 . . . . 1.24 117.138 -174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -84.2 -9.42 58.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 111.688 -2.256 . . . . 1.3700000000000001 111.27 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.72 129.87 55.97 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.723 1.602 . . . . 1.8500000000000001 113.343 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -126.64 129.58 48.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.839 1.655 . . . . 3.9900000000000002 114.247 -161.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 m -127.84 121.56 30.4 Favored 'General case' 0 CA--C 1.453 -2.76 0 C-N-CA 125.131 1.372 . . . . 0.28999999999999998 108.304 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.42 121.19 44.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.843 3.257 . . . . 0.28999999999999998 105.9 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -131.36 131.28 43.58 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.241 -1.537 . . . . 1.22 110.413 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -112.6 128.32 56.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 1.5 109.187 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -119.31 109.89 16.34 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.932 -1.136 . . . . 2.21 107.932 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -65.05 133.11 50.94 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.709 -1.589 . . . . 0.67000000000000004 106.709 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -68.17 -26.06 65.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.548 0.739 . . . . 2.5699999999999998 112.848 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.78 -0.66 27.06 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.654 1.597 . . . . 2.4500000000000002 115.695 163.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.68 54.84 1.11 Allowed Glycine 0 CA--C 1.473 -2.569 0 N-CA-C 118.175 2.03 . . . . 1.5600000000000001 118.175 155.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -145.25 141.41 28.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.781 -1.423 . . . . 1.1699999999999999 108.734 162.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.2 m -110.0 145.62 36.68 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.622 -1.621 . . . . 0.72999999999999998 106.622 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.0 ptm -144.45 156.53 44.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.089 0.955 . . . . 1.1299999999999999 113.091 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 63.9 p -129.41 153.99 47.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.955 1.836 . . . . 0.68000000000000005 115.056 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -133.12 113.44 12.74 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 103.951 -2.611 . . . . 0.83999999999999997 103.951 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -131.3 106.91 8.6 Favored 'General case' 0 C--O 1.181 -2.52 0 C-N-CA 127.176 2.19 . . . . 0.82999999999999996 106.466 -157.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -147.37 178.47 8.4 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 118.825 -2.422 . . . . 0.57999999999999996 112.374 -168.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -134.07 123.19 24.07 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 104.923 -2.251 . . . . 0.28999999999999998 104.923 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.6 142.09 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 C-N-CA 124.506 1.123 . . . . 0.85999999999999999 110.023 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.35 1.81 90.31 Favored Glycine 0 C--O 1.267 2.219 0 N-CA-C 110.389 -1.085 . . . . 0.26000000000000001 110.389 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -122.5 138.67 54.48 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 119.04 -2.447 . . . . 1.54 112.043 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -77.24 168.31 20.27 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.387 1.089 . . . . 0.62 112.55 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 m 67.9 19.77 9.4 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 125.884 1.674 . . . . 1.3 114.945 156.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -115.09 6.65 15.23 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.928 -1.107 . . . . 0.97999999999999998 111.878 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 H191 ' A' ' 202' ' ' CHO . 2.4 mp -94.57 126.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.872 1.669 . . . . 0.29999999999999999 107.531 -165.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -118.47 161.45 19.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.424 0.29 . . . . 1.96 110.756 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 p -95.25 179.66 5.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.833 1.049 . . . . 0.47999999999999998 113.833 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.432 ' HB2' H222 ' A' ' 202' ' ' CHO . 40.9 tpp -71.06 -31.76 68.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.507 1.299 . . . . 1.1100000000000001 114.507 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.91 -2.02 78.91 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.722 -0.751 . . . . 0.72999999999999998 112.456 166.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.99 17.4 16.43 Favored Glycine 0 CA--C 1.544 1.849 0 O-C-N 119.169 -2.371 . . . . 0.63 118.954 166.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -92.65 142.06 27.79 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.19 2.196 . . . . 1.76 112.481 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.2 m -89.51 121.78 32.06 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 120.911 1.687 . . . . 0.54000000000000004 110.379 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . 0.274 0.0 OUTLIER -126.67 171.34 11.24 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 124.354 1.034 . . . . 0.34999999999999998 111.351 166.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -126.26 99.71 5.99 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 124.151 1.929 . . . . 1.96 111.97 -164.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . . . -137.65 171.56 14.27 Favored 'General case' 0 CA--C 1.471 -2.081 0 O-C-N 116.941 -3.599 . . . . 0.25 108.613 167.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.5 m -104.46 108.56 20.04 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 104.888 -2.264 . . . . 0.28000000000000003 104.888 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.479 HG22 H192 ' A' ' 202' ' ' CHO . 8.9 t -63.3 135.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.394 -1.275 . . . . 0.17999999999999999 110.184 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -131.01 155.58 46.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.315 0.507 . . . . 0.52000000000000002 110.441 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.6 mtp -102.44 125.69 49.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 118.205 -0.902 . . . . 0.23000000000000001 109.385 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -119.04 104.89 10.89 Favored 'General case' 0 C--O 1.181 -2.5 0 CA-C-O 122.658 1.218 . . . . 1.53 111.215 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.08 11.49 83.61 Favored Glycine 0 CA--C 1.469 -2.835 0 O-C-N 120.337 -1.477 . . . . 1.05 113.02 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.74 15.53 52.21 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 116.488 -2.285 . . . . 0.35999999999999999 114.141 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -116.49 133.91 55.47 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 121.073 2.436 . . . . 2.7000000000000002 106.999 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.0 mt -98.31 130.26 45.0 Favored 'General case' 0 CA--C 1.45 -2.884 0 CA-C-O 125.803 2.716 . . . . 0.23000000000000001 110.901 -171.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.67 138.64 47.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 112.611 -2.086 . . . . 0.23000000000000001 113.682 -165.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.27 165.27 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 118.401 -2.687 . . . . 0.65000000000000002 112.711 155.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -133.62 149.32 51.59 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.648 2.379 . . . . 1.8899999999999999 110.61 160.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 84.0 m-85 -152.06 170.21 8.32 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 130.448 3.499 . . . . 0.26000000000000001 109.368 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -59.72 -21.4 63.01 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.644 2.229 . . . . 0.46000000000000002 117.256 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -130.61 -24.35 2.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.558 1.072 . . . . 1.8899999999999999 112.515 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -100.89 139.44 36.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.61 1.707 . . . . 0.27000000000000002 115.61 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -147.97 151.52 35.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.548 2.339 . . . . 0.35999999999999999 109.223 170.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -179.36 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.702 1.137 . . . . 1.48 113.847 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.8 108.86 2.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.40000000000000002 110.661 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -88.2 123.34 32.74 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.117 1.895 . . . . 1.24 116.117 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.18 155.21 42.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 117.31 -3.369 . . . . 1.6699999999999999 116.755 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.45 137.52 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 108.574 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.52 112.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 107.111 -1.44 . . . . 0.59999999999999998 107.111 155.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.01 -108.15 2.21 Favored Glycine 0 C--N 1.358 1.753 0 O-C-N 117.5 -3.25 . . . . 0.68000000000000005 115.947 171.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -98.43 -4.41 34.67 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 118.042 -3.034 . . . . 2.2999999999999998 112.678 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -132.52 150.91 52.08 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 116.926 2.195 . . . . 2.27 116.926 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.32 116.8 32.11 Favored 'General case' 0 N--CA 1.428 -1.575 0 O-C-N 117.926 -2.984 . . . . 0.59999999999999998 110.263 -163.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.31 132.07 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.804 1.642 . . . . 0.87 110.871 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -104.6 142.43 34.67 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 107.761 -1.2 . . . . 2.0699999999999998 107.761 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.78 116.09 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.002 -1.061 . . . . 0.27000000000000002 112.096 167.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.77 144.48 50.29 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.578 1.151 . . . . 0.87 112.363 -153.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.5 m -138.86 115.56 10.68 Favored 'General case' 0 C--O 1.257 1.483 0 N-CA-C 117.937 2.569 . . . . 0.26000000000000001 117.937 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.2 mt -115.36 120.35 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 121.221 1.828 . . . . 0.27000000000000002 108.62 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.61 13.57 68.66 Favored Glycine 0 CA--C 1.452 -3.895 0 CA-C-O 124.068 1.927 . . . . 0.28999999999999998 114.638 171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 -7.1 82.68 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 119.48 -2.188 . . . . 0.20999999999999999 113.411 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.318 0.3 OUTLIER -85.94 125.01 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.561 2.181 . . . . 0.17000000000000001 113.917 171.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.96 151.06 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.935 2.198 . . . . 0.27000000000000002 116.935 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.64 141.03 50.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.562 1.945 . . . . 0.59999999999999998 112.205 161.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -154.63 112.45 3.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.998 2.181 . . . . 0.88 109.441 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -153.61 159.3 42.09 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 116.015 1.858 . . . . 6.0899999999999999 116.015 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.25 139.09 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.244 2.218 . . . . 0.89000000000000001 112.641 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -121.32 135.44 55.1 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 106.206 -1.776 . . . . 1.1299999999999999 106.206 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 pttp -100.8 132.13 46.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.212 1.805 . . . . 1.76 112.76 -167.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -75.86 140.32 42.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.703 1.201 . . . . 2.0600000000000001 112.201 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.28 0.0 OUTLIER -143.21 29.73 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.143 1.377 . . . . 0.40999999999999998 112.128 165.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.75 ' HB2' ' H ' ' A' ' 5' ' ' LYS . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.573 1.149 . . . . 30.0 111.709 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.65 ' H41' HG21 ' A' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.614 H191 HG23 ' A' ' 71' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 118.774 2.879 . . . . 1.01 118.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -136.51 21.66 3.15 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 105.572 -2.01 . . . . 0.35999999999999999 105.572 -170.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.1 m -54.93 135.75 48.04 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.534 3.534 . . . . 0.27000000000000002 113.236 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.23 167.9 12.59 Favored Glycine 0 C--O 1.213 -1.217 0 N-CA-C 120.705 3.042 . . . . 0.46000000000000002 120.705 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 120.45 24.36 Favored 'General case' 0 C--O 1.182 -2.487 0 N-CA-C 117.216 2.302 . . . . 0.72999999999999998 117.216 163.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 108' ' ' LEU . 34.5 m-85 -132.35 151.37 51.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.372 -1.344 . . . . 0.42999999999999999 107.372 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -121.63 113.84 20.32 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 118.286 -0.864 . . . . 1.98 111.039 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.6 ttt -55.59 141.76 36.23 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 128.732 2.813 . . . . 0.96999999999999997 114.283 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.95 110.81 0.72 Allowed 'General case' 0 C--N 1.371 1.535 0 CA-C-O 115.41 -2.233 . . . . 2.75 106.866 159.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 m 144.73 104.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 122.109 2.231 . . . . 2.52 107.018 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -118.26 130.15 55.89 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.294 -1.372 . . . . 1.9199999999999999 107.294 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -141.46 110.16 6.08 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 118.838 -2.414 . . . . 1.8999999999999999 109.264 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.0 t30 67.26 22.87 9.52 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.047 1.739 . . . . 0.23999999999999999 114.469 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -57.96 -33.94 69.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.266 1.826 . . . . 2.54 113.709 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -52.27 -47.21 65.94 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 125.945 1.698 . . . . 1.6699999999999999 113.172 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.87 -49.79 16.92 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 126.194 1.798 . . . . 1.0 111.316 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 112' ' ' SER . 34.8 t80 -73.18 -44.57 59.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.672 -1.604 . . . . 0.22 109.983 -156.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.5 mmt -72.8 -27.32 61.9 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 113.24 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -69.89 -49.69 49.69 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.488 0.921 . . . . 1.8200000000000001 113.488 170.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.7 mt -41.56 -54.03 3.31 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 127.465 2.306 . . . . 0.27000000000000002 112.606 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.57 -16.53 63.89 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.098 1.518 . . . . 1.2 115.098 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.97 13.8 7.58 Favored Glycine 0 N--CA 1.475 1.273 0 CA-C-O 113.652 -3.86 . . . . 0.40000000000000002 114.936 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.539 HD11 ' HN ' ' A' ' 202' ' ' CHO . 23.3 mt -111.51 104.14 16.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 CA-C-N 121.53 2.665 . . . . 0.38 108.537 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -68.57 -48.05 65.23 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.045 2.609 . . . . 0.70999999999999996 118.045 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -147.8 -8.52 0.42 Allowed 'General case' 0 C--N 1.375 1.715 0 O-C-N 120.974 -1.079 . . . . 1.04 111.578 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -67.39 -50.63 58.77 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 115.583 1.697 . . . . 1.29 115.583 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -31.77 5.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 O-C-N 121.311 -0.868 . . . . 0.57999999999999996 112.983 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -73.72 -47.39 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 123.645 0.778 . . . . 0.28000000000000003 109.524 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.58 -24.36 67.51 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 119.182 -2.199 . . . . 1.48 111.934 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.9 -49.31 10.46 Favored 'General case' 0 C--O 1.247 0.943 0 O-C-N 116.935 -3.603 . . . . 1.1899999999999999 115.63 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.61 89.28 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 117.037 2.236 . . . . 0.40000000000000002 117.037 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -66.63 -30.59 70.9 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.664 -1.272 . . . . 2.3999999999999999 112.301 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -90.57 -86.2 0.21 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.984 0.914 . . . . 1.0900000000000001 112.811 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.82 0.6 52.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.142 2.577 . . . . 2.8399999999999999 116.01 -174.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 57.2 177.9 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.283 1.833 . . . . 2.5600000000000001 111.594 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.45 115.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 119.548 -1.97 . . . . 0.44 110.486 -159.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.17 148.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 119.89 -1.756 . . . . 0.84999999999999998 114.146 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.28 144.81 29.68 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.06 1.874 . . . . 0.39000000000000001 116.06 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -132.06 106.94 8.32 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.337 1.055 . . . . 1.4099999999999999 109.906 166.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -106.16 150.88 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.606 1.562 . . . . 0.20000000000000001 112.85 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -152.88 118.52 5.33 Favored 'General case' 0 C--O 1.266 1.933 1 C-N-CA 132.121 4.169 . . . . 2.1499999999999999 103.879 174.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -129.1 150.35 50.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.48 -2.415 . . . . 1.1599999999999999 104.48 167.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.74 119.95 8.34 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 119.612 -1.93 . . . . 1.6799999999999999 109.684 163.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.84 -116.92 9.53 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 113.391 -1.731 . . . . 1.24 112.53 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -83.08 -22.8 33.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.39 2.276 . . . . 1.3700000000000001 109.99 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.8 151.05 25.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 117.073 2.249 . . . . 1.8500000000000001 117.073 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.418 ' HE2' ' H2 ' ' A' ' 201' ' ' GCH . 32.1 t80 -143.03 146.8 34.19 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-O 123.755 1.74 . . . . 3.9900000000000002 108.816 -167.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -145.03 127.53 16.01 Favored 'General case' 1 N--CA 1.544 4.25 0 CA-C-N 110.813 -2.903 . . . . 0.28999999999999998 110.378 160.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.26 129.79 56.46 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.42 -1.696 . . . . 0.28999999999999998 106.42 150.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -100.81 142.97 31.53 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.037 -2.208 . . . . 1.22 105.037 162.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -144.9 121.9 11.38 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.273 -1.517 . . . . 1.5 108.495 -164.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -123.68 110.52 15.07 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.551 -1.343 . . . . 2.21 110.047 -160.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 57' ' ' HIS . 7.9 m-30 -59.24 132.56 54.37 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.918 -1.512 . . . . 0.83999999999999997 106.918 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -75.58 6.99 4.07 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 126.46 3.028 . . . . 2.5699999999999998 115.445 164.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.18 -7.54 88.33 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 119.021 -2.3 . . . . 2.4500000000000002 115.665 159.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.56 47.83 2.27 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 121.161 2.48 . . . . 1.5600000000000001 116.39 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 56.7 t-80 -154.06 162.9 40.87 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.755 1.277 . . . . 1.1699999999999999 109.347 170.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -132.71 151.09 52.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.111 1.364 . . . . 0.72999999999999998 112.117 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.33 38.11 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.322 -1.733 . . . . 1.1299999999999999 106.322 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.3 OUTLIER -123.63 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.259 1.207 . . . . 0.68000000000000005 114.259 -177.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.98 111.36 14.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.484 -1.385 . . . . 0.83999999999999997 109.423 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -116.43 128.89 55.89 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 125.383 1.473 . . . . 0.82999999999999996 112.988 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 83' ' ' VAL . 23.8 p90 -153.61 -178.8 7.26 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.879 -1.156 . . . . 0.57999999999999996 107.879 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 130.09 44.38 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 103.56 -2.756 . . . . 0.28999999999999998 103.56 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.267 0.8 OUTLIER -65.2 143.16 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 119.72 -1.862 . . . . 0.85999999999999999 115.827 177.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.92 82.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.674 -1.266 . . . . 0.26000000000000001 114.181 -169.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -132.28 165.08 24.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.281 1.832 . . . . 1.54 109.539 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -112.78 171.87 7.27 Favored 'General case' 0 N--CA 1.402 -2.859 0 C-N-CA 127.903 2.481 . . . . 0.62 111.759 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.2 p 80.71 -20.96 0.35 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 119.146 3.017 . . . . 1.3 119.146 154.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -109.11 26.82 10.18 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.433 1.015 . . . . 0.97999999999999998 112.461 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.63 98.87 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 127.552 2.341 . . . . 0.29999999999999999 105.497 -167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -85.2 157.79 20.53 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 119.825 -1.797 . . . . 1.96 113.208 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.636 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 14.0 p -102.09 -177.71 3.49 Favored 'General case' 0 C--O 1.188 -2.184 0 CA-C-N 121.623 2.01 . . . . 0.47999999999999998 115.842 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.44 ' H ' H162 ' A' ' 202' ' ' CHO . 1.1 tpp -69.01 -36.16 77.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 118.695 -2.503 . . . . 1.1100000000000001 109.449 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.04 -2.77 89.4 Favored Glycine 0 CA--C 1.456 -3.632 0 CA-C-O 118.367 -1.241 . . . . 0.72999999999999998 115.45 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 14.72 59.24 Favored Glycine 0 C--O 1.203 -1.808 0 CA-C-O 117.4 -1.778 . . . . 0.63 113.819 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.52 164.64 9.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 123.874 3.837 . . . . 1.76 110.967 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -124.52 120.38 31.82 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 106.277 -1.749 . . . . 0.54000000000000004 106.277 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.424 0.0 OUTLIER -117.58 164.25 15.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.234 2.309 . . . . 0.34999999999999998 117.234 175.711 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 102.25 13.07 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.527 1.131 . . . . 1.96 110.37 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.61 166.33 31.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.467 2.307 . . . . 0.25 107.801 167.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -114.27 105.89 13.7 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 128.903 2.881 . . . . 0.28000000000000003 111.049 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 63' ' ' PHE . 5.5 t -70.73 134.04 30.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 119.915 -0.714 . . . . 0.17999999999999999 111.344 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -109.88 147.28 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.749 1.22 . . . . 0.52000000000000002 109.567 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mtp -92.05 135.5 33.91 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.07 -0.967 . . . . 0.23000000000000001 109.021 159.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -130.74 99.1 4.83 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.478 0.656 . . . . 1.53 109.294 160.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.5 -69.32 2.82 Favored Glycine 0 C--N 1.383 3.156 0 O-C-N 118.255 -2.778 . . . . 1.05 113.669 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 36.7 0.38 Allowed Glycine 1 CA--C 1.45 -4.005 0 O-C-N 117.66 -3.259 . . . . 0.35999999999999999 111.154 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -140.35 125.04 18.09 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-O 114.326 -2.749 . . . . 2.7000000000000002 110.707 -163.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.24 139.61 30.82 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 123.353 2.797 . . . . 0.23000000000000001 109.23 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.63 145.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 116.903 -1.919 . . . . 0.23000000000000001 106.716 -166.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.84 167.42 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 119.24 -2.163 . . . . 0.65000000000000002 110.625 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.55 101.8 1.52 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.508 -0.923 . . . . 1.8899999999999999 108.508 -165.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.82 169.93 7.23 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.76 -1.114 . . . . 0.26000000000000001 108.235 162.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -61.38 -18.03 56.75 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.652 1.568 . . . . 0.46000000000000002 113.626 170.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -115.59 -9.76 11.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 116.467 -1.73 . . . . 1.8899999999999999 114.956 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -147.1 147.03 30.17 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 122.274 2.306 . . . . 0.27000000000000002 115.454 -168.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.78 157.45 44.17 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.306 -2.746 . . . . 0.35999999999999999 109.341 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 159.69 42.58 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.549 -0.719 . . . . 1.48 110.005 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.79 131.91 24.75 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 103.935 -2.617 . . . . 0.40000000000000002 103.935 174.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.67 103.6 5.49 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.097 1.359 . . . . 1.24 110.429 -172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.84 167.79 23.04 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.648 1.351 . . . . 1.6699999999999999 114.648 -170.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.87 138.57 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 0.28000000000000003 111.043 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.8 t -142.06 108.1 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.987 0 CA-C-O 126.021 2.819 . . . . 0.59999999999999998 103.643 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -129.04 25.86 Favored Glycine 0 N--CA 1.502 3.08 0 CA-C-O 126.154 3.086 . . . . 0.68000000000000005 114.0 -166.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.82 -6.8 55.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 119.494 -2.18 . . . . 2.2999999999999998 115.125 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.07 164.93 11.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.08 2.152 . . . . 2.27 111.281 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 6' ' ' PHE . 3.4 mp -115.97 119.81 37.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 128.032 2.533 . . . . 0.59999999999999998 105.915 -172.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.6 t -128.05 104.87 12.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 116.797 2.147 . . . . 0.87 116.797 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 112' ' ' SER . 10.9 tm-20 -87.36 154.54 20.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.18 1.392 . . . . 2.0699999999999998 110.548 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.31 143.69 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 102.55 -3.13 . . . . 0.27000000000000002 102.55 169.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -148.24 144.05 27.4 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 117.711 -3.118 . . . . 0.87 109.211 -152.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 4.0 m -144.07 128.85 18.31 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 122.669 2.486 . . . . 0.26000000000000001 109.347 -170.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.03 119.47 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.174 1.79 . . . . 0.27000000000000002 108.447 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 49.8 35.98 25.18 Favored Glycine 0 C--O 1.194 -2.344 0 C-N-CA 125.149 1.357 . . . . 0.28999999999999998 113.187 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.24 -7.72 69.34 Favored Glycine 0 CA--C 1.481 -2.09 0 O-C-N 119.272 -2.31 . . . . 0.20999999999999999 117.754 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' THR . 0.8 OUTLIER -104.56 141.21 20.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 C-N-CA 125.844 1.658 . . . . 0.17000000000000001 111.448 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -115.31 142.88 46.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.805 1.409 . . . . 0.27000000000000002 114.805 -161.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -112.91 148.93 33.93 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 103.692 -2.707 . . . . 0.59999999999999998 103.692 163.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.62 131.77 32.04 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 102.143 -3.28 . . . . 0.88 102.143 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 119' ' ' TYR . 66.7 mtm180 -137.28 153.39 50.32 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.157 -2.214 . . . . 6.0899999999999999 113.485 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 t -134.04 160.03 42.02 Favored 'Isoleucine or valine' 0 C--O 1.264 1.848 0 N-CA-C 108.654 -0.869 . . . . 0.89000000000000001 108.654 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 t -163.54 145.47 9.56 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 123.428 1.585 . . . . 1.1299999999999999 107.479 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -116.07 146.54 42.12 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.052 -1.655 . . . . 1.76 110.909 -166.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -79.48 148.32 31.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.556 -2.59 . . . . 2.0600000000000001 114.628 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -142.51 22.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.358 1.463 . . . . 0.40999999999999998 110.394 161.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 123.525 0.73 . . . . 30.0 111.304 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.43 ' C24' HH11 ' A' ' 121' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.539 ' HN ' HD11 ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 122.302 1.048 . . . . 1.01 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' H9 ' ' A' ' 201' ' ' GCH . 56.7 m-85 -89.71 -9.8 48.11 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.196 2.295 . . . . 0.35999999999999999 117.196 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m -30.58 121.9 0.2 Allowed 'General case' 0 CA--C 1.464 -2.345 0 C-N-CA 130.712 3.605 . . . . 0.27000000000000002 120.322 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.86 175.36 14.26 Favored Glycine 0 N--CA 1.445 -0.762 0 O-C-N 118.072 -2.893 . . . . 0.46000000000000002 116.545 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 125.26 43.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.063 1.745 . . . . 0.72999999999999998 108.689 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 2.6 m-85 -129.97 170.84 13.44 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.155 1.382 . . . . 0.42999999999999999 109.273 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -152.43 115.07 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.059 1.743 . . . . 1.98 108.657 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG2' ' H ' ' A' ' 10' ' ' SER . 46.0 ttp -92.88 135.82 33.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.709 1.204 . . . . 0.96999999999999997 109.793 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -137.36 34.67 2.51 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 122.53 1.157 . . . . 2.75 111.442 168.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' MET . 16.2 m -140.24 132.47 28.17 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 119.329 -2.107 . . . . 2.52 107.955 175.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.58 156.55 44.01 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.353 -0.385 . . . . 1.9199999999999999 110.455 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -161.05 116.78 2.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 119.971 -1.705 . . . . 1.8999999999999999 113.225 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 t30 72.94 12.55 5.1 Favored 'General case' 0 CA--C 1.585 2.291 0 O-C-N 119.513 -1.992 . . . . 0.23999999999999999 109.649 -174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -61.22 -39.12 89.06 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 116.238 1.94 . . . . 2.54 116.238 -168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.07 -58.15 8.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.78 1.03 . . . . 1.6699999999999999 113.78 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -64.57 -36.86 85.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.032 -0.985 . . . . 1.0 111.36 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 114' ' ' ILE . 17.5 t80 -72.56 -41.87 65.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.432 1.469 . . . . 0.22 108.96 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 mmt -70.39 -38.77 74.75 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.339 1.427 . . . . 1.0600000000000001 113.08 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -62.05 -49.78 74.61 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 123.745 1.736 . . . . 1.8200000000000001 109.561 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.57 -44.61 95.91 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 118.087 -2.883 . . . . 0.27000000000000002 111.016 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 97' ' ' TYR . 14.1 tp -73.77 -19.53 60.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 116.957 -1.897 . . . . 1.2 113.691 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.37 30.09 1.12 Allowed Glycine 0 N--CA 1.409 -3.122 0 C-N-CA 120.483 -0.865 . . . . 0.40000000000000002 114.226 162.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.8 127.61 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 119.533 -0.867 . . . . 0.38 111.319 161.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -77.33 -58.9 3.02 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.817 0.847 . . . . 0.70999999999999996 110.677 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -143.88 -32.52 0.44 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 117.796 -1.097 . . . . 1.04 112.56 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.4 -41.51 97.26 Favored 'General case' 0 CA--C 1.453 -2.774 0 N-CA-C 117.016 2.228 . . . . 1.29 117.016 -155.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.32 -26.56 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 O-C-N 117.841 -3.037 . . . . 0.57999999999999996 111.612 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.49 -32.9 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.136 0 O-C-N 118.569 -2.582 . . . . 0.28000000000000003 110.881 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.74 -29.03 70.3 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 125.98 2.05 . . . . 1.48 113.878 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.651 ' HE2' ' CD2' ' A' ' 53' ' ' TYR . 43.0 mmtm -78.56 -40.34 35.07 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.513 -1.367 . . . . 1.1899999999999999 110.734 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.2 -58.06 8.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.573 1.549 . . . . 0.40000000000000002 112.606 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -65.35 -26.01 67.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.544 0.942 . . . . 2.3999999999999999 113.544 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -95.24 -96.14 0.17 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 104.341 -2.466 . . . . 1.0900000000000001 104.341 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -83.91 -4.79 58.97 Favored 'General case' 0 N--CA 1.468 0.443 1 N-CA-C 121.825 4.009 . . . . 2.8399999999999999 121.825 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 61.11 176.45 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 121.612 2.005 . . . . 2.5600000000000001 114.333 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -114.74 144.71 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-O 124.095 1.902 . . . . 0.44 112.917 -166.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 1.2 m -106.32 151.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.203 1.401 . . . . 0.84999999999999998 113.746 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.659 ' CG2' ' H41' ' A' ' 201' ' ' GCH 0.294 25.1 m -118.26 141.29 48.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.751 2.021 . . . . 0.39000000000000001 110.338 -161.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.4 132.19 31.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 125.471 1.732 . . . . 1.4099999999999999 109.92 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.48 HG22 ' H5 ' ' A' ' 201' ' ' GCH . 12.2 t -127.45 134.34 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.514 1.125 . . . . 0.20000000000000001 111.654 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.52 119.18 16.03 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.908 -1.145 . . . . 2.1499999999999999 107.908 163.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -149.15 132.5 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.149 -0.686 . . . . 1.1599999999999999 109.149 -165.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -147.33 106.27 3.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.606 1.193 . . . . 1.6799999999999999 108.759 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.65 -103.75 0.88 Allowed Glycine 1 CA--C 1.579 4.04 0 C-N-CA 124.897 1.237 . . . . 1.24 111.783 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -99.39 -13.18 19.69 Favored 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 121.268 -1.137 . . . . 1.3700000000000001 111.261 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.309 52.3 m-20 -95.81 127.28 41.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.995 1.48 . . . . 1.8500000000000001 114.995 175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.29 122.18 37.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.645 1.578 . . . . 3.9900000000000002 110.94 -166.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.8 m -114.68 109.43 18.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 117.731 2.493 . . . . 0.28999999999999998 117.731 161.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.747 ' CH2' ' H14' ' A' ' 202' ' ' CHO . 0.4 OUTLIER -94.69 123.65 38.26 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.004 1.721 . . . . 0.28999999999999998 107.572 169.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -132.18 153.32 50.67 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 105.404 -2.073 . . . . 1.22 105.404 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.546 ' NE2' ' HE1' ' A' ' 49' ' ' TRP . 39.3 mt-30 -145.47 161.2 40.28 Favored 'General case' 0 N--CA 1.396 -3.174 0 O-C-N 119.144 -2.223 . . . . 1.5 112.16 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -131.19 128.61 40.34 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 113.669 -1.605 . . . . 2.21 112.062 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.651 ' CD2' ' HE2' ' A' ' 30' ' ' LYS . 4.0 m-30 -58.07 121.38 10.49 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.55 -2.019 . . . . 0.83999999999999997 105.55 154.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -58.26 124.34 19.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.856 -0.794 . . . . 2.5699999999999998 108.856 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.6 -5.68 54.64 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.022 -1.432 . . . . 2.4500000000000002 116.225 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.21 69.32 0.63 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 119.95 1.875 . . . . 1.5600000000000001 116.314 158.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.66 155.17 40.69 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.599 -1.53 . . . . 1.1699999999999999 109.431 158.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -129.18 135.29 48.65 Favored 'General case' 0 CA--C 1.59 2.489 0 N-CA-C 104.354 -2.461 . . . . 0.72999999999999998 104.354 -166.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -129.49 121.68 27.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.108 -1.442 . . . . 1.1299999999999999 107.108 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.352 0.7 OUTLIER -122.73 131.93 54.01 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.805 0.842 . . . . 0.68000000000000005 113.152 -172.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -127.74 92.74 3.54 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 126.766 2.027 . . . . 0.83999999999999997 111.537 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -111.76 129.31 56.16 Favored 'General case' 0 C--O 1.251 1.147 0 O-C-N 117.457 -3.277 . . . . 0.82999999999999996 107.724 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.82 173.42 16.0 Favored 'General case' 0 N--CA 1.406 -2.653 0 O-C-N 119.916 -1.74 . . . . 0.57999999999999996 110.526 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 133.29 55.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.202 1.801 . . . . 0.28999999999999998 109.778 173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.22 139.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.131 1.332 . . . . 0.85999999999999999 113.401 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.02 82.57 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 114.777 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -110.46 139.81 45.32 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 130.899 3.68 . . . . 1.54 108.513 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -99.49 153.95 18.62 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.044 -1.889 . . . . 0.62 115.021 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.6 p 73.12 -7.01 1.59 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 119.694 3.22 . . . . 1.3 119.694 166.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.0 31.72 2.32 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.944 1.247 . . . . 0.97999999999999998 113.415 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.33 134.8 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.437 -1.415 . . . . 0.29999999999999999 110.588 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -120.19 147.82 44.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.432 1.093 . . . . 1.96 111.191 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.607 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 72.0 p -76.68 -174.95 3.18 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 131.173 3.789 . . . . 0.47999999999999998 118.662 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.4 tpp -66.52 -50.75 62.18 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 118.236 -2.79 . . . . 1.1100000000000001 112.65 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.66 -14.27 67.07 Favored Glycine 0 CA--C 1.568 3.397 0 N-CA-C 109.141 -1.583 . . . . 0.72999999999999998 109.141 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.06 22.97 18.66 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 127.198 2.332 . . . . 0.63 113.41 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -84.43 122.88 29.59 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.718 2.259 . . . . 1.76 108.873 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.53 126.18 26.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.872 1.064 . . . . 0.54000000000000004 113.872 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 73' ' ' THR 0.397 0.0 OUTLIER -127.0 156.71 41.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 117.161 2.282 . . . . 0.34999999999999998 117.161 164.979 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.26 61.22 4.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.523 1.929 . . . . 1.96 114.446 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.5 152.99 18.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.194 -0.908 . . . . 0.25 111.274 171.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.7 m -102.07 115.81 31.34 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.556 0.743 . . . . 0.28000000000000003 109.253 150.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.52 129.43 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 C-N-CA 125.353 1.461 . . . . 0.17999999999999999 109.039 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -106.77 167.45 9.86 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.49 -1.381 . . . . 0.52000000000000002 108.712 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttt -127.2 100.04 5.92 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.101 -0.999 . . . . 0.23000000000000001 110.297 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.45 87.31 6.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 123.279 1.514 . . . . 1.53 112.279 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.74 -72.9 0.65 Allowed Glycine 1 C--O 1.155 -4.797 0 C-N-CA 127.707 2.575 . . . . 1.05 113.612 -174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.77 0.12 6.7 Favored Glycine 0 C--O 1.284 3.281 0 O-C-N 118.615 -2.697 . . . . 0.35999999999999999 110.308 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -108.01 120.87 43.55 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 113.293 0.849 . . . . 2.7000000000000002 113.293 -164.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -89.77 130.52 36.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.505 1.048 . . . . 0.23000000000000001 110.277 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.05 147.88 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.085 0.554 . . . . 0.23000000000000001 112.023 -155.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.64 164.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.549 1.54 . . . . 0.65000000000000002 108.904 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -144.88 136.18 25.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.373 1.869 . . . . 1.8899999999999999 108.336 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -128.05 179.03 1.36 Allowed Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 129.959 3.303 . . . . 0.26000000000000001 110.213 164.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -58.59 -21.19 53.84 Favored 'Trans proline' 0 CA--C 1.552 1.391 0 N-CA-C 117.578 2.107 . . . . 0.46000000000000002 117.578 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -135.23 1.39 2.93 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 116.982 -1.485 . . . . 1.8899999999999999 113.958 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 21' ' ' LEU . 93.6 t80 -135.83 134.26 38.69 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 121.449 1.931 . . . . 0.26000000000000001 107.683 -162.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -155.82 158.2 37.7 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 121.849 2.113 . . . . 0.35999999999999999 111.579 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.495 ' CD ' H112 ' A' ' 202' ' ' CHO . 9.2 pt20 -158.95 177.29 11.31 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.682 1.128 . . . . 1.48 111.739 157.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.72 129.77 14.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 103.279 -2.86 . . . . 0.40000000000000002 103.279 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.9 m -136.98 126.87 25.74 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-O 118.169 -0.92 . . . . 1.24 110.804 -164.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -146.3 153.61 40.74 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 123.876 3.034 . . . . 1.6699999999999999 116.592 -169.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.47 142.43 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.164 -1.585 . . . . 0.28000000000000003 110.246 168.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.17 100.41 6.74 Favored 'Isoleucine or valine' 0 C--O 1.296 3.508 0 CA-C-O 123.151 1.453 . . . . 0.59999999999999998 108.474 157.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 55.64 -112.37 3.04 Favored Glycine 0 CA--C 1.474 -2.504 0 CA-C-O 113.803 -3.776 . . . . 0.68000000000000005 115.265 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.9 -2.34 57.75 Favored 'General case' 0 CA--C 1.592 2.571 0 O-C-N 126.771 2.101 . . . . 2.2999999999999998 112.407 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -109.77 170.93 7.75 Favored 'General case' 0 CA--C 1.449 -2.926 0 CA-C-O 126.154 2.883 . . . . 2.27 108.733 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.804 HD21 ' H37' ' A' ' 201' ' ' GCH . 8.0 tp -151.71 108.7 3.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.954 -1.93 . . . . 0.59999999999999998 108.678 -154.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.18 121.96 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.961 1.704 . . . . 0.87 110.735 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -101.61 142.54 32.81 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.928 1.691 . . . . 2.0699999999999998 110.561 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.18 114.13 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.005 1.384 . . . . 0.27000000000000002 112.531 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -126.78 163.02 24.48 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 125.253 1.421 . . . . 0.87 110.324 -168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.5 m -146.32 117.69 7.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 120.912 -1.118 . . . . 0.26000000000000001 108.157 -169.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -129.14 113.97 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.636 -1.246 . . . . 0.27000000000000002 107.636 178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.65 26.99 72.99 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 126.486 1.993 . . . . 0.28999999999999998 112.34 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.83 -10.09 74.48 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.036 -1.424 . . . . 0.20999999999999999 113.213 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.278 3.4 p -97.7 134.6 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.997 2.899 . . . . 0.17000000000000001 114.171 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 m -98.23 139.95 33.25 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 118.51 2.781 . . . . 0.27000000000000002 118.51 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -105.88 140.61 38.63 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 102.774 -3.047 . . . . 0.59999999999999998 102.774 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -154.77 124.9 6.74 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 106.225 -1.768 . . . . 0.88 106.225 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -162.86 174.27 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 121.58 1.991 . . . . 6.0899999999999999 116.249 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.58 140.16 48.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 122.222 1.011 . . . . 0.89000000000000001 113.123 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.6 m -115.03 164.0 14.79 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.077 2.551 . . . . 1.1299999999999999 110.012 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.42 41.51 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 113.593 0.96 . . . . 1.76 113.593 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 36.8 ptt180 -72.65 155.69 39.75 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.791 0.723 . . . . 2.0600000000000001 112.291 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.4 8.6 0.81 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.135 1.161 . . . . 0.40999999999999998 114.135 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 119.903 1.229 . . . . 30.0 110.906 161.507 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.804 ' H37' HD21 ' A' ' 108' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.747 ' H14' ' CH2' ' A' ' 49' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.092 -1.077 . . . . 1.01 108.092 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.476 ' CG ' ' H12' ' A' ' 201' ' ' GCH . 98.6 m-85 -128.72 9.07 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.047 2.24 . . . . 0.35999999999999999 117.047 -160.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -34.87 125.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.957 2.503 . . . . 0.27000000000000002 113.462 172.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.1 -150.67 22.46 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 115.36 -0.836 . . . . 0.46000000000000002 115.071 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 136.49 47.32 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 107.682 -1.229 . . . . 0.72999999999999998 107.682 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -154.02 137.47 15.87 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.642 -1.286 . . . . 0.42999999999999999 108.691 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -117.58 131.02 56.75 Favored 'General case' 0 C--O 1.178 -2.679 0 CA-C-O 125.086 2.374 . . . . 1.98 108.08 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.58 ' HB2' ' H27' ' A' ' 201' ' ' GCH 0.276 16.4 ttt -60.6 140.05 57.56 Favored 'General case' 0 CA--C 1.469 -2.167 0 O-C-N 118.157 -2.84 . . . . 0.96999999999999997 113.946 176.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -147.79 76.12 1.38 Allowed 'General case' 0 C--O 1.252 1.195 0 O-C-N 119.082 -2.262 . . . . 2.75 106.39 152.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 122' ' ' VAL . 6.4 t -159.71 159.86 33.39 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 116.997 -3.564 . . . . 2.52 113.985 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -165.84 80.65 0.29 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 102.612 -3.107 . . . . 1.9199999999999999 102.612 -162.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -118.85 108.25 14.59 Favored 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 120.034 -1.667 . . . . 1.8999999999999999 110.633 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.26 39.93 22.01 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.76 1.288 . . . . 0.23999999999999999 113.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -69.72 -42.82 73.49 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.356 -1.465 . . . . 2.54 114.201 -171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.89 -45.83 92.04 Favored 'General case' 0 CA--C 1.603 2.99 0 CA-C-O 127.061 3.315 . . . . 1.6699999999999999 116.134 -165.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.21 -41.96 56.61 Favored 'General case' 0 CA--C 1.463 -2.388 0 O-C-N 117.497 -3.252 . . . . 1.0 112.406 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.32 -45.54 66.02 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.094 -1.629 . . . . 0.22 109.176 -173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 mmt -68.01 -37.31 81.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 116.981 -1.485 . . . . 1.0600000000000001 111.204 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -62.16 -43.19 99.38 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 116.647 2.091 . . . . 1.8200000000000001 116.647 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -59.47 -42.13 91.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 126.016 2.073 . . . . 0.27000000000000002 112.63 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD23 ' O24' ' A' ' 202' ' ' CHO . 8.9 tp -87.31 -0.16 56.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.005 1.113 . . . . 1.2 114.005 -172.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.82 -6.91 2.95 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 117.719 -1.6 . . . . 0.40000000000000002 115.76 159.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.32 149.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 C-N-CA 114.553 -2.859 . . . . 0.38 110.321 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -108.33 -62.52 1.44 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.485 1.039 . . . . 0.70999999999999996 112.757 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.1 m -108.64 -38.67 5.6 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 124.282 1.992 . . . . 1.04 113.645 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . 0.3 26.0 t0 -51.8 -66.76 0.33 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.298 -1.501 . . . . 1.29 114.723 -153.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 1.6 t -85.76 -19.97 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 115.248 1.573 . . . . 0.57999999999999996 115.248 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.85 -41.7 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.239 1.381 . . . . 0.28000000000000003 111.616 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.61 -28.38 58.85 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 123.857 1.789 . . . . 1.48 111.931 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -72.39 -41.35 66.4 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 118.273 -2.767 . . . . 1.1899999999999999 109.711 175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -46.75 38.21 Favored 'General case' 0 CA--C 1.476 -1.903 0 N-CA-C 113.769 1.025 . . . . 0.40000000000000002 113.769 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -60.15 -39.42 86.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.017 1.735 . . . . 2.3999999999999999 113.975 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.6 -85.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.97 1.419 . . . . 1.0900000000000001 112.441 -173.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -7.09 46.87 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 117.549 2.425 . . . . 2.8399999999999999 117.549 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 49.66 177.1 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 125.449 2.547 . . . . 2.5600000000000001 115.326 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mm -108.44 144.96 16.06 Favored 'Isoleucine or valine' 0 C--O 1.257 1.475 0 O-C-N 117.891 -3.006 . . . . 0.44 110.391 -159.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.86 132.68 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.264 0 C-N-CA 125.836 1.654 . . . . 0.84999999999999998 113.848 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -114.06 140.52 48.4 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 118.874 -2.391 . . . . 0.39000000000000001 115.534 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -123.92 135.16 53.51 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 126.33 1.852 . . . . 1.4099999999999999 109.857 172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.435 HG21 ' H4 ' ' A' ' 201' ' ' GCH . 2.6 t -135.26 146.87 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.839 -1.788 . . . . 0.20000000000000001 113.132 -163.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -142.82 139.13 30.8 Favored 'General case' 0 N--CA 1.528 3.439 0 CA-C-O 118.772 -0.632 . . . . 2.1499999999999999 111.145 160.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 55.7 tt0 -140.96 142.96 34.28 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 118.738 -2.476 . . . . 1.1599999999999999 111.012 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -143.53 92.04 2.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.528 1.632 . . . . 1.6799999999999999 108.435 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.4 -110.71 3.09 Favored Glycine 0 N--CA 1.508 3.476 0 O-C-N 120.37 -1.456 . . . . 1.24 115.559 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.22 -25.15 23.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.075 -1.441 . . . . 1.3700000000000001 111.827 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -81.96 147.74 29.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.644 1.566 . . . . 1.8500000000000001 109.559 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.74 144.76 23.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.889 1.44 . . . . 3.9900000000000002 114.889 -160.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -143.45 129.97 20.11 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.34 -1.475 . . . . 0.28999999999999998 107.737 168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -121.18 134.85 55.22 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.457 1.503 . . . . 0.28999999999999998 107.749 165.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -141.7 126.53 18.14 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.905 1.336 . . . . 1.22 108.067 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -109.82 146.15 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.139 1.776 . . . . 1.5 109.325 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -135.68 115.83 13.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.532 1.133 . . . . 2.21 108.27 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -62.35 151.97 35.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 105.038 -2.208 . . . . 0.83999999999999997 105.038 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -63.88 -18.93 64.68 Favored 'General case' 0 N--CA 1.518 2.928 0 O-C-N 121.788 -0.57 . . . . 2.5699999999999998 110.066 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.71 3.48 63.96 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 117.639 1.816 . . . . 2.4500000000000002 117.639 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.16 33.81 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.628 -2.101 . . . . 1.5600000000000001 116.329 167.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -114.33 145.45 41.78 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.952 1.376 . . . . 1.1699999999999999 111.183 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.2 m -110.72 148.61 31.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.013 1.325 . . . . 0.72999999999999998 110.127 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.68 165.46 24.9 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.998 1.719 . . . . 1.1299999999999999 110.495 155.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 144.12 41.08 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 128.217 2.607 . . . . 0.68000000000000005 109.332 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.6 133.59 51.0 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 114.182 -1.372 . . . . 0.83999999999999997 108.41 162.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -146.88 132.09 18.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 120.96 1.709 . . . . 0.82999999999999996 113.977 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -162.59 161.61 26.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.068 1.347 . . . . 0.57999999999999996 112.752 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.44 130.24 35.85 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.287 1.217 . . . . 0.28999999999999998 114.287 157.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 148.43 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.98 2.173 . . . . 0.85999999999999999 115.195 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 10.99 84.65 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 118.7 0.682 . . . . 0.26000000000000001 113.54 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -127.81 154.19 45.71 Favored 'General case' 0 CA--C 1.473 -1.991 0 C-N-CA 128.83 2.852 . . . . 1.54 104.755 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.12 175.66 5.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.049 -1.887 . . . . 0.62 110.162 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.0 m 66.43 32.54 7.44 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.014 2.227 . . . . 1.3 117.014 163.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -150.71 10.65 0.64 Allowed 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 127.749 2.42 . . . . 0.97999999999999998 106.44 -165.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -109.68 140.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 O-C-N 119.887 -1.758 . . . . 0.29999999999999999 106.529 -162.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -142.4 159.6 41.92 Favored 'General case' 0 C--N 1.378 1.841 0 O-C-N 118.808 -2.432 . . . . 1.96 108.495 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.862 ' HB ' ' C27' ' A' ' 202' ' ' CHO . 36.9 p -93.05 -175.43 3.86 Favored 'General case' 0 C--N 1.379 1.88 0 CA-C-N 111.357 -2.656 . . . . 0.47999999999999998 111.925 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.64 -34.0 74.97 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 118.096 -2.878 . . . . 1.1100000000000001 113.1 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.81 -10.97 84.45 Favored Glycine 0 CA--C 1.458 -3.491 0 N-CA-C 107.467 -2.253 . . . . 0.72999999999999998 107.467 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.66 65.12 Favored Glycine 0 N--CA 1.491 2.309 0 CA-C-N 121.049 2.424 . . . . 0.63 117.659 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.02 131.53 46.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.741 1.771 . . . . 1.76 109.507 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.0 m -77.6 146.54 36.14 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.129 1.331 . . . . 0.54000000000000004 108.865 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -140.31 162.04 36.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.298 0.954 . . . . 0.34999999999999998 111.93 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -99.14 85.2 3.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.145 -0.972 . . . . 1.96 112.511 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.54 142.75 51.43 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 125.085 1.354 . . . . 0.25 109.807 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.5 m -95.18 116.43 28.72 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-N 115.367 -0.833 . . . . 0.28000000000000003 112.353 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.8 131.76 34.05 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 O-C-N 121.034 -1.041 . . . . 0.17999999999999999 109.039 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 3.3 pt20 -118.64 163.41 16.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.202 -1.561 . . . . 0.52000000000000002 109.992 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 60.1 mtp -117.28 80.5 1.5 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.878 2.071 . . . . 0.23000000000000001 113.759 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -72.52 98.05 2.22 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.326 -0.859 . . . . 1.53 110.96 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.59 34.86 90.21 Favored Glycine 0 CA--C 1.542 1.725 0 O-C-N 120.212 -1.555 . . . . 1.05 114.994 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.83 -5.52 74.86 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.578 1.561 . . . . 0.35999999999999999 115.492 -170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -93.4 114.55 26.98 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.698 1.999 . . . . 2.7000000000000002 108.171 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 3.1 mt -76.59 151.63 36.2 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 125.129 1.518 . . . . 0.23000000000000001 109.61 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.74 145.29 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 129.991 3.316 . . . . 0.23000000000000001 111.182 -165.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -127.14 158.45 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 119.002 -2.311 . . . . 0.65000000000000002 108.943 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -136.52 139.28 42.13 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.702 -2.332 . . . . 1.8899999999999999 104.702 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -155.98 165.05 19.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 102.974 -2.973 . . . . 0.26000000000000001 102.974 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -54.98 -30.78 71.21 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.111 2.541 . . . . 0.46000000000000002 116.292 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -112.91 -0.99 14.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 116.096 -1.907 . . . . 1.8899999999999999 112.848 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -140.34 143.15 35.63 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 122.115 2.234 . . . . 0.27000000000000002 116.148 -160.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -141.72 149.75 40.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.689 1.596 . . . . 0.35999999999999999 108.41 169.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.484 ' CG ' ' HB3' ' A' ' 112' ' ' SER . 1.6 tm0? -142.65 162.44 35.45 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.837 0.855 . . . . 1.48 109.276 168.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.77 144.16 26.85 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.532 1.145 . . . . 0.40000000000000002 108.163 161.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 m -122.62 146.97 46.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.661 1.984 . . . . 1.24 113.872 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.96 158.32 30.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.566 2.432 . . . . 1.6699999999999999 117.566 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 108' ' ' LEU . 4.6 mt -93.7 134.27 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.894 0 C-N-CA 127.246 2.218 . . . . 0.28000000000000003 107.622 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.27 80.13 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.967 1.707 . . . . 0.59999999999999998 109.822 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.19 -103.19 0.89 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.379 0.99 . . . . 0.68000000000000005 112.116 -172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.63 -7.37 20.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.533 1.679 . . . . 2.2999999999999998 115.533 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' C ' HD22 ' A' ' 108' ' ' LEU . 14.6 mmmm -100.59 149.58 23.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.803 1.641 . . . . 2.27 109.411 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' H15' ' A' ' 201' ' ' GCH 0.266 3.8 mm? -125.34 128.4 48.14 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.104 -2.184 . . . . 0.59999999999999998 105.104 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.99 139.25 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 C-N-CA 125.627 1.571 . . . . 0.87 110.873 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -146.82 128.19 14.9 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 120.516 -1.365 . . . . 2.0699999999999998 110.034 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -131.65 128.94 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.19 -0.914 . . . . 0.27000000000000002 109.037 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' A' ' 99' ' ' GLN . 28.4 p -141.35 161.25 38.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.793 1.179 . . . . 0.87 112.688 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.4 m -136.35 115.88 12.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.307 1.043 . . . . 0.26000000000000001 109.072 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.68 124.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.406 -0.961 . . . . 0.27000000000000002 108.406 166.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.39 0.12 77.23 Favored Glycine 0 N--CA 1.485 1.934 0 O-C-N 120.223 -1.548 . . . . 0.28999999999999998 111.825 162.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.72 9.74 54.11 Favored Glycine 0 CA--C 1.469 -2.81 0 C-N-CA 127.25 2.357 . . . . 0.20999999999999999 114.073 -167.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.261 0.3 OUTLIER -112.04 139.31 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 118.041 -3.035 . . . . 0.17000000000000001 113.118 172.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.6 m -117.21 133.18 56.29 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 128.196 2.598 . . . . 0.27000000000000002 115.524 -154.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -119.71 153.07 36.17 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 127.416 2.286 . . . . 0.59999999999999998 108.378 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.68 145.79 31.91 Favored 'General case' 0 C--O 1.265 1.884 0 C-N-CA 125.96 1.704 . . . . 0.88 108.034 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.642 ' HD3' ' H26' ' A' ' 201' ' ' GCH . 6.4 ptp180 -135.78 165.55 25.33 Favored 'General case' 0 C--O 1.271 2.22 0 N-CA-C 107.111 -1.44 . . . . 6.0899999999999999 107.111 164.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' A' ' 10' ' ' SER . 8.6 p -142.22 155.23 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.019 2.128 . . . . 0.89000000000000001 111.019 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.109 ' CB ' ' H32' ' A' ' 201' ' ' GCH . 3.4 t -159.76 158.89 32.05 Favored 'General case' 0 N--CA 1.391 -3.38 0 C-N-CA 125.646 1.579 . . . . 1.1299999999999999 112.498 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -118.87 140.08 50.57 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 126.069 2.106 . . . . 1.76 108.562 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 155.49 22.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.273 1.029 . . . . 2.0600000000000001 112.14 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.08 19.29 0.43 Allowed 'General case' 0 C--O 1.287 3.048 0 C-N-CA 120.171 -0.612 . . . . 0.40999999999999998 110.735 169.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.583 2.236 0 O-C-N 118.314 -2.741 . . . . 30.0 109.624 163.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 1.109 ' H32' ' CB ' ' A' ' 123' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.862 ' C27' ' HB ' ' A' ' 73' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_